<SEC-DOCUMENT>0001821268-25-000251.txt : 20251124
<SEC-HEADER>0001821268-25-000251.hdr.sgml : 20251124
<ACCEPTANCE-DATETIME>20251121213107
ACCESSION NUMBER:		0001821268-25-000251
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251124
DATE AS OF CHANGE:		20251121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		CENTRAL INDEX KEY:			0001380936
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291739
		FILM NUMBER:		251509435

	BUSINESS ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLAYMORE/GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore/Guggenheim Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20070605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20061113
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>gug89339-424b5.htm
<DESCRIPTION>GOF
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:GOF="http://guggenheiminvestments.com/20251128">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_CEF%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_GOF_guggenheiminvestments.com_20251128 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251121_20251121 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0001380936 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000004" name="dei:EntityCentralIndexKey">0001380936</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="xdx2ixbrl0010" name="dei:DocumentType">424B5</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gof-20251128.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-11-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-012025-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-01</xbrli:startDate>
        <xbrli:endDate>2025-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-012025-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-01</xbrli:startDate>
        <xbrli:endDate>2025-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-012025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_PrincipalRisksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:PrincipalRisksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:MarketDiscountAndPriceVolatilityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:DebtOverlayStrategyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:SyntheticAutocallableELNStrategyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000027"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000027 Footnote000028"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000030"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000031 Footnote000032"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000031 Footnote000033"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000031 Footnote000034"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000031 Footnote000035"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000031 Footnote000037"/>
  <ix:relationship fromRefs="Fact000040" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000041" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000042" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000043" toRefs="Footnote000044"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: right"><b>Filed Pursuant to Rule <span id="xdx_906_edei--DocumentType_dxL_c20251121__20251121_zQW4wO7uDaA5" title="::XDX::424B5"><span style="-sec-ix-hidden: xdx2ixbrl0010">424</span></span>(b)(5)<br/>
Securities Act File No. 333-291739</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: right"><b>Investment Company Act File No. 811-21982</b></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"></span><img src="guggenheimlogonew2.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">&#160;</p>

<p id="xdx_984_edei--AmendmentFlag_dbF_c20251121__20251121_zTRAOG19wD4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><b><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000011" name="dei:AmendmentFlag">PROSPECTUS SUPPLEMENT<br/>
(to Prospectus dated November 21, 2025)</ix:nonNumeric></b></p>

<p id="xdx_988_edei--EntityRegistrantName_c20251121__20251121_ztQuqY7Gv6N8" style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000012" name="dei:EntityRegistrantName">GUGGENHEIM STRATEGIC OPPORTUNITIES FUND</ix:nonNumeric></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b>Common Shares of Beneficial Interests</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b>Having an Aggregate Initial Offering Price
of Up to $1,000,000,000</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Guggenheim
Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s investment
objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based
investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities
that deviate from their perceived fair value and/or historical norms. The Fund&#8217;s sub-adviser seeks to combine a credit-managed fixed-income
portfolio with access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is
predicated upon the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform
benchmark indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes. The Fund
cannot ensure investors that it will achieve its investment objective.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
Fund seeks to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities
(&#8220;Income Securities&#8221;) selected from a variety of sectors and credit qualities, including, but not limited to, corporate bonds,
loans and loan participations, structured finance investments, U.S. government and agency securities and sovereign or supranational debt
obligations, mezzanine and preferred securities and convertible securities, and in common stocks, limited liability company interests,
trust certificates and other equity investments (&#8220;Common Equity Securities&#8221;) that the Fund&#8217;s sub-adviser believes offer
attractive yield and/or capital appreciation potential, including employing a strategy of writing (selling) covered call options and may,
from time to time, buy or sell put options on individual Common Equity Securities and, to a lesser extent, on indices of securities and
sectors of securities. The Fund may also invest in asset-backed securities (&#8220;ABS&#8221;) and mortgage-related securities. These
securities may include complex instruments, such as collateralized mortgage obligations, real estate investment trusts (&#8220;REITs&#8221;)
(including debt and preferred stock issued by REITs), and other real estate-related securities.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
Fund has entered into a Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated July 1, 2019, as amended by First Amendment to
Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering<sup>SM
</sup>Sales Agreement, dated September 16, 2021, Third Amendment to Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated March
27, 2023, Fourth Amendment to Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated May 3, 2024 (as amended the &#8220;Sales
Agreement&#8221;) and Fifth Amendment to Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated November 21, 2025, by and among
the Fund, the Fund&#8217;s investment adviser, Guggenheim Funds Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;), and Cantor
Fitzgerald &amp; Co. (&#8220;Cantor Fitzgerald&#8221;) relating to the Fund&#8217;s common shares of beneficial interest, par value $0.01
per share (the &#8220;Common Shares&#8221;), offered by this Prospectus Supplement and the accompanying Prospectus. In accordance with
the terms of the Sales Agreement, the Fund may offer and sell Common Shares having an aggregate initial offering price of up to $1,000,000,000,
from time to time, through Cantor Fitzgerald as agent for the Fund for the offer and sale of the Common Shares.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Cantor
Fitzgerald will be entitled to compensation of up to 2.00% of the gross proceeds of the sale of any Common Shares under the Sales Agreement,
with the exact amount of such compensation to be mutually agreed upon by the Fund and Cantor Fitzgerald from time to time. In connection
with the sale of the Common Shares on behalf of the Fund, Cantor Fitzgerald may be deemed to be an &#8220;underwriter&#8221; within the
meaning of the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), and the compensation of Cantor Fitzgerald may be deemed
to be underwriting commissions or discounts.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Sales
of the Common Shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions
or by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">defined in Rule 415(a)(4) under the 1933 Act. The Fund or the
Fund and Cantor Fitzgerald will determine whether any sales of the Common Shares will be authorized on a particular day.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
Fund&#8217;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus Supplement and the accompanying
Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221;
At the close of business on November 14, 2025, the net asset value per share of the Fund&#8217;s Common Shares was $11.38 and the last
reported sale price for the Fund&#8217;s Common Shares on the NYSE on such date was $12.91 per share, representing a premium to net asset
value of 13.44%. To the extent that the market price per Common Share, less any distributing commission or discount, is less than the
then current net asset value per Common Share on any given day, the Fund will instruct Cantor Fitzgerald not to make any sales on such
day.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">This
Prospectus Supplement, together with the accompanying Prospectus, dated November 21, 2025, sets forth concisely the information that you
should know before investing in the Fund&#8217;s Common Shares. You should read this Prospectus Supplement and the accompanying Prospectus
(and documents incorporated by reference herein or therein), which contain important information about the Fund, before deciding whether
to invest in the Common Shares of the Fund, and you should retain these documents for future reference. A Statement of Additional Information, dated November 21, 2025
(the &#8220;SAI&#8221;), as supplemented from time to time, containing additional information about the Fund, has been filed with the
Securities and Exchange Commission (&#8220;SEC&#8221;) and is incorporated by reference in its entirety into this Prospectus Supplement
and the accompanying Prospectus. This Prospectus Supplement, the accompanying Prospectus and the SAI are part of a &#8220;shelf&#8221;
registration statement filed with the SEC. This Prospectus Supplement describes the specific details regarding this offering, including
the method of distribution. If information in this Prospectus Supplement is inconsistent with the accompanying Prospectus or the SAI,
you should rely on this Prospectus Supplement. You may request a free copy of the SAI or request other information about the Fund (including
the Fund&#8217;s annual and semi-annual reports) or make shareholder inquiries by calling (800) 345-7999 or by writing the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago, Illinois 60606, or you
may obtain a copy (and other information regarding the Fund) from the SEC&#8217;s web site (http://www.sec.gov). The information contained
in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus Supplement or the accompanying Prospectus.
Free copies of the Fund&#8217;s reports and the SAI also are available from the Fund&#8217;s website at www.guggenheiminvestments.com/gof.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt"><b>The
Fund&#8217;s Common Shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured
depository institution and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other
government agency. Investors could lose money by investing in the Fund.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Capitalized
terms used herein that are not otherwise defined shall have the meanings assigned to them in the accompanying Prospectus.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.25in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt"><b>Investing
in the Fund&#8217;s Common Shares involves certain risks, including the risks associated with the Fund&#8217;s use of leverage. An investment
in the Fund is subject to investment risk, including the possible loss of the entire principal amount that you invest. See &#8220;Risks&#8221;
beginning on page 31 of the accompanying Prospectus. You should consider carefully these risks together with all of the other information
contained in this Prospectus Supplement and the accompanying Prospectus before making a decision to purchase Common Shares.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this Prospectus Supplement or the accompanying Prospectus is truthful or complete. Any representation to the contrary is a criminal
offense.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.25in"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><img src="cantor.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><span style="font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">This Prospectus Supplement is dated November
21, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">* * *</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">ii</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING
STATEMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">This
Prospectus Supplement, the accompanying Prospectus and the Fund&#8217;s SAI, including documents incorporated by reference herein and
therein, contain &#8220;forward-looking statements.&#8221; These statements describe the Fund&#8217;s plans, strategies and goals, and the Fund's beliefs
and assumptions concerning future economic and other conditions and the outlook for the Fund, based on currently available information.
Forward-looking statements can be identified by words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221;
&#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such
terms. By their nature, all forward- looking statements involve risks and uncertainties and may be expressed differently, and actual results
could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect the Fund&#8217;s
actual results are the performance of the portfolio of securities and other investments held by the Fund, the conditions in the U.S. and
international economies and financial and other markets, the price at which the Fund&#8217;s Common Shares will trade in the public markets
and other factors discussed in the Fund&#8217;s periodic filings with the SEC.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Although
the Fund believes that the expectations expressed in any forward-looking statements are reasonable, actual results could differ materially
from those expressed or implied in any forward-looking statements. The Fund&#8217;s future financial condition and results of operations,
as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed
in the &#8220;Risks&#8221; section of the accompanying Prospectus. You are cautioned not to place undue reliance on these forward- looking
statements. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus
are made as of the date of this Prospectus Supplement or the accompanying Prospectus, as the case may be. Except for the Fund&#8217;s
ongoing obligations under the federal securities laws, the Fund does not intend, and the Fund undertakes no obligation, to update any
forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the
Fund&#8217;s SAI are excluded from the safe harbor protection provided by Section 27A of the 1933 Act.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Currently
known risk factors that could cause actual results to differ materially from the Fund&#8217;s expectations include, but are not limited
to, the factors described in the &#8220;Risks&#8221; section of the accompanying Prospectus. The Fund urges you to review carefully those
sections for a more detailed discussion of the risks of an investment in the Fund&#8217;s Common Shares.</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
    OF CONTENTS</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupSummary">PROSPECTUS SUPPLEMENT SUMMARY</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupSummaryFundExp">SUMMARY OF FUND EXPENSES</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupSummaryCap">CAPITALIZATION</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupUse">USE OF PROCEEDS</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupPlan">PLAN OF DISTRIBUTION</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupLegal">LEGAL MATTERS</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupIncorp">INCORPORATION BY REFERENCE</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ProSupAdditional">ADDITIONAL INFORMATION</a></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">You
should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus
in making your investment decisions. This Prospectus Supplement, which describes the specific terms of this offering, also adds to information
contained in the accompanying Prospectus and the documents incorporated by reference in the Prospectus. Neither the Fund nor Cantor Fitzgerald
has authorized any other person to provide you with different or inconsistent information. If anyone provides you with different or inconsistent
information, you should not rely on it. The Fund and Cantor Fitzgerald take no responsibility for, and can provide no assurance as to
the reliability of, any other information that others may give you. This Prospectus Supplement and the accompanying Prospectus do not
constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction where the offer or sale is not permitted.
You should assume the information appearing in this Prospectus Supplement and in the accompanying Prospectus is accurate only as of the
respective dates on their front covers. The Fund&#8217;s business, financial condition and prospects may have changed since such dates.
The Fund will advise investors of any material changes to the extent required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">iii</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><span id="ProSupSummary"></span><b>PROSPECTUS SUPPLEMENT SUMMARY</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt"><i>This
is only a summary of information contained elsewhere in this Prospectus Supplement and the accompanying Prospectus. This summary does
not contain all of the information that you should consider before investing in the Fund&#8217;s Common Shares. The following summary
is qualified in its entirety by reference to the more detailed information included elsewhere in this Prospectus Supplement and in the
accompanying Prospectus and in the Fund&#8217;s Statement of Additional Information, dated November 21, 2025 (the &#8220;SAI&#8221;).
You should carefully read the more detailed information contained in this Prospectus Supplement and the accompanying Prospectus, dated
November 21, 2025, especially the information set forth under the headings &#8220;Investment Objective and Policies&#8221; and &#8220;Risks&#8221;
prior to making an investment in the Fund. You may also wish to request a copy of the SAI, which contains additional information about
the Fund and is incorporated by reference in its entirety into this Prospectus Supplement and the accompanying Prospectus. Capitalized
terms used herein that are not otherwise defined shall have the meanings assigned to them in the accompanying Prospectus.</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr>
    <td style="padding: 0.75pt; width: 30%">&#160;</td>
    <td style="padding: 0.75pt; width: 70%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Fund</b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company that commenced operations on July 26, 2007. The Fund&#8217;s objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate from their perceived fair value and/or historical norms.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares of beneficial interest, par value $0.01 per share, are called &#8220;Common Shares&#8221; and the holders
of the Common Shares are called &#8220;Common Shareholders&#8221; throughout this Prospectus Supplement and the accompanying Prospectus.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management
of the Fund </b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim
Funds Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;) acts as the Fund&#8217;s investment adviser and is responsible
for the management of the Fund. Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;) is responsible for the
management of the Fund&#8217;s portfolio of securities. Each of the Investment Adviser and the Sub-Adviser are wholly-owned subsidiaries
of Guggenheim Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial services firm with wealth
management, capital markets, investment management and proprietary investing businesses, whose clients are a mix of individuals, family
offices, endowments, investment funds, foundations, insurance companies and other institutions that have entrusted Guggenheim Partners
with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners is headquartered in Chicago and
New York with a global network of offices throughout the United States, Europe, and Asia.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing
and Symbol</b></span> &#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s currently outstanding Common Shares are, and Common Shares offered by this Prospectus Supplement and the accompanying Prospectus
will be, subject to notice of issuance, listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221;
As of the close of business on November 14, 2025, the net asset value per share of the Fund&#8217;s Common Shares was $11.38 and the
last reported sale price for the Fund&#8217;s Common Shares on the NYSE on such date was $12.91 per share, representing a premium to
net asset value of 13.44%.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distributions</b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has paid distributions to Common Shareholders monthly since inception. Payment of future distributions is subject to approval by
the Fund&#8217;s Board of Trustees, as well as meeting the covenants of any outstanding borrowings and the asset coverage requirements
of the</span></td>
</tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">1</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr>
    <td style="padding: 0.75pt; width: 30%">&#160;</td>
    <td style="padding: 0.75pt; width: 70%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s distribution rate is not constant and the amount of distributions, when declared by the Fund&#8217;s Board of Trustees, is subject to change. The Fund expects that distributions paid on Common Shares will generally consist of (i) investment company taxable income expected to be taxed as ordinary income, which includes, among other things, investment income, short-term capital gains and income from certain hedging and interest rate transactions, (ii) long-term capital gains and (iii) return of capital. There is no guarantee of any future distribution or that the current distribution rates will be maintained.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Offering</b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has entered into a Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated July 1, 2019, as amended by First Amendment to
Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering<sup>SM
</sup>Sales Agreement, dated September 16, 2021, Third Amendment to Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated March
27, 2023, Fourth Amendment to Controlled Equity Offering<sup>SM </sup>Sales Agreement, dated May 3, 2024, and Fifth Amendment to Controlled
Equity Offering<sup>SM </sup>Sales Agreement, dated November 21, 2025 (as amended, the &#8220;Sales Agreement&#8221;), by and among the
Fund, the Investment Adviser, and Cantor Fitzgerald &amp; Co. (&#8220;Cantor Fitzgerald&#8221;) relating to the Fund&#8217;s Common Shares
offered by this Prospectus Supplement and the accompanying Prospectus. In accordance with the terms of the Sales Agreement, the Fund
may offer and sell Common Shares having an aggregate initial offering price of up to $1,000,000,000, from time to time, through Cantor
Fitzgerald as agent for the Fund for the offer and sale of the Common Shares.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales of the Common Shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;). See &#8220;Plan of Distribution&#8221; in this Prospectus Supplement.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Shares may not be sold through agents, underwriters
or dealers without delivery or deemed delivery of the Prospectus and this Prospectus Supplement describing the method and terms of the
offering of the Common Shares.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund may not sell Common Shares at a price below the then current net asset value per Common Share, exclusive of any
distributing commission or discount.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks</b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &#8220;Risks&#8221; beginning on page 31 of the accompanying Prospectus for a discussion of factors you should consider carefully before deciding to invest in the Fund&#8217;s Common Shares.</span></p>
                                                                               <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
</tr>
<tr style="vertical-align: bottom">
  <td style="text-align: left; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Proceeds </b></span>&#160;</td>
  <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund intends to invest the net proceeds of the offering in accordance with its investment objective and policies as stated in the accompanying
Prospectus or otherwise invest the net proceeds as follows. It is currently anticipated that the Fund will be able to invest most of
the net proceeds of the offering in accordance with its investment objective and policies within three months after receipt of such proceeds.
Pending such investment, it is anticipated that the proceeds will be invested in U.S. government securities or high</span></td>
</tr>
</table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">2</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt 120pt">quality, short-term money-market securities. The Fund
may also use the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses. A
portion of the cash held by the Fund, including net proceeds of the offering, is usually used to pay distributions in accordance
with the Fund&#8217;s distribution policy and may be a return of capital, which is in effect a partial return of the amount a Common
Shareholder invested in the Fund. Common Shareholders who receive the payment of a distribution consisting of a return of capital
may be under the impression that they are receiving net investment income or profit when they are not. The Fund&#8217;s
distributions may be greater than the Fund&#8217;s net investment income or profit. The offering of Common Shares supports the
Fund&#8217;s asset level and if the Fund does not offer or sell Common Shares, the Fund may not be able to maintain historical
distribution levels for extended periods of time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"><span id="ProSupSummaryFundExp"></span><b>SUMMARY OF FUND EXPENSES</b></p>

<p id="xdx_98F_ecef--PurposeOfFeeTableNoteTextBlock_c20251121__20251121_zp6gCKiK8896" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000013" name="cef:PurposeOfFeeTableNoteTextBlock">The following table contains information about the costs and expenses
that the Common Shareholders will bear directly or indirectly. The table reflects the use of leverage in an amount equal to approximately
16% of the Fund&#8217;s total managed assets, which reflects approximately the percentage of the Fund&#8217;s total managed assets attributable
to leverage as of May 31, 2025 (audited), and shows Fund expenses as a percentage of net assets attributable to Common Shares. The table
and example below are based on the Fund&#8217;s capital structure as of May 31, 2025 (audited) after giving effect to the anticipated
net proceeds of the Common Shares offered pursuant to this Prospectus Supplement and assuming the Fund incurs the estimated offering expenses
described below. The extent of the Fund&#8217;s assets attributable to leverage following an offering, and the Fund&#8217;s associated
expenses, are likely to vary (perhaps significantly) from these assumptions. The purpose of the table and the example below is to help
you understand the fees and expenses that you, as a Common Shareholder, would bear directly or indirectly. The following table should
not be considered a representation of the Fund&#8217;s future expenses. Actual expenses may be greater or less than shown. The following
table shows estimated Fund expenses as a percentage of average net assets attributable to Common Shares, and not as a percentage of managed
assets. See &#8220;Management of the Fund&#8221; in the accompanying Prospectus.</ix:nonNumeric></p>

<ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000015" name="cef:ShareholderTransactionExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_z2y2e9RZ92pd" summary="xdx: Disclosure - ShareholderTransactionExpenses" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 74%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    load (<span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zBWckfJSG7ed"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000016" name="cef:BasisOfTransactionFeesNoteTextBlock">as a percentage of offering price</ix:nonNumeric></span>)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecef--SalesLoadPercent_c20251121__20251121_fKDEp_z6UnYZnJq9zd"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2025-11-21" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.00</ix:nonFraction>%</span><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    expenses borne by the Fund (as a percentage of offering price)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zpKblAGbcg4j"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000018" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.60</ix:nonFraction>%</span><sup>(1),(2)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan fees<sup>(3)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zOjvtsbiRmF3"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2025-11-21" id="Fact000019" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">None</ix:nonFraction></span></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000021" name="cef:AnnualExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88C_ecef--AnnualExpensesTableTextBlock_zeXzA1pV4WUl" summary="xdx: Disclosure - AnnualExpenses" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
    Expenses </b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to Common Shares<sup>(4)</sup></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    fees<sup>(5)</sup></span></td>
    <td style="padding: 0.75pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zemq8N7t62We"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2025-11-21" id="Fact000022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.19</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquired
    fund fees and expenses<sup>(6)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____z586YeyWySFh"><ix:nonFraction name="cef:AcquiredFundFeesAndExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000023" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.03</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses<sup>(7)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zcXQCTRKuz81"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2025-11-21" id="Fact000024" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.89</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expenses<sup>(8)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____z0hMJo7ICW95"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000025" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.10</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    annual expenses<sup>(9)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDQpICg5KQ_____ziPkcHmbW9ji"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000026" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.21</ix:nonFraction>%</span></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 0pt; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F0A_zwyDJlpkVtP5">(1)</sup></td><td style="width: 5pt"/><td id="xdx_F1F_ztiXuu5K7woe"><ix:footnote id="Footnote000027" xml:lang="en-US">Represents the estimated commission with respect to Common Shares being sold in this offering.
Cantor Fitzgerald will be entitled to compensation of up to 2.00% of the gross proceeds of the sale of any Common Shares under the Sales
Agreement, with the exact amount of such compensation to be mutually agreed upon by the Fund and Cantor Fitzgerald from time to time.
The Fund has assumed that Cantor Fitzgerald will receive a commission of 2.00% of the gross sale price of the Common Shares sold in this
offering.</ix:footnote></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F03_z4rnFH2hD2ce">(2)</sup></td><td style="width: 5pt"/><td id="xdx_F1E_zw9PABKrezQk"><span id="xdx_90B_ecef--OtherTransactionFeesNoteTextBlock_c20251121__20251121_zwEpCZU5UJo6"><ix:footnote id="Footnote000028" xml:lang="en-US"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000029" name="cef:OtherTransactionFeesNoteTextBlock">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s
registration statement and any offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under
such registration statement, to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s
behalf in an amount up to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common
Shares sold in such offerings. Amounts in excess of 0.60% of the total offering price of shares sold pursuant to the registration statement
will not be subject to recoupment from the Fund. This agreement will be in effect for the life of the registration statement with respect
to all Common Shares sold pursuant to the registration statement and may only be terminated by the Board of Trustees of the Fund.</ix:nonNumeric></ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">3</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 3pt 20pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F08_z671VnaDUmC6">(3)</sup></td><td style="width: 5pt"/><td id="xdx_F15_z2WjKYzWVIsi"><ix:footnote id="Footnote000030" xml:lang="en-US">You will pay brokerage charges if you direct the Plan Agent to sell your Common Shares held
in a dividend reinvestment account. See &#8220;Dividend Reinvestment Plan&#8221; in the accompanying Prospectus.</ix:footnote></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F0C_zmJB2baDvvJg">(4)</sup></td><td style="width: 5pt"/><td id="xdx_F14_zXbVf16whC6k"><ix:footnote id="Footnote000031" xml:lang="en-US">Based upon average net assets attributable to Common Shares during the fiscal year ended
May 31, 2025, after giving effect to the anticipated net proceeds of all of the Common Shares offered by this Prospectus Supplement based
on an assumed price per share of $12.91 (the last reported sale price of the Fund&#8217;s Common Shares on the NYSE as of November 14,
2025). The price per share of any sale of the Common Shares may be greater or less than the price assumed herein, depending on the market
price of the Common Shares at the time of any sale. There is no guarantee that there will be any sales of the Common Shares pursuant
to this Prospectus Supplement. The number of the Common Shares actually sold pursuant to this Prospectus Supplement may be less than
as assumed herein.</ix:footnote></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F0D_zf25wuzrHLc2">(5)</sup></td><td style="width: 5pt"/><td id="xdx_F1A_zj1Y1zXYLqOa"><ix:footnote id="Footnote000032" xml:lang="en-US">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to
1.00% of the Fund&#8217;s average daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable
to the assets purchased with the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other
forms of debt (&#8220;Borrowings&#8221;) or reverse repurchase agreements, dollar rolls or similar transactions or through a combination
of the foregoing (collectively &#8220;Financial Leverage&#8221;), which means that Common Shareholders effectively bear the entire advisory
fee. Because the management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#8217;s Managed Assets, the
management fee as a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial
Leverage. If Financial Leverage of more than 16% of the Fund&#8217;s Managed Assets is used, the management fee shown would be higher.</ix:footnote></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F0E_zdmZuPKX1Ar4">(6)</sup></td><td style="width: 5pt"/><td id="xdx_F16_zXl9OlACXCp9"><ix:footnote id="Footnote000033" xml:lang="en-US">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the
Fund as an investor in other investment companies during the fiscal year ended May 31, 2025.</ix:footnote></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F04_zD0MNQT2KLZb">(7)</sup></td><td style="width: 5pt"/><td id="xdx_F1C_zOL0Nt31wtw7"><ix:footnote id="Footnote000034" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements.
Interest payments on borrowed funds is estimated based upon the Fund&#8217;s outstanding Borrowings as of May 31, 2025, which included
Borrowings under the Fund&#8217;s committed facility agreement in an amount equal to 2.08% of the Fund&#8217;s Managed Assets, at an
average interest rate of 5.08%. Interest expense on reverse repurchase agreements is estimated based on the Fund&#8217;s outstanding
reverse repurchase agreements as of May 31, 2025, which included leverage in the form of reverse repurchase agreements in an amount equal
to 13.77% of the Fund&#8217;s Managed Assets, at a weighted average interest rate cost to the Fund of 4.52%. The  actual amount of interest payments and expenses borne by the Fund will vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</ix:footnote></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F09_zImBxTNJiZha">(8)</sup></td><td style="width: 5pt"/><td id="xdx_F19_z8kmQNxzemI"><span id="xdx_905_ecef--OtherExpensesNoteTextBlock_c20251121__20251121_zbsHN5jTgM0k"><ix:footnote id="Footnote000035" xml:lang="en-US"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000036" name="cef:OtherExpensesNoteTextBlock">Other expenses are based on estimated amounts for the current fiscal year.</ix:nonNumeric></ix:footnote></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: left"><sup id="xdx_F04_zjly9odZooPl">(9)</sup></td><td style="width: 5pt"/><td id="xdx_F16_z03nPanPfWHl"><ix:footnote id="Footnote000037" xml:lang="en-US">The total annual expenses in this fee table may not correlate to the expense
ratios in the Fund&#8217;s financial highlights and financial statements because the financial highlights and financial statements reflect
only the operating expenses of the Fund and do not include Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly
by the Fund through its investments in certain underlying investment companies.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center">4</p>


<!-- Field: Page; Sequence: 7 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><b>Example</b></p>
<div id="xdx_88C_ecef--ExpenseExampleTableTextBlock_zLcPVCEHGwfe"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000039" name="cef:ExpenseExampleTableTextBlock">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">As required by relevant SEC regulations, the following Example
illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual expenses&#8221;
of 2.21% of net assets attributable to Common Shares and (2) the sales load of $20 and estimated offering expenses of $6, and (3) a 5%
annual return*:</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Annual Expense Paid by Common Shareholders </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zKFxI2H6dFx3">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2025-11-21" id="Fact000040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48</ix:nonFraction></span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zEtVxhsAwuB4">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2025-11-21" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93</ix:nonFraction></span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_z6C2CQU7Bgth">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2025-11-21" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">141</ix:nonFraction></span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3XobfVXfa05">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2025-11-21" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">274</ix:nonFraction></span></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 15pt; text-align: right">*</td><td style="width: 5pt"/><td><b>The Example should not be considered a representation of future expenses or returns. Actual
expenses may be higher or lower than those assumed. Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the
hypothetical 5% return shown in the Example. The Example assumes that all dividends and distributions are reinvested at net asset value.
</b>See &#8220;Distributions&#8221; and &#8220;Dividend Reinvestment Plan&#8221; in the accompanying Prospectus.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt 20pt">The above table and Example and the assumption in the Example
of the 5% annual return are required by the regulations of the SEC. The assumed 5% annual return is not a prediction of, and does not
represent, the projected or actual performance of the Fund&#8217;s Common Shares. For more complete descriptions of certain of the Fund&#8217;s
costs and expenses, see &#8220;Management of the Fund&#8221; in the accompanying Prospectus. The Example assumes that the estimated &#8220;Other
expenses&#8221; set forth in the table are accurate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b><span id="ProSupSummaryCap"></span>CAPITALIZATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">In
accordance with the terms of the Sales Agreement, the Fund may offer and sell Common Shares having an aggregate initial offering price
of up to $1,000,000,000, from time to time, through Cantor Fitzgerald as the Fund&#8217;s agent for the offer and sale of the Common Shares.
The price per share of any of the Common Shares sold hereunder may be greater or less than the price of $12.91 per share (the last reported
sale price for the Fund&#8217;s Common Shares on the NYSE as of November 14, 2025) assumed herein, depending on the market price of the
Common Shares at the time of such sale. Furthermore, there is no guarantee that the Fund will sell all of the Common Shares available
for sale hereunder or that there will be any sales of the Common Shares hereunder. To the extent that the market price per Common Share,
less any distributing commission or discount, is less than the then current net asset value per Common Share on any given day, the Fund
will instruct Cantor Fitzgerald not to make any sales on such day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt 20pt">The following table sets forth the Fund&#8217;s capitalization:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 40pt; text-align: center">(i)</td><td style="width: 5pt"/><td>on a historical basis as of May 31, 2025 (audited);</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 40pt; text-align: center">(ii)</td><td style="width: 5pt"/><td>on an as adjusted basis, as of November 14, 2025 (unaudited), to reflect the issuance of
an aggregate of 1,557,285 Common Shares pursuant to the Fund&#8217;s Automatic Dividend Reinvestment Plan, and the application of the
net proceeds from such issuances of the Common Shares; and the issuance and sale of 21,933,075 Common Shares issued and sold after May
31, 2025, but prior to the date of this Prospectus Supplement (less the commission paid and offering expenses payable by the Fund in
connection with the issuance and sale of such Common Shares); and a decrease in Borrowings of $45,800,000 and a decrease in reverse repurchase
agreements of $63,781,715; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 40pt; text-align: center">(iii)</td><td style="width: 5pt"/><td>on an as further adjusted basis (unaudited) to reflect the assumed sale of 77,459,334 Common
Shares at a price of $12.91 per share (the last reported sale price for the Fund&#8217;s Common Shares on the NYSE as of November 14,
2025), in an offering under this Prospectus Supplement and the accompanying Prospectus less the assumed commission of $20,000,000 (representing
an estimated commission paid to Cantor Fitzgerald of 2.00% of the gross proceeds of the sale of the Common Shares effected by Cantor
Fitzgerald in this offering) and estimated offering expenses payable by the Fund of $6,000,000.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">5</p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 9in">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actual
    as of</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    Adjusted as of</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    Further</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>May
    31, 2025</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>November
    14, 2025</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(audited)</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-Term
    Debt:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings
    and Reverse Repurchase Agreements</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$378,321,024</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$268,739,309</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$268,739,309</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Shareholder&#8217;s Equity:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    shares of beneficial interest, par value $0.01 per share;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlimited
    shares authorized, 175,777,487 shares issued and</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
    (actual as of May 31, 2025), 199,267,847 shares issued</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    outstanding (as adjusted), and 276,727,181 shares issued and</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
    (as further adjusted)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,757,775</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,992,678</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,767,272</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,129,139,431</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,462,231,253</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,435,456,659</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    distributable earnings (loss)</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$(122,081,376)</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$(122,081,376)</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$(122,081,376)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    assets</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,008,815,830</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,342,142,555</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,316,142,555</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><span id="ProSupUse"></span><b>USE OF PROCEEDS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Sales
of the Common Shares, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions
or by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the 1933 Act.
Assuming the sale of $1,000,000,000 of the Common Shares under this Prospectus Supplement and the accompanying Prospectus, the net proceeds
to the Fund from this offering will be approximately $974,000,000, after deducting the estimated commission and estimated offering expenses.
There is no guarantee that there will be any sales of the Common Shares pursuant to the Prospectus Supplement. The price per share of
any Common Share sold hereunder may be greater or less than the price assumed herein, depending on the market price of the Common Shares
at the time of such sale.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Furthermore,
there is no guarantee that the Fund will sell all of the Common Shares available for sale hereunder or that there will be any sales of
the Common Shares hereunder. To the extent that the market price per Common Share, less any distributing commission or discount, is less
than the then current net asset value per Common Share on any given day, the Fund will instruct Cantor Fitzgerald not to make any sales
on such day. As a result, the proceeds received by the Fund may be less than the amount of net proceeds estimated in this Prospectus Supplement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
Fund intends to invest the net proceeds of the offering in accordance with its investment objective and policies as stated in the accompanying
Prospectus or otherwise invest the net proceeds as follows. It is currently anticipated that the Fund will be able to invest most of the
net proceeds of the offering in accordance with its investment objective and policies within three months after the receipt of such proceeds.
Pending such investment, it is anticipated that the proceeds will be invested in U.S. government securities or high quality, short-term
money-market securities. The Fund may also use the proceeds for working capital purposes, including the payment of distributions, interest
and operating expenses. A portion of the cash held by the Fund, including net proceeds of the offering, is usually used to pay distributions
in accordance with the Fund&#8217;s distribution policy and may be a return of capital, which is in effect a partial return of the amount
a Common Shareholder invested in the Fund. Common Shareholders who receive the payment of a distribution consisting of a return of capital
may be under the impression that they are receiving net investment income or profit when they are not. The Fund&#8217;s distributions
may be greater than the Fund&#8217;s net investment income or profit. The offering of Common Shares supports the Fund&#8217;s asset level and if the Fund does not offer or sell Common Shares, the Fund may not
be able to maintain distributions at historical levels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b><span id="ProSupPlan"></span>PLAN OF DISTRIBUTION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Under
the Sales Agreement, upon written instructions from the Fund, Cantor Fitzgerald will use its commercially reasonable efforts consistent
with its sales and trading practices, to solicit offers to purchase Common Shares under the terms and subject to the conditions set forth
in the Sales Agreement. Cantor Fitzgerald&#8217;s solicitation will continue until the Fund instructs Cantor Fitzgerald to suspend the
solicitations and offers. The Fund will instruct Cantor Fitzgerald as to the amount of the Common Shares to be sold by Cantor Fitzgerald.
The Fund may instruct Cantor Fitzgerald not to sell Common Shares if the sales cannot be effected at or above the price designated by
the Fund in any instruction. The Fund or Cantor Fitzgerald may suspend the offering of the Common Shares upon proper notice and subject
to other conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">6</p>


<!-- Field: Page; Sequence: 9 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Cantor
Fitzgerald will provide written confirmation to the Fund not later than the opening of the trading day on the NYSE following any trading
day on which Common Shares are sold under the Sales Agreement. Each confirmation will include the number of the Common Shares sold on
the preceding day, the net proceeds to the Fund and the compensation payable by the Fund to Cantor Fitzgerald in connection with the sales.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
Fund will pay Cantor Fitzgerald commissions for its services in acting as agent for the sale of the Common Shares. Cantor Fitzgerald will
be entitled to compensation of up to 2.00% of the gross proceeds of the sale of any Common Shares under the Sales Agreement, with the
exact amount of such compensation to be mutually agreed upon by the Fund and Cantor Fitzgerald from time to time. There is no guarantee
that there will be any sales of the Common Shares pursuant to this Prospectus Supplement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Settlement
for sales of the Common Shares will occur on the first trading day following the
date on which such sales are made, or on some other date that is agreed upon by the Fund and Cantor Fitzgerald in connection with a particular
transaction, in return for payment of the net proceeds to the Fund. There is no arrangement for funds to be deposited in escrow, trust
or similar arrangement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">In
connection with the sale of the Common Shares on behalf of the Fund, Cantor Fitzgerald may be deemed to be an &#8220;underwriter&#8221;
within the meaning of the 1933 Act, and the compensation paid to Cantor Fitzgerald may be deemed to be underwriting commissions or discounts.
The Fund and the Investment Adviser have agreed to provide indemnification and contribution to Cantor Fitzgerald against certain civil
liabilities, including liabilities under the 1933 Act. The Fund and the Investment Adviser have also agreed to reimburse Cantor Fitzgerald
for other specified expenses.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
offering of the Common Shares pursuant to the Sales Agreement will terminate upon the earlier of (1) the sale of all Common Shares subject
to the Sales Agreement or (2) the termination of the Sales Agreement. The Sales Agreement may be terminated by the Fund in its sole discretion
at any time by giving 10 days&#8217; notice to Cantor Fitzgerald. The Sales Agreement may be terminated by the Investment Adviser in its
sole discretion in the event the Investment Adviser ceases to act as investment adviser to the Fund. In addition, Cantor Fitzgerald may
terminate the Sales Agreement under the circumstances specified in the Sales Agreement and in its sole discretion at any time following
a period of 30 days from the date of the Sales Agreement by giving 10 days&#8217; notice to the Fund.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Under
the 1940 Act, the Fund may not sell Common Shares at a price below the then current net asset value per Common Share, exclusive of any
distributing commission or discount. To the extent that the market price per Common Share, less any distributing commission or discount,
is less than the then current net asset value per Common Share on any given day, the Fund will instruct Cantor Fitzgerald not to make
any sales on such day.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">In
accordance with the terms of the Sales Agreement, the Fund may offer and sell Common Shares having an aggregate initial offering price
of up to $1,000,000,000, from time to time, through Cantor Fitzgerald as agent for the Fund for the offer and sale of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt 30pt">The principal business address of Cantor Fitzgerald is 499 Park
Avenue, New York, New York 10022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><b><span id="ProSupLegal"></span>LEGAL MATTERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">Certain
legal matters will be passed on by Dechert LLP, Washington, D.C., as counsel to the Fund in connection with the offering of the Common
Shares. Certain legal matters will be passed on by Hunton Andrews Kurth LLP, Houston, Texas, as special counsel to Cantor Fitzgerald in
connection with the offering of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><span id="ProSupIncorp"></span><b>INCORPORATION BY REFERENCE</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">This
Prospectus Supplement is part of a registration statement filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221;
the information filed with the SEC, which means that the Fund can disclose important information to you by referring you to those documents.
The information incorporated by reference is considered to be part of this Prospectus Supplement, and later information that the Fund
files with the SEC will automatically update and supersede this information.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">The
documents listed below, and any reports and other documents subsequently filed with the SEC pursuant to Section 30(b)(2) of the 1940 Act
and Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, prior</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">7</p>


<!-- Field: Page; Sequence: 10 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">to the termination of this offering will be incorporated by reference
into this Prospectus Supplement and deemed to be part of this Prospectus Supplement from the date of the filing of such reports and documents:</p>

<p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 23.5pt"/><td style="width: 15.55pt"><span style="font-family: Verdana, Helvetica, Sans-Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">the
                                            Fund&#8217;s Statement of Additional Information, dated <span style="letter-spacing: -0.1pt">November
                                            21, 2025</span>, filed <span style="letter-spacing: -0.05pt">with the SEC </span>with the
                                            accompanying <span style="letter-spacing: -0.1pt">Prospectus on November 21, 2025</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 8.45pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 23.5pt"/><td style="width: 15.55pt"><span style="font-family: Verdana, Helvetica, Sans-Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">The
                                            <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
                                            annual report on Form N-CSR for the fiscal year ended May 31, 2025</a>, filed with the SEC
                                            on August 4, 2025<span style="letter-spacing: -0.2pt">; and</span></span></td></tr></table>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 8.35pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 23.5pt"/><td style="width: 15.55pt"><span style="font-family: Verdana, Helvetica, Sans-Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-size: 10pt">the
                                            Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1380936/000134100407001955/chi551212.htm">description
                                            of the Common Shares</a> on Form 8-A, filed with the SEC on June 27, <span style="letter-spacing: -0.1pt">2007.</span></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">You
may request a free copy of the information incorporated by reference into this Prospectus Supplement by calling (800) 345-7999 or by writing
to the Investment Adviser at Guggenheim Funds Investment Advisors, LLC, 227 West Monroe Street, Chicago, Illinois 60606, or you may obtain
a copy (and other information regarding the Fund) from the SEC&#8217;s web site (http://www.sec.gov). Free copies of the Fund&#8217;s
reports will also be available from the Fund&#8217;s web site at www.guggenheiminvestments.com/gof. The information contained in, or that
can be accessed through, the Fund&#8217;s website is not part of this Prospectus Supplement, the Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><span id="ProSupAdditional"></span><b>ADDITIONAL INFORMATION</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.25in"><span style="font-size: 12pt">&#160;&#160;&#160;&#160;&#160;</span><span style="font-size: 10pt">This
Prospectus Supplement and the accompanying Prospectus constitute part of a Registration Statement filed by the Fund with the SEC under
the 1933 Act and the 1940 Act. This Prospectus Supplement and the accompanying Prospectus omit certain of the information contained in
the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with
respect to the Fund and Common Shares offered hereby. Any statements contained herein concerning the provisions of any document are not
necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement
or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement,
other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, may be obtained from
the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s web site (http://www.sec.gov),
by calling (800) 345-7999, by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago,
Illinois 60606, or by visiting our website at www.guggenheiminvestments.com.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 12pt">8</p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>&#160;<img src="guggenheimlogonew2.jpg" alt=""/></b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>Guggenheim Strategic Opportunities Fund</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>$1,000,000,000</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>Common Shares<br/>
________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Objective and Philosophy. </i>Guggenheim
Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s investment
objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based
investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities
that deviate from their perceived fair value and/or historical norms. The Fund&#8217;s sub-adviser seeks to combine a credit-managed fixed-income
portfolio with access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is
predicated upon the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform
benchmark indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes. The Fund
cannot ensure investors that it will achieve its investment objective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Portfolio. </i>The Fund seeks to
achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities, including, but not limited to, corporate bonds, loans and
loan participations, structured finance investments, U.S. government and agency securities and sovereign or supranational debt obligations,
mezzanine and preferred securities and convertible securities, and in common stocks, limited liability company interests, trust certificates
and other equity investments (&#8220;Common Equity Securities&#8221;) that the Fund&#8217;s sub-adviser believes offer attractive yield
and/or capital appreciation potential, including employing a strategy of writing (selling) covered call options and may, from time to
time, buy or sell put options on individual Common Equity Securities and, to a lesser extent, on indices of securities and sectors of
securities. The Fund may also invest in asset-backed securities (&#8220;ABS&#8221;) and mortgage-related securities. These securities
may include complex instruments, such as collateralized mortgage obligations, real estate investment trusts (&#8220;REITs&#8221;) (including
debt and preferred stock issued by REITs), and other real estate-related securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offering. </i>The Fund may offer, from time
to time, up to $1,000,000,000 aggregate initial offering price of the Fund&#8217;s common shares of beneficial interest, par value $0.01
per share (&#8220;Common Shares&#8221;), in one or more offerings in amounts, at prices and on terms set forth in one or more supplements
to this Prospectus (each, a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and any related Prospectus Supplement
carefully before you decide to invest in the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer Common Shares (1) directly
to one or more purchasers, (2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers.
The Prospectus Supplement relating to a particular offering of Common Shares will identify any agents or underwriters involved in the
sale of Common Shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and
agents or underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Common Shares
through agents, underwriters or dealers without delivery of this Prospectus and the Prospectus Supplement describing the method and terms
of the offering of Common Shares. See &#8220;Plan of Distribution.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>Investing in the Fund&#8217;s Common Shares
involves certain risks, including the risks associated with the Fund&#8217;s use of leverage. An investment in the Fund is subject to
investment risk, including the possible loss of the entire principal amount that you invest. See &#8220;Risks&#8221; on page 31 of this
Prospectus and the section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Information Regarding
the Fund</b>&#8212;<b>Principal Risks of the Fund,&#8221; which is incorporated by reference herein. You should carefully consider these
risks together with all of the other information contained in this Prospectus before making a decision to purchase the Fund&#8217;s Common
Shares.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">i&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>Neither the Securities and Exchange Commission
(&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Prospectus dated November 21, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Investment Adviser and Sub-Adviser. </i>Guggenheim
Funds Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;) acts as the Fund&#8217;s investment adviser and is responsible for
the management of the Fund. Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;) is responsible for the management
of the Fund&#8217;s portfolio of securities. Each of the Investment Adviser and the Sub-Adviser is a wholly-owned subsidiary of Guggenheim
Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial services firm with wealth management,
capital markets, investment management and proprietary investing businesses, the clients of which are a mix of individuals, family offices,
endowments, investment funds, foundations, insurance companies and other institutions that have entrusted Guggenheim Partners with the
supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners is headquartered in Chicago and New
York with a global network of offices throughout the United States, Europe, and Asia. The Investment Adviser and the Sub-Adviser are referred
to herein collectively as the &#8220;Adviser.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Investment Policies. </i>The Fund may allocate
its assets among a wide variety of Income Securities and Common Equity Securities. The Fund may invest without limitation in below-investment
grade securities (e.g., securities rated below Baa3 by Moody&#8217;s Investors Service, Inc., below BBB- by Standard &amp; Poor&#8217;s
Ratings Group or Fitch Ratings or comparably rated by another nationally recognized statistical rating organization or, if unrated, determined
by the Sub-Adviser to be of comparable quality). Below investment grade securities are commonly referred to as &#8220;high-yield&#8221;
or &#8220;junk&#8221; bonds and are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal.
The Fund&#8217;s investments in any of the sectors and types of Income Securities in which the Fund may invest may include, without limitation,
below-investment grade securities. Under normal market conditions, the Fund will not invest more than: 50% of its total assets in Common
Equity Securities consisting of common stock; 30% of its total assets in other investment companies, including registered investment companies,
private investment funds and/or other pooled investment vehicles; 20% of its total assets in non-U.S. dollar-denominated Income Securities
of corporate and governmental issuers located outside the United States; and 10% of its total assets in Income Securities of issuers in
emerging markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Shares. </i>The Fund&#8217;s currently
outstanding Common Shares are, and the Common Shares offered in this Prospectus will be, subject to notice of issuance, listed on the
New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221; The net asset value of the Common Shares at the close
of business on November 14, 2025 was $11.38 per share and the last sale price of the Common Shares on the NYSE on such date was $12.91,
representing a premium to net asset value of 13.44%. See &#8220;Market and Net Asset Value Information.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Financial Leverage. </i>The Fund may seek
to enhance total returns as well as the level of its current distributions by utilizing financial leverage through, among other things:
(i) the issuance of preferred shares (&#8220;Preferred Shares&#8221;), (ii) borrowing or the issuance of commercial paper or other forms
of debt (&#8220;Borrowings&#8221;), (iii) reverse repurchase agreements, dollar rolls or similar transactions or (iv) a combination of
the foregoing (&#8220;leveraged transactions&#8221; and collectively, &#8220;Financial Leverage&#8221;). The Fund may utilize Financial
Leverage up to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;); however, the aggregate
amount of Financial Leverage is not currently expected to exceed 33 <span style="font-size: 8.5pt">1</span>/<span style="font-size: 8.5pt">3</span>%
of the Fund&#8217;s Managed Assets (as defined herein) after such issuance and/or borrowing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund maintains a committed facility agreement
with BNP Paribas Prime Brokerage International, Ltd. (&#8220;BNP Paribas&#8221;), pursuant to which the Fund may borrow up to $150 million.
The maximum amount available to borrow under the committed facility may change from time to time pursuant to the terms of the agreement
governing the committed facility. As of May 31, 2025, outstanding Borrowings under the Fund&#8217;s committed facility agreement were
approximately $50 million, representing approximately 2% of the Fund&#8217;s Managed Assets as of such date, and there was approximately
$329 million in reverse repurchase agreements outstanding, representing approximately 14% of the Fund&#8217;s Managed Assets as of such
date. As of May 31, 2025, the Fund&#8217;s total Financial Leverage represented approximately 16% of the Fund&#8217;s Managed Assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">ii</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s use of leverage through reverse
repurchase agreements, dollar rolls and economically similar transactions will be included when calculating the Fund&#8217;s Financial
Leverage and therefore will be limited by the Fund&#8217;s maximum overall Financial Leverage levels, and may be further limited by the
applicable requirements of the SEC discussed herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act, and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s total Financial Leverage may
vary significantly over time based on, among other factors, the Sub-Adviser&#8217;s assessment of market and economic conditions, available
investment opportunities and cost of Financial Leverage. The Fund has at times used greater levels of Financial Leverage than on May 31,
2025. The Fund may in the future increase Financial Leverage up to the parameters set forth herein. Although the use of Financial Leverage
by the Fund may create an opportunity for increased total return for the Common Shares, it also results in additional risks and can magnify
the effect of any losses. Financial Leverage involves risks and special considerations for shareholders, including the likelihood of greater
volatility of net asset value, market price of, and dividends on, the Common Shares. To the extent the Fund increases its amount of Financial
Leverage outstanding, it will be more exposed to these risks. The cost of Financial Leverage, including the portion of the investment
advisory fee attributable to the assets purchased with the proceeds of Financial Leverage, is borne by Common Shareholders. To the extent
the Fund increases its amount of Financial Leverage outstanding, the Fund&#8217;s annual expenses as a percentage of net assets attributable
to Common Shares will increase. There can be no assurance that a leveraging strategy will be utilized or, if utilized, will be successful.
See &#8220;Use of Leverage&#8221; and the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">You should read this Prospectus (and documents
incorporated by reference herein), which contains important information about the Fund, together with any Prospectus Supplement, before
deciding whether to invest in the Common Shares of the Fund, and retain these documents for future reference. A Statement of Additional
Information (File No. 811-21982), dated November 21, 2025 (the &#8220;SAI&#8221;), as supplemented from time to time, containing additional
information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into this Prospectus. The SEC
maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC (http://www.sec.gov). You may request a free copy of the SAI or request other
information about the Fund (including the Fund&#8217;s annual and semi-annual reports) or make shareholder inquiries by calling (800)
345-7999 or by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago, Illinois 60606,
or you may obtain a copy (and other information regarding the Fund) from the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s
reports and the SAI will also be available from the Fund&#8217;s website at www.guggenheiminvestments.com/gof. The information contained
in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The Fund&#8217;s Common Shares do not represent
a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally
insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency. Investors could lose money
by investing in the Fund.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">iii</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>You should rely only on
the information contained or incorporated by reference into this Prospectus and any accompanying Prospectus Supplement in making your
investment decisions. The Fund has not authorized any other person to provide you with different information. If anyone provides you with
different or inconsistent information, you should not rely on it. The Fund is not making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume that the information appearing in this Prospectus is accurate only as of the
date of this Prospectus. The Fund&#8217;s business, financial conditions and prospects may have changed since such date. The Fund will
advise investors of any material changes to the extent required by applicable law.</b></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>Table
of Contents</b></span></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: right"><b>Page</b></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSummary">Prospectus Summary</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSummaryFundExp">Summary of Fund Expenses</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">7</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProFinancialHighlights">Financial Highlights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">9</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSeniorHighlights">Senior Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProTheFund">The Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUseProceeds">Use of Proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProMarketNetAssetInfo">Market and Net Asset Value Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProObjPolicies">Investment Objective and Policies</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUseLeverage">Use of Leverage</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProRisks">Risks</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProManagementFund">Management of the Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProNetAssetValue">Net Asset Value</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDistributions">Distributions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDividend">Dividend Reinvestment Plan</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDescCapStruct">Description of Capital Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProAntiTakeover">Anti-Takeover and Other Provisions in the Fund&#8217;s Governing Documents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProClosedEndFundStruct">Closed-End Fund Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProRepurchaseConversion">Repurchase of Common Shares; Conversion to Open-End Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUSFedIncTax">U.S. Federal Income Tax Considerations</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProPlanDistributions">Plan of Distribution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProCustAdminTransAgDiv">Custodian, Administrator, Transfer Agent and Dividend Disbursing Agent</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProLegalMatters">Legal Matters</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProIndRegPubAcctFirm">Independent Registered Public Accounting Firm</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProAdditionalInfo">Additional Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProPrivacy">Privacy Principles of the Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProIncorp">Incorporation By Reference</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This Prospectus, including
documents incorporated by reference herein, contains or incorporates by reference forward-looking statements, within the meaning of the
federal securities laws, that involve risks and uncertainties. These statements describe the Fund&#8217;s plans, strategies, and goals
and the Fund&#8217;s beliefs and assumptions concerning future economic and other conditions and the outlook for the Fund, based on currently
available information. In this Prospectus, words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221;
&#8220;goals,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; and similar expressions are used in an effort to identify forward-looking statements, although some forward-looking
statements may be expressed differently. The Fund is not entitled to the safe harbor for forward-looking statements pursuant to Section
27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">iv</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProSummary"></span>Prospectus Summary</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>This is only a summary of information contained
elsewhere in this Prospectus. This summary does not contain all of the information that you should consider before investing in the Fund&#8217;s
common shares of beneficial interest, par value $0.01 per share (&#8220;Common Shares&#8221;). You should carefully read the more detailed
information contained elsewhere in this Prospectus and any related Prospectus Supplement(s) prior to making an investment in the Fund,
especially the information set forth under the headings &#8220;Investment Objective and Policies&#8221; and &#8220;Risks.&#8221; You may
also wish to request a copy of the Fund&#8217;s Statement of Additional Information dated November 21, 2025 (the &#8220;SAI&#8221;), as
supplemented from time to time, which contains additional information about the Fund.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>The Fund</b></td>
    <td style="width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Guggenheim Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company that commenced operations on July 26, 2007. The Fund&#8217;s objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate from their perceived fair value and/or historical norms.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s common shares of beneficial interest, par value $0.01 per share, are called &#8220;Common Shares&#8221; and the holders of Common Shares are called &#8220;Common Shareholders&#8221; <span style="background-color: white">throughout this Prospectus and any accompanying Prospectus Supplement(s)</span>.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>The Offering</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund may offer, from time to time, up to $1,000,000,000 aggregate initial offering price of Common Shares, in one or more offerings in amounts, at prices and on terms to be set forth in one or more supplements to this Prospectus (each, a &#8220;Prospectus Supplement&#8221;).</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund may offer Common Shares (1) directly to one or more purchasers, (2) through agents that the Fund may designate from time to time, or (3) to or through underwriters or dealers. The Prospectus Supplement relating to a particular offering will identify any agents or underwriters involved in the sale of Common Shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Common Shares through agents, underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement describing the method and terms of the offering of Common Shares. See &#8220;Plan of Distribution.&#8221;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Use of Proceeds</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Unless otherwise specified in a prospectus supplement, the Fund intends to invest the net proceeds of the offering of Common Shares
    in accordance with its investment objective and policies as stated below or otherwise invest the
    net proceeds as follows. It is currently anticipated that the Fund will be able to invest most of the net proceeds of an offering of
    Common Shares in accordance with its investment objective and policies within three months after the receipt of such proceeds.
    Pending such investment, it is anticipated that the proceeds will be invested in U.S. government securities or high quality,
    short-term money-market securities. The Fund may also use the proceeds for working capital purposes, including the payment of
    distributions, interest and operating expenses. A portion of the cash held by the Fund, including net proceeds of the offering, is
    usually used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital, which is
    in effect a partial return of the amount a Common Shareholder invested in the Fund. Common Shareholders who receive the payment of a
    distribution consisting of a return of capital may be under the impression that they are receiving net investment income or profit
    when they are not. The Fund&#8217;s distributions may be greater than the Fund&#8217;s net investment income or profit. The offering
    of Common Shares supports the Fund&#8217;s asset level and if the Fund does not offer or sell Common Shares, the Fund may not be
    able to maintain historical distribution levels for extended periods of time.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>&#160;</i></p>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Objective</b></span></td>
  <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s investment objective
  is to maximize total return through a combination of current income and capital appreciation. The Fund cannot ensure investors that
  it will achieve its investment objective. The Fund&#8217;s investment objective is considered fundamental and may not be changed without
  the approval of Common Shareholders.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Investment Strategies</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Investment Strategies
  and Portfolio Composition&#8212;Principal Investment Strategies,&#8221; which is incorporated by reference herein, for a discussion
  of the Fund&#8217;s principal investment strategies. You should carefully consider this information together with all of the other
  information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Principal Investment Strategies&#8221;
  beginning on page 12, before making a decision to purchase the Fund&#8217;s Common Shares.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Portfolio</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Investment Strategies
  and Portfolio Composition&#8212;Portfolio Composition,&#8221; which is incorporated by reference herein, for a discussion of the types
  of securities and other instruments in which the Fund will or may ordinarily invest. You should carefully consider this information
  together with all of the other information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Additional
  Information About the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition&#8221; beginning on page 13, before
  making a decision to purchase the Fund&#8217;s Common Shares.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Leverage and Leveraged Transactions</b></span></td>
  <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund may seek to enhance total returns as well as the level of
its current distributions by utilizing financial leverage through, among other things: (i) the issuance of preferred shares (&#8220;Preferred
Shares&#8221;), (ii) borrowing or the issuance of commercial paper or other forms of debt (&#8220;Borrowings&#8221;), (iii) reverse repurchase
agreements, dollar rolls or similar transactions or (iv) a combination of the foregoing (&#8220;leveraged transactions&#8221; and collectively,
&#8220;Financial Leverage&#8221;). The Fund may utilize Financial Leverage up to the limits imposed by the Investment Company Act of 1940,
as amended (the &#8220;1940 Act&#8221;); however, the aggregate amount of Financial Leverage is not currently expected to exceed 33 1/3%
of the Fund&#8217;s Managed Assets (as defined herein) after such issuance and/or borrowing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund maintains a committed facility agreement with BNP Paribas
Prime Brokerage International, Ltd., pursuant to which the Fund may borrow up to $150 million. The maximum amount available to borrow
under the committed facility may change from time to time pursuant to the terms of the agreement governing the committed facility. As
of May 31, 2025, outstanding Borrowings under the Fund&#8217;s committed facility agreement were approximately $50 million, which represented
approximately 2% of the Fund&#8217;s Managed Assets as of such date, and there was approximately $329 million in reverse repurchase agreements
outstanding, which represented approximately 14% of the Fund&#8217;s Managed Assets as of such date. As of May 31, 2025, the Fund&#8217;s
total Financial Leverage represented approximately 16% of the Fund&#8217;s Managed Assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">The Fund&#8217;s use of leverage through reverse
repurchase agreements, dollar rolls and economically similar transactions will be included when calculating the Fund&#8217;s Financial
Leverage and therefore will be limited by the Fund&#8217;s maximum overall Financial Leverage levels, and may be further limited by the
applicable requirements of the SEC discussed herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition, the Fund may engage in certain derivatives transactions that
have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be considered indebtedness
for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s Financial Leverage,</p>
</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 25%">&#160;</td>
  <td style="width: 75%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">but the Fund&#8217;s use of such transactions may
be limited by Rule 18f-4 under the 1940 Act and the applicable requirements of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Fund&#8217;s total Financial Leverage may vary significantly over time
based on, among other factors, the Sub-Adviser&#8217;s assessment of market and economic conditions, available investment opportunities
and cost of Financial Leverage. The Fund has at times used greater levels of Financial Leverage than on May 31, 2025. The Fund may in
the future increase Financial Leverage up to the parameters set forth herein. Although the use of Financial Leverage and leveraged transactions
by the Fund may create an opportunity for increased total return for Common Shares, it also results in additional risks and can magnify
the effect of any losses. Financial Leverage and the use of leveraged transactions involve risks and special considerations for shareholders,
including the likelihood of greater volatility of net asset value, market price of, and dividends on, the Common Shares. To the extent
the Fund increases its amount of Financial Leverage and leveraged transactions outstanding, it will be more exposed to these risks. The
cost of Financial Leverage and leveraged transactions, including the portion of the investment advisory fee attributable to the assets
purchased with the proceeds of Financial Leverage and leveraged transactions, is borne by Common Shareholders. To the extent the Fund
increases its amount of Financial Leverage outstanding, the Fund&#8217;s annual expenses as a percentage of net assets attributable to
Common Shares will increase. There can be no assurance that a leveraging strategy will be utilized or, if utilized, will be successful.
See &#8220;Use of Leverage&#8221; and the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the Fund&#8212;Financial
Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein for a discussion of associated risks.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Temporary Investments</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time when a temporary posture is believed by the
  Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets in
  money market instruments and repurchase agreements in respect of those instruments. The Fund may not achieve its investment objective
  during a temporary period or be able to sustain its historical distribution levels. See &#8220;The Fund&#8217;s Investments&#8212;Temporary
  Investments.&#8221;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management of the Fund</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim Funds Investment Advisors, LLC (the &#8220;Investment
  Adviser&#8221;) acts as the Fund&#8217;s investment adviser pursuant to an advisory agreement with the Fund (the &#8220;Advisory Agreement&#8221;).
  Pursuant to the Advisory Agreement, the Investment Adviser is responsible for the management of the Fund and administers the affairs
  of the Fund to the extent requested by the board of trustees of the Fund (the &#8220;Board of Trustees&#8221; or the &#8220;Board&#8221;).
  As compensation for its services, the Fund pays the Investment Adviser a fee, payable monthly in arrears at an annual rate equal to
  1.00% of the Fund&#8217;s average daily Managed Assets. &#8220;Managed Assets&#8221; for purposes of calculating the fees payable under
  the Advisory and Sub-Advisory Agreements (as defined herein) means the total assets of the Fund (other than assets attributable to
  any investments by the Fund in Affiliated Investment Funds), including the assets attributable to the proceeds from any borrowings
  or other forms of Financial Leverage, minus liabilities, other than liabilities related to any Financial Leverage. &#8220;Affiliated
  Investment Funds&#8221; means investment companies, including registered investment companies, private investment funds and/or other
  pooled investment vehicles, advised or managed by the Fund&#8217;s investment Sub-Adviser or any of its affiliates. &#8220;Managed
  Assets&#8221; for all other purposes means the total assets of the Fund, including the assets attributable to the proceeds from any
  borrowings or other forms of Financial Leverage, minus liabilities, other than liabilities related to any Financial Leverage. Please
  refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the
  Fund,&#8221; which is incorporated by reference herein, for a discussion of associated risks of the Fund&#8217;s use of Financial Leverage.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;) acts as the Fund&#8217;s sub-adviser pursuant to a sub-advisory agreement with the Fund and the Investment Adviser (the &#8220;Sub-Advisory Agreement&#8221;). Pursuant to the Sub-Advisory Agreement, the Sub-Adviser is responsible for the management of the Fund&#8217;s portfolio of securities. As compensation for its services, the Investment Adviser pays the Sub-Adviser a fee, payable monthly in arrears at an annual rate equal to 0.50% of the Fund&#8217;s average daily Managed Assets, less 0.50% of the Fund&#8217;s average daily assets attributable to any investments by the Fund in Affiliated Investment Funds.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Each of the Investment Adviser and the Sub-Adviser are wholly-owned
    subsidiaries of Guggenheim Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial services
    firm with wealth management, capital markets, investment management and proprietary investing businesses, the clients of which are a mix
    of individuals, family offices, endowments, investment funds, foundations, insurance companies and other institutions that have entrusted
    Guggenheim Partners with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners is headquartered
    in Chicago and New York with a global network of offices throughout the United States, Europe, and Asia.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">References to the &#8220;Adviser&#8221; may include the Investment
    Adviser or the Sub-Adviser, as applicable.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">See &#8220;Management of the Fund.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Distributions</b></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund intends to pay substantially all of its net investment income
    to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net realized long-term capital gains
    to Common Shareholders as long-term capital gain dividends at least annually. The Fund expects that distributions paid on the Common Shares
    will generally consist of (i) investment company taxable income expected to be taxed as ordinary income, which includes, among other things,
    investment income, short-term capital gains and income from certain hedging and interest rate transactions, (ii) long-term capital gains
    and (iii) return of capital. Distributions may be paid by the Fund from any permitted source and, from time to time, all or a portion
    of a distribution may be a return of capital. To the extent the Fund receives dividends with respect to its investments in Common Equity
    Securities that consist of qualified dividend income (income from domestic and certain foreign corporations), a portion of the Fund&#8217;s
    distributions to its Common Shareholders may consist of qualified dividend income. The Fund cannot assure you, however, as to what percentage
    of the dividends paid on Common Shares, if any, will consist of qualified dividend income or long-term capital gains, which are taxed
    at lower rates for individuals than ordinary income. In certain circumstances, the Fund may elect to retain income or capital gain and
    pay income or excise tax on such undistributed amount. Alternatively, the distributions paid by the Fund for any particular month may
    be more than the amount of net investment income from that monthly period. As a result, all or a portion of a distribution may be a return
    of capital, which is in effect a partial return of the amount a Common Shareholder invested in the Fund. For U.S. federal income tax purposes,
    a return of capital distribution is generally not taxable up to the amount of the Common Shareholder&#8217;s tax basis in their Common
    Shares and would reduce such tax basis, and any amounts exceeding such basis will be treated as a gain from the sale of their Common Shares.
    Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the
    Common Shareholder&#8217;s potential loss, on any subsequent sale or other disposition of Common Shares. Common Shareholders who receive
    the payment of a distribution consisting of a return of capital may be under the impression that they are receiving net investment income
    or profits when they are not. Common Shareholders should not assume that the source of a distribution from the Fund is net investment
    income or profit. See &#8220;Distributions&#8221; and &#8220;U.S. Federal Income Tax Considerations.&#8221;</p>
    </td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 25%">&#160;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; width: 75%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Distributions paid on the Common Shares that consist of
    investment company taxable income and/or long-term capital gains are taxable even if they are paid from income or gains earned by
    the Fund before your investment in the Fund (and thus were included in the price paid for your Common Shares). These distributions
    are likely to occur in respect of Common Shares purchased at a time when the Fund&#8217;s net asset value (&#8220;NAV&#8221;)
    reflects earnings realized but not distributed. These distributions may be taxable despite constituting an economic return of your
    investment.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund&#8217;s distribution rate is not constant and the amount
    of distributions, when declared by the Fund&#8217;s Board of Trustees, is subject to change. There is no guarantee of any future distribution
    or that the current returns and distribution rate will be maintained.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">If you hold your Common Shares in your own name or if you hold your
    Common Shares with a brokerage firm that participates in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;), unless
    you elect to receive cash, all dividends and distributions that are declared by the Fund (net of withholding) will be automatically reinvested
    in additional Common Shares of the Fund pursuant to the Plan. If you hold your Common Shares with a brokerage firm that does not participate
    in the Plan, you will not be able to participate in the Plan and any dividend reinvestment may be effected on different terms than those
    described above. Consult your financial advisor for more information. See &#8220;Dividend Reinvestment Plan.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Listing and Symbol</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221; The net asset value of the Common Shares at the close of business on November 14, 2025 was $11.38 per share and the last reported sale price of the Common Shares on the NYSE on such date was $12.91, representing a premium to net asset value of 13.44%.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Special Risk Considerations</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">An investment in Common Shares of the Fund involves special risk considerations. Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the Fund,&#8221; which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund. You should carefully consider these risks together with all of the other information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Risks&#8221; beginning on page 31, before making a decision to purchase the Fund&#8217;s Common Shares.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Anti-Takeover Provisions in the Fund&#8217;s Governing Documents</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s Amended and Restated Agreement and Declaration of Trust (the &#8220;Declaration of Trust&#8221;) and the Fund&#8217;s Bylaws, each as may be amended and/or restated from time to time (collectively, the &#8220;Governing Documents&#8221;), include provisions that could limit the ability of other entities or persons to acquire control of the Fund or convert the Fund to an open-end fund. These provisions could have the effect of depriving the Common Shareholders of opportunities to sell their Common Shares at a premium over the then-current market price of the Common Shares. See &#8220;Anti-Takeover and Other Provisions in the Fund&#8217;s Governing Documents&#8221; and &#8220;Risks&#8212;Anti-Takeover Provisions.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Administrator, Custodian, Transfer Agent and Dividend Disbursing Agent</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Bank of New York Mellon (&#8220;BNY&#8221;) acts as the custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the custodian holds the Fund&#8217;s assets in compliance with the 1940 Act. For its services, the custodian receives a monthly fee based upon, among other things, the average value of the total assets of the Fund, plus certain securities transactions.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Computershare Inc. acts as the Fund&#8217;s dividend disbursing agent, transfer agent and registrar with respect to the Common Shares of the Fund, and Computershare Trust Company, N.A. acts as agent under the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan Agent&#8221;).</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 25%">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 75%">MUFG Investor Services (US) LLC (&#8220;MUFG&#8221;) acts as the Fund&#8217;s administrator and fund accounting agent. Pursuant to an administration agreement, MUFG provides certain administrative services to the Fund. Pursuant to an accounting and administration agreement, MUFG is responsible for maintaining the books and records of the Fund&#8217;s securities and cash. For its services, MUFG receives a monthly fee based upon the average daily Managed Assets of the Fund. </td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;<i>&#160;</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProSummaryFundExp"></span>Summary of Fund
Expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of May 31, 2025. The following table should not be considered a representation of the Fund&#8217;s future expenses. Actual expenses
may be greater or less than shown. The following table shows estimated Fund expenses as a percentage of average net assets attributable
to Common Shares, and not as a percentage of Managed Assets. See &#8220;Management of the Fund.&#8221;</p>

<table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - ShareholderTransactionExpenses" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 77%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Shareholder Transaction Expenses</b></td>
    <td style="width: 23%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Sales load paid by you (<span>as a percentage of offering price</span>) <span style="background-color: #CCEEFF"><sup>(</sup></span><sup>1)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span style="background-color: #CCEEFF">&#160;&#160;<span>&#8212;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Offering expenses borne by the Fund (as a percentage of offering price) <span style="font-size: 8.5pt"><sup>(1),(2)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span>0.60%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Dividend Reinvestment Plan fees<span style="font-size: 8.5pt"><sup>(3)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 0.5pt"><span>None</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - AnnualExpenses" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 60%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Annual Expenses</b></td>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>As a Percentage of Average Net Assets Attributable to Common Shares<span style="font-size: 8.5pt"><sup>(4)</sup></span></b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Management fees<span style="font-size: 8.5pt"><sup>(5)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>1.21%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Acquired fund fees and expenses<sup>(6)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>0.05%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Interest expenses<span style="font-size: 8.5pt"><sup>(7)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>1.08%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Other expenses<span style="font-size: 8.5pt"><sup>(8)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>0.10%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Total annual expenses<sup>(9)</sup></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>2.44%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(1)</span></td><td>If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement will set forth any
applicable sales load to be paid by investors and the estimated offering expenses borne by the Fund.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(2)</span></td><td>The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s registration statement and any
offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under this registration statement,
to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s behalf in an amount up
to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common Shares sold in such offerings.
Amounts in excess of 0.60% of the total offering price of shares sold pursuant to this registration statement will not be subject to recoupment
from the Fund. This agreement will be in effect for the life of the registration statement with respect to all Common Shares sold pursuant
to the registration statement and may only be terminated by the Board of Trustees of the Fund.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(3)</span></td><td>Common Shareholders will pay brokerage charges if they direct Computershare Trust Company, N.A. (the &#8220;Plan Agent&#8221;) to
sell Common Shares held in a dividend reinvestment account. See &#8220;Dividend Reinvestment Plan.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(4)</span></td><td>Based upon average net assets attributable to Common Shares during the fiscal year ended May 31, 2025.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(5)</span></td><td>The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to 1.00% of the Fund&#8217;s average daily Managed
Assets (as defined herein). Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with
the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other forms of debt (&#8220;Borrowings&#8221;)
or reverse repurchase agreements, dollar rolls or similar transactions or a combination of the foregoing (collectively &#8220;Financial
Leverage&#8221;), which means that Common Shareholders effectively bear the entire advisory fee. Because <span style="background-color: white">the
management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#8217;s Managed Assets, the management fee as
a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial Leverage. If Financial
Leverage of more than 16% of the Fund&#8217;s Managed Assets is used, the management fee shown would be higher.</span></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(6)</span></td><td><span style="background-color: white">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the Fund
as an investor in other investment companies during the fiscal year ended May 31, 2025.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(7)</span></td><td>Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is estimated based upon the Fund&#8217;s outstanding Borrowings as of May 31, 2025, which included Borrowings under the Fund&#8217;s
committed facility agreement in an amount equal to 2.08% of the Fund&#8217;s Managed Assets, at an average interest rate of 5.08%. Interest
expense on reverse repurchase agreements is estimated based on the Fund&#8217;s outstanding reverse repurchase agreements as of May 31,
2025, which included leverage in the form of reverse repurchase agreements in an amount equal to 13.77% of the Fund&#8217;s Managed Assets,
at a weighted average interest rate cost to the Fund of 4.52%. The actual amount of interest payments and expenses borne by the Fund will
vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</td></tr></table>
<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(8)</span></td><td>Other expenses are based on estimated amounts for the current fiscal year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(9)</span></td><td>The total annual expenses in this fee table may not correlate to the expense ratios in the Fund&#8217;s financial highlights and financial
statements because the financial highlights and financial statements reflect only the operating expenses of the Fund and do not include
Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly by the Fund through its investments in certain underlying
investment companies.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center">Example</p>
<div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As required by relevant SEC regulations, the
following example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual
expenses&#8221; of 2.44% of net assets attributable to Common Shares and (2) a 5% annual return*:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>1 Year</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>3 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>5 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>10 Years</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Total Annual Expense Paid by Common Shareholders</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>$25</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>$76</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>$130</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>$277</span></td></tr>
  </table>
  </div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F0A_zR8oVTgbnnFl" style="width: 0.4in">*</td><td><b id="xdx_F10_z33Hq3dqWE9k"><ix:footnote id="Footnote000044" xml:lang="en-US">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#8220;Distributions&#8221;
and &#8220;Dividend Reinvestment Plan.&#8221;</ix:footnote></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.4in">The example does not include sales loads or estimated
offering costs which, if reflected, would result in higher expenses. In connection with an offering of Common Shares, the Prospectus Supplement
will set forth an example including sales load and estimated offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.4in">The above table and example and the assumption
in the example of the 5% annual return are provided to assist in your understanding of the various costs and expenses that an investor
in the Fund will bear directly or indirectly. The assumed 5% annual return is not a prediction of, and does not represent, the projected
or actual performance of the Fund&#8217;s Common Shares.</p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProFinancialHighlights"></span>Financial Highlights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The financial highlights table is intended to
help you understand the Fund&#8217;s financial performance. The information in this table is derived from the Fund&#8217;s financial statements
and has been audited by Ernst &amp; Young LLP, independent registered public accounting firm for the Fund. The Fund&#8217;s audited financial
statements appearing in the Fund&#8217;s annual report to shareholders for the year ended May 31, 2025, including the report of Ernst
&amp; Young LLP thereon and accompanying notes thereto, are incorporated by reference in the SAI.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2025</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2024</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2023</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2022</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Per Share Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, beginning of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.95</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12.34</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.33</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.05</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 15.29</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Income from investment operations:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income<sup>(a)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.82</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.82</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.75</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.95</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net gain (loss) on investments (realized and unrealized)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.85</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.98</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.55)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">3.00</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total from investment operations</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.67</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.80</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.20</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.53)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">3.95</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Less distributions from:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.70)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.81)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.76)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.04)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.97)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Capital gains</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.15)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Return of capital</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.49)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.23)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.25)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.96)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.22)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total distributions to shareholders</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.43</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.95</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12.34</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.33</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.05</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.73</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.68</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 15.69</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.92</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 20.90</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Total Return<sup>(b)</sup></b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.09%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.72%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">2.09%<sup>(f)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(3.99%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">27.20%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">16.48%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">9.77%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(3.48%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">45.59%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Ratios/Supplemental Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net assets, end of period (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 2,008,816</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,703,619</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,473,694</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,492,615</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 878,041</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Ratio to average net assets of:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income, including interest expense</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.95%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.79%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.81%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">4.75%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.72%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total expenses, including interest expense<sup>(c)(d)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.40%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.90%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.88%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">1.83%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.83%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Portfolio turnover rate</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">25%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">30%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">26%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">47%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">64%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Senior Indebtedness</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total Borrowings outstanding (in thousands)<sup>(g)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 378,321</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 361,456</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 343,500</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 128,000</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 38,501</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Asset Coverage per $1,000 of indebtedness<sup>(e)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 6,310</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 5,713</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 5,290</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12,661</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 23,806</span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(a)</span></td><td>Based on average shares outstanding.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(b)</span></td><td>Total return is calculated assuming a purchase of a Common Share at the beginning of the period and a sale on the last day of the
period reported either at net asset value (&#8220;NAV&#8221;) or market price per share. Dividends and distributions are assumed to be
reinvested at NAV for NAV returns or the prices obtained under the Fund&#8217;s Dividend Reinvestment Plan for market value returns. Total
return does not reflect brokerage commissions. A return calculated for a period of less than one year is not annualized.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(c)</span></td><td>The ratios of total expenses to average net assets applicable to common shares do not reflect fees and expenses incurred indirectly
by the Fund as a result of its investment in shares of other investment companies. If these fees were included in the expense ratios,
for the years ended May 31, the expense ratios would increase by:</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2025</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2024</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2023</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2022</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2021</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2020</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2019</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2018</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2017</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2016</i></b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.05%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.07%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.07%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.06%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.06%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.09%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.08%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(d)</span></td><td>Excluding interest expense, the operating expense ratios for the years ended May 31, would be:</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2025</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2024</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2023</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2022</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2021</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2020</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2019</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2018</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2017</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2016</i></b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.32%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.39%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.44%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.51%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.55%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.17%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.15%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.33%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.62%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.74%</i></span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2020</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2019</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2018</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2017</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2016</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Per Share Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, beginning of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.91</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.12</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.78</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.50</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.61</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Income from investment operations:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income<sup>(a)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.89</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.97</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.23</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.61</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.40</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net gain (loss) on investments (realized and unrealized)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.32)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.01</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.30</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.86</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total from investment operations</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.43)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.98</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.53</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">4.47</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.07</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Less distributions from:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.86)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.12)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.01)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.82)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Capital gains</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.16)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.01)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.36)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Return of capital</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.91)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total distributions to shareholders</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.18)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.29</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">17.91</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">19.12</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">19.78</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">17.50</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 16.20</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.96</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 21.29</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 20.94</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.61</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Total Return<sup>(b)</sup></b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(2.79%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.43%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">8.02%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">26.76%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(7.96%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">4.94%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">13.31%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">33.33%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">-6.07%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Ratios/Supplemental Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net assets, end of period (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 648,892</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 641,825</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 530,250</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 410,465</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 310,246</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Ratio to average net assets of:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income, including interest expense</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">5.29%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.26%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.27%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">8.55%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">7.79%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total expenses, including interest expense<sup>(c) (d)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">1.21%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.17%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.52%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.35%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.38%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Portfolio turnover rate</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">41%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">38%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">48%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">41%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">116%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Senior Indebtedness</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total borrowings outstanding (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19,300</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 16,705</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 9,355</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Asset coverage per $1,000 of indebtedness<sup>(e)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 34,621</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 25,571</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 34,164</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(e)</span></td><td>Calculated by subtracting the Fund&#8217;s total liabilities (not including the borrowings) from the Fund&#8217;s total assets and
dividing by the borrowings. Effective August 19, 2022, the Fund&#8217;s obligations under reverse repurchase agreement transactions are
treated as senior securities representing indebtedness for purposes of the 1940 Act. Accordingly, for the years ended May 31, 2025, May
31, 2024 and May 31, 2023, Asset Coverage is calculated by subtracting the Fund&#8217;s total liabilities (not including the borrowings
or reverse repurchase agreements) from the Fund&#8217;s total assets and dividing by the sum of the borrowings and reverse repurchase
agreements.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(f)</span></td><td>The net increase from the payment by the Investment Adviser totaling $216,351 relating to an operational issue contributed 0.01% to
total return at net asset value for the year ended May 31, 2023.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(g)</span></td><td>Effective August 19, 2022, the Fund&#8217;s obligations under reverse repurchase agreement transactions are treated as senior securities
representing indebtedness for purposes of the 1940 Act.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">*</span></td><td><span style="background-color: white">Less than 0.01%.</span></td></tr></table>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProSeniorHighlights"></span>Senior Securities</p>

<p id="xdx_984_ecef--SeniorSecuritiesNoteTextBlock_c20251121__20251121_z9RZBQB1Yqph" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000045" name="cef:SeniorSecuritiesNoteTextBlock">For information about the Fund&#8217;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Other Information (unaudited)&#8212;Senior Securities&#8221;
which is incorporated by reference herein. Information regarding the Fund&#8217;s senior securities is also contained in the Financial
Highlights in the Fund&#8217;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp; Young LLP for the last five
fiscal years. The Fund&#8217;s audited financial statements, including the report of Ernst &amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#8217;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.</ix:nonNumeric></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProTheFund"></span>The Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Guggenheim Strategic Opportunities Fund (the
&#8220;Fund&#8221;) is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as
amended (the &#8220;1940 Act&#8221;), that commenced operations on July 26, 2007. The Fund was organized as a statutory trust on November
13, 2006, pursuant to a Certificate of Trust, and is governed by the laws of the State of Delaware. Its principal office is located at
227 West Monroe Street, Chicago, Illinois 60606, and its telephone number is (312) 827-0100.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as otherwise noted, all percentage limitations
set forth in this Prospectus apply immediately after a purchase or initial investment and any subsequent change in any applicable percentage
resulting from market fluctuations does not require any action.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProUseProceeds"></span>Use
of Proceeds</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Unless otherwise specified in a prospectus
supplement, the Fund intends to invest the net proceeds of the offering of Common Shares in accordance with its investment objective
and policies as stated above or otherwise invest the net proceeds as follows. It is currently anticipated that the Fund will be able
to invest most of the net proceeds of an offering of Common Shares in accordance with its investment objective and policies within
three months after the receipt of such proceeds. Pending such investment, it is anticipated that the proceeds will be invested in
U.S. government securities or high quality, short-term money-market securities. The Fund may also use the proceeds for working
capital purposes, including the payment of distributions, interest and operating expenses. A portion of the cash held by the Fund,
including net proceeds of the offering, is usually used to pay distributions in accordance with the Fund&#8217;s distribution policy
and may be a return of capital, which is in effect a partial return of the amount a Common Shareholder invested in the Fund. Common
Shareholders who receive the payment of a distribution consisting of a return of capital may be under the impression that they are
receiving net investment income or profit when they are not. The Fund&#8217;s distributions may be greater than the Fund&#8217;s net
investment income or profit. The offering of Common Shares supports the Fund&#8217;s asset level and if the Fund does not offer or
sell Common Shares, the Fund may not be able to maintain historical distribution levels for extended periods of time. There is no
guarantee that the Fund will sell all of the Common Shares available for sale under its shelf registration statement or that there
will be any sales of common shares thereunder and, from time to time, the Fund may be unable to sell its common shares under its
shelf registration statement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProMarketNetAssetInfo"></span>Market and Net
Asset Value Information</p>

<div id="xdx_882_ecef--SharePriceTableTextBlock_zFx0g45qnHbb"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000047" name="cef:SharePriceTableTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#8220;NYSE&#8221;) under the symbol &#8220;GOF&#8221;. The Fund&#8217;s Common Shares commenced trading on the NYSE on July 27,
2007.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#8217;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#8217;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
</p>

<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div id="xdx_234_zSRe7QbZety8" style="margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zDj5Z4qCpbkg" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zokwCLDusBH" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zy0elSGdSa5d" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#8220;Risks&#8212;Market Discount
and Price Volatility Risk.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#8220;Net Asset Value&#8221; for information as to the determination of the Fund&#8217;s net asset value.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">&#160;</td>
    <td id="xdx_48F_ecef--HighestPriceOrBid_zO3IGU7U3t91" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--LowestPriceOrBid_zPkCalkajAZc" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_480_ecef--HighestPriceOrBidNav_zOgODog8Fyha" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_480_ecef--LowestPriceOrBidNav_zphdGz8OJ2R1" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_48C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zLmJtETNL4x4" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_486_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zq3jvEzA6Rxh" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Fiscal Quarter Ended</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Market Price</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>NAV per Common<br/>
Share on Date of Market<br/>
Price High and Low<span style="font-size: 8.5pt"><sup>(1)</sup></span></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Premium/(Discount) on<br/>
Date of Market Price</b><br/>
<b>High and Low<span style="font-size: 8.5pt"><sup>(2)</sup></span></b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td></tr>
  <tr id="xdx_41C_20250601__20250831_zGSPc6ziVBE1" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-06-012025-08-31" id="Fact000048" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.10</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-06-012025-08-31" id="Fact000049" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.55</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-06-012025-08-31" id="Fact000050" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-06-012025-08-31" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.38</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-06-012025-08-31" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">31.30</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-06-012025-08-31" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.86</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41A_20250301__20250531_z32gpkuCXGX" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-03-012025-05-31" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.91</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-03-012025-05-31" id="Fact000055" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.74</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-03-012025-05-31" id="Fact000056" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.67</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-03-012025-05-31" id="Fact000057" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.06</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-03-012025-05-31" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">36.33</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-03-012025-05-31" id="Fact000059" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">24.23</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_413_20241201__20250228_zExVTB8B9ySf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 28, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-12-012025-02-28" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.99</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-12-012025-02-28" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.00</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-12-012025-02-28" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.01</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-12-012025-02-28" id="Fact000063" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.74</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28" id="Fact000064" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">33.14</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28" id="Fact000065" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.77</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_414_20240901__20241130_zXDzAhdrZVmf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-09-012024-11-30" id="Fact000066" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.03</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-09-012024-11-30" id="Fact000067" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.26</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-09-012024-11-30" id="Fact000068" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.99</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-09-012024-11-30" id="Fact000069" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.01</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">33.69</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30" id="Fact000071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.06</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_414_20240601__20240831_zSarr1dFl2V5" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-06-012024-08-31" id="Fact000072" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.75</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-06-012024-08-31" id="Fact000073" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.65</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-06-012024-08-31" id="Fact000074" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.06</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-06-012024-08-31" id="Fact000075" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.93</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31" id="Fact000076" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">30.60</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31" id="Fact000077" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">22.80</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41B_20240301__20240531_zcXEJChhSsgf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-03-012024-05-31" id="Fact000078" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.90</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-03-012024-05-31" id="Fact000079" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.80</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-03-012024-05-31" id="Fact000080" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.26</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-03-012024-05-31" id="Fact000081" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.82</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31" id="Fact000082" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">21.53</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31" id="Fact000083" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">16.75</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_411_20231201__20240229_zBaztg4uzQw7" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 29, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-12-012024-02-29" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.29</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-12-012024-02-29" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.67</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-12-012024-02-29" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.12</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-12-012024-02-29" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.34</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">17.90</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.67</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_413_20230901__20231130_zVGetGPX04Nj" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-09-012023-11-30" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.96</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-09-012023-11-30" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.16</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-09-012023-11-30" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.30</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-09-012023-11-30" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.71</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">29.76</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.70</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41C_20230601__20230831_zWTrLzH0iW75" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-06-012023-08-31" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.28</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-06-012023-08-31" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.51</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-06-012023-08-31" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.48</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-06-012023-08-31" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.30</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">30.45</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">26.10</ix:nonFraction>%</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(1)</td><td>Based on the Fund&#8217;s computations.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(2)</td><td>Calculated based on the information presented. Percentages are rounded.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The last reported market price, net asset value
per Common Share and percentage premium to net asset value per Common Share as of November 14, 2025 was $12.91, $11.38 and <span>13.44%</span>, respectively.
The Fund cannot predict whether its Common Shares will trade in the future at a premium to or discount from net asset value, or the level
of any premium or discount. Shares of closed-end investment companies frequently trade at a discount from net asset value. The Fund&#8217;s
Common Shares have in the past traded both above and below their net asset value. As of November 14, 2025, 199,267,847 Common Shares of
the Fund were outstanding.</p></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProObjPolicies"></span>Investment Objective
and Policies</p>

<p id="xdx_982_ecef--InvestmentObjectivesAndPracticesTextBlock_c20251121__20251121_gBFIOAPTB-BPKXUZ_zAE6r36jO2re" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><ix:nonNumeric contextRef="AsOf2025-11-21" continuedAt="ConU000129-01" escape="true" id="Fact000129" name="cef:InvestmentObjectivesAndPracticesTextBlock">Investment Objective</ix:nonNumeric></p>

<div id="xdx_C05_gBFIOAPTB-BPKXUZ_z4PxOkp6R8k7"><ix:continuation continuedAt="ConU000129-02" id="ConU000129-01"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Investment Objective,&#8221; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.</span></p></ix:continuation></div>

<div id="xdx_C03_gBFIOAPTB-BPKXUZ_z0X3AhfRwWaa"><ix:continuation continuedAt="ConU000129-03" id="ConU000129-02"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Policies</p></ix:continuation></div>

<div id="xdx_C05_gBFIOAPTB-BPKXUZ_zKQpkvaqgRq9"><ix:continuation continuedAt="ConU000129-04" id="ConU000129-03"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Principal Investment Strategies and Portfolio
Composition</span><span style="font-weight: normal">&#8212;Investment Policies<span style="color: windowtext">&#8221; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#8217;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#8217;s and S&amp;P&#8217;s ratings.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><span style="color: windowtext">Rating agencies, such as Moody&#8217;s or S&amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#8217;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#8217;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#8217;s credit analysis than would be the case when
the Fund invests in rated securities.</span></span></p></ix:continuation></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<div id="xdx_C04_gBFIOAPTB-BPKXUZ_zCDxsMOAcIy3"><ix:continuation continuedAt="ConU000129-05" id="ConU000129-04"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Principal Investment Strategies</b></p></ix:continuation></div>

<div id="xdx_C07_gBFIOAPTB-BPKXUZ_zbudnz4zJjW9"><ix:continuation continuedAt="ConU000129-06" id="ConU000129-05"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is predicated</p></ix:continuation></div>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C01_gBFIOAPTB-BPKXUZ_zLBHBnUcymx7"><ix:continuation continuedAt="ConU000129-07" id="ConU000129-06"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.</p></ix:continuation></div>

<div id="xdx_C03_gBFIOAPTB-BPKXUZ_zzo9z869F6p9"><ix:continuation continuedAt="ConU000129-08" id="ConU000129-07"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s analysis of a fixed-income
security&#8217;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#8217;s
industry to determine the Sub-Adviser&#8217;s internal judgment as to the security&#8217;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#8217;s judgment, may provide risk-adjusted outperformance.</p></ix:continuation></div>

<div id="xdx_C0E_gBFIOAPTB-BPKXUZ_zAlSmQEvScEe"><ix:continuation continuedAt="ConU000129-09" id="ConU000129-08"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#8217;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.</p></ix:continuation></div>

<div id="xdx_C06_gBFIOAPTB-BPKXUZ_zefNLNYFDvKa"><ix:continuation continuedAt="ConU000129-10" id="ConU000129-09"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In the Sub-Adviser&#8217;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#8217;s
desired sector exposures.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Additional Information About
the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Income Securities Strategy. </i>The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#8220;high-yield&#8221; or &#8220;junk&#8221;
bonds), which are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Corporate bonds;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Loans and loan participations (including senior secured floating rate loans, &#8220;second lien&#8221; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#8220;debtor-in-possession&#8221; financings) (collectively, &#8220;Loans&#8221;);</td></tr>
  </table></ix:continuation></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>
<div id="xdx_C0C_gBFIOAPTB-BPKXUZ_z47918ZKyCHb"><ix:continuation continuedAt="ConU000129-11" id="ConU000129-10">
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">U.S. government and agency securities and sovereign or supranational debt obligations;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Mezzanine and preferred securities; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Convertible securities.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Debt Overlay Strategy. </i>As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#8220;Debt
Overlay Basket&#8221;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#8220;Underlying Bond ETF&#8221;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#8220;Debt Overlay Strategy&#8221;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#8220;covered,&#8221;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#8217;s shares) in the amount necessary to meet the Fund&#8217;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#8217;s options counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Equity Securities and Covered Call
Options Strategy. </i>The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#8220;Common Equity Securities&#8221;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#8220;naked&#8221; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#8220;OTC options&#8221;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#8220;ETFs&#8221;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Autocallable ELN Strategy.</i> The
Fund may employ a synthetic autocallable equity linked-note (&#8220;ELN&#8221;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#8220;Synthetic
Autocallable ELN Strategy&#8221;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable </p></ix:continuation></div>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0D_gBFIOAPTB-BPKXUZ_zw3ahdTp0ki7"><ix:continuation continuedAt="ConU000129-12" id="ConU000129-11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#8220;Synthetic Autocallable Contracts&#8221;),
and will typically not invest directly in autocallable ELNs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;P 500 Index, Russell
2000 Index, or &#8220;worst of&#8221; two or more indices) (the &#8220;Autocallable ELN Reference Index&#8221;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#8220;Maturity Barrier&#8221; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#8220;buyer&#8221; and its counterparty as &#8220;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#8217;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#8217;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#8220;Coupon Payment&#8221; and a &#8220;Principal Payment&#8221;) net of the financing amount owed
to the counterparty, subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Autocall Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#8220;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Coupon Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#8220;Coupon Barrier&#8221;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>No-Coupon Zone</i>. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#8220;Missed
Coupon&#8221;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Full Principal Zone</i>. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#8220;Maturity Barrier&#8221;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.</td></tr></table></ix:continuation></div>
<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<div id="xdx_C08_gBFIOAPTB-BPKXUZ_zrz6OewURpRa"><ix:continuation continuedAt="ConU000129-13" id="ConU000129-12"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Reduced Principal Zone</i>. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Real Property Asset Companies. </i>The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#8220;real property assets,&#8221; such as real estate and the natural resources upon or within real estate (&#8220;Real Property Asset
Companies&#8221;). These Real Property Asset Companies include:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#8220;REITs&#8221;); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Personal Property Asset Companies. </i>The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#8220;Personal Property Asset Companies&#8221;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Securities. </i>The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#8220;Private Securities&#8221;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Funds. </i>As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#8220;Investment Funds&#8221;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#8217;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#8220;hedge funds,&#8221; or &#8220;private equity funds&#8221;
(including &#8220;single asset continuation funds&#8221;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Investments. </i>As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#8220;SOFR&#8221;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be</p></ix:continuation></div>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C07_gBFIOAPTB-BPKXUZ_zXiNRnM4Lkgc"><ix:continuation continuedAt="ConU000129-14" id="ConU000129-13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#8217;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#8217;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#8217;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#8217;s return could be adversely affected by an adverse tax ruling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>Portfolio Contents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>The Fund&#8217;s investment portfolio consists
of investments in the following types of securities:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Corporate Bonds. </i>Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#8217;s
performance and perceptions of the corporation in the marketplace. <i>Investment Grade Bonds. </i>The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#8220;Investment Grade Bonds&#8221;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#8217;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed </p></ix:continuation></div>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0B_gBFIOAPTB-BPKXUZ_zdWVjD5ozXs4"><ix:continuation continuedAt="ConU000129-15" id="ConU000129-14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Below-Investment Grade Bonds. </i>The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#8220;Below-Investment Grade Bonds&#8221;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#8217;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#8220;debtor-in-possession&#8221; or &#8220;DIP&#8221; financings
newly issued in connection with &#8220;special situation&#8221; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#8217;s otherwise unencumbered assets or secured by a junior lien on the debtor&#8217;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distressed and Defaulted Securities. </i>The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Structured Finance Investments. </i>The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#8217;s investment policies, structured finance investments
are not deemed to be &#8220;private investment funds&#8221; (as discussed below). Structured finance investments primarily include (among
others):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Mortgage-Related Securities</span>. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the</p></ix:continuation></div>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C02_gBFIOAPTB-BPKXUZ_zytvp55HkdVf"><ix:continuation continuedAt="ConU000129-16" id="ConU000129-15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Asset-Backed Securities</span>. Asset-backed securities (&#8220;ABS&#8221;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Collateralized Debt Obligations</span>. A collateralized debt
obligation (&#8220;CDO&#8221;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#8220;CBO&#8221;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#8220;CLO&#8221;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#8217;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions
are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#8217;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Risk-Linked Securities</span>. Risk-linked securities (&#8220;RLS&#8221;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#8220;trigger event.&#8221; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#8217;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other</p></ix:continuation></div>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C07_gBFIOAPTB-BPKXUZ_z14aySK5aWUg"><ix:continuation continuedAt="ConU000129-17" id="ConU000129-16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Senior Loans. </i>Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#8220;Prime Rate&#8221;) and the certificate of deposit (&#8220;CD&#8221;) rate or
other base lending rates used by commercial lenders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Second Lien Loans. </i>Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Subordinated Secured Loans. </i>Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#8217;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Unsecured Loans. </i>Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
</p></ix:continuation></div>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C08_gBFIOAPTB-BPKXUZ_zLBOhQdwD2x6"><ix:continuation continuedAt="ConU000129-18" id="ConU000129-17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mezzanine Investments. </i>The Fund may invest
in certain lower grade securities known as &#8220;Mezzanine Investments,&#8221; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Convertible Securities. </i>Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#8217;s capital structure and, therefore, generally entail
less risk than the corporation&#8217;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#8217;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Stocks. </i>Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#8217;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#8217; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#8217;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#8217;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>U.S. Government Securities. </i>The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#8220;STRIPS&#8221;), all of which are backed by the full faith and</p></ix:continuation></div>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C00_gBFIOAPTB-BPKXUZ_zhBHnpsBEDY"><ix:continuation continuedAt="ConU000129-19" id="ConU000129-18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Securities. </i>While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#8217;s assets denominated in that currency and the Fund&#8217;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#8220;&#8212;Derivative Transactions&#8212;Foreign Currency Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sovereign and Supranational Obligations. </i>The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#8217;s and S&amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#8217;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#8217;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#8217;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<div id="xdx_C05_gBFIOAPTB-BPKXUZ_zqtHEzYRlvG1"><ix:continuation continuedAt="ConU000129-20" id="ConU000129-19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Stocks and Other Common Equity Securities.
</i>The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options. </i>As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#8220;American style&#8221; options may be exercised at any time during the term of the option. Other options, known
as &#8220;European style&#8221; options, may be exercised only on the expiration date of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will follow a strategy known as &#8220;covered
call option writing,&#8221; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as disclosed further below and in connection
with the Fund&#8217;s Debt Overlay Strategy, the Fund may not sell &#8220;naked&#8221; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#8220;covered&#8221;
if the Fund owns the security <span style="background-color: white">or instrument</span> underlying the call or has an absolute and immediate
right to acquire that security <span style="background-color: white">or instrument</span> without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<div id="xdx_C0B_gBFIOAPTB-BPKXUZ_zhqXMiTaoN1a"><ix:continuation continuedAt="ConU000129-21" id="ConU000129-20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#8217;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#8217;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#8217;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Restricted and Illiquid Securities. </i>The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Government Sponsored Investment Programs</i>.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Derivatives Transactions</i>. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; </p></ix:continuation></div>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C00_gBFIOAPTB-BPKXUZ_z9paXzxezpq6"><ix:continuation continuedAt="ConU000129-22" id="ConU000129-21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#8217;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#8220;VaR&#8221;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#8220;limited derivatives users&#8221; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#8220;limited derivatives user&#8221; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#8217;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#8220;interested persons&#8221; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#8217;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#8217;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#8220;derivatives transaction&#8221; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Credit Derivatives. </i>Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#8220;buyer&#8221; in a credit default swap contract
is obligated to pay the &#8220;seller&#8221; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#8220;par value,&#8221; of the reference obligation. Credit default swap transactions are either &#8220;physical delivery&#8221; settled
or </p></ix:continuation></div>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0A_gBFIOAPTB-BPKXUZ_zBFXmDmq1wz3"><ix:continuation continuedAt="ConU000129-23" id="ConU000129-22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#8220;cash&#8221; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Currency Transactions. </i>The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Sub-Adviser seeks to use derivatives
to further the Fund&#8217;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#8217;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#8220;Investment Objective and Policies&#8212;Derivative Instruments&#8221; in the Fund&#8217;s SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Municipal Securities</i>. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Temporary Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;P
or Prime-1 by Moody&#8217;s; and certificates of deposit and bankers&#8217; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#8217;s limitations on investments in other investment companies. See &#8220;Investment Restrictions&#8221; in
the Fund&#8217;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#8220;Management of
the Fund.&#8221; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<div id="xdx_C09_gBFIOAPTB-BPKXUZ_zueQmpDIIM54"><ix:continuation continuedAt="ConU000129-24" id="ConU000129-23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Certain Other Investment Practices</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>When Issued, Delayed Delivery Securities
and Forward Commitments</i>. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#8220;when
issued&#8221; or &#8220;delayed delivery&#8221; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#8217;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#8217;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Loans of Portfolio Securities</i>. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#8217;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#8217;s ability to sell the collateral and the Fund would suffer a
loss. See &#8220;Investment Objective and Policies Loans of Portfolio Securities&#8221; in the Fund&#8217;s SAI.<br/>
<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offsetting. </i>In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#8220;ISDA Master Agreement&#8221;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The </p></ix:continuation></div>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C08_gBFIOAPTB-BPKXUZ_z53H7Ao9gqbe"><ix:continuation continuedAt="ConU000129-25" id="ConU000129-24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Repurchase Agreements</i>. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#8220;Qualifying
Collateral&#8221;) and meet certain liquidity standards generally may be deemed to be &#8220;collateralized fully&#8221; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#8220;Alternative Collateral&#8221;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#8220;collateralized fully&#8221; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#8220;collateralized fully&#8221; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#8217;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#8217;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#8217;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Reverse Repurchase Agreements</i>. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#8217;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss </p></ix:continuation></div>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0F_gBFIOAPTB-BPKXUZ_zjpT9HffOw96"><ix:continuation continuedAt="ConU000129-26" id="ConU000129-25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#8217;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#8217;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#8217;s cash available for distribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Sleeve Structure.
</i>The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#8217;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#8217;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Interest Rate <span style="color: windowtext">Transactions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Interest Rate Transactions,&#8221;
which is incorporated by reference herein, for a discussion of the Fund&#8217;s use of interest rate transactions in connection with the
Fund&#8217;s use of Financial Leverage.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Portfolio Turnover</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#8217;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#8217;s portfolio turnover rate was 25% and 30%, respectively.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Restrictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#8220;Investment Restrictions&#8221;
in the SAI for a complete list of the fundamental investment policies of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="ProUseLeverage"></span>Use of Leverage</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Use of Leverage,&#8221; which is incorporated
by reference herein, for a discussion of the Fund&#8217;s use of leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">See the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Borrowing</i>. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#8217;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the </p></ix:continuation></div>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0F_gBFIOAPTB-BPKXUZ_zRstkD48gdK5"><ix:continuation continuedAt="ConU000129-27" id="ConU000129-26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#8217;s portfolio in accordance with the Fund&#8217;s investment objective and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#8217;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#8217;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#8217;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#8217;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#8217;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#8217;s audited and unaudited financial statements contained in the Fund&#8217;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Reverse Repurchase Agreements and Dollar Roll
Transactions. </i>The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
</p></ix:continuation></div>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C04_gBFIOAPTB-BPKXUZ_z9x3p2w0Kude"><ix:continuation id="ConU000129-27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Shares.</i> The Fund&#8217;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.</p></ix:continuation></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Effects
of Financial Leverage</i><span style="color: windowtext">. Please refer to the section of the </span></span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Effects of Leverage,&#8221; which is
incorporated by reference herein, for a discussion of the effects of leverage.</span></p>

<p id="ProRisks" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center">Risks</p>

<p id="xdx_984_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--PrincipalRisksMember_zOhC3eiJAmye" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_PrincipalRisksMember" escape="true" id="Fact000130" name="cef:RiskTextBlock"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; text-transform: none">Principal Risks of the Fund,&#8221;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.</span></ix:nonNumeric></p>

<p id="xdx_987_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--MarketDiscountAndPriceVolatilityRiskMember_gBFRTB-JTXN_ztRD9HRsfafh" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember" continuedAt="ConU000133-01" escape="true" id="Fact000133" name="cef:RiskTextBlock"><b>Market Discount and Price Volatility Risk</b></ix:nonNumeric></p>

<div id="xdx_C0D_gBFRTB-JTXN_zxcSudC6t4Od"><ix:continuation continuedAt="ConU000133-02" id="ConU000133-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#8217;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often</p></ix:continuation></div>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C02_gBFRTB-JTXN_z70on9szaupj"><ix:continuation id="ConU000133-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#8217;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#8217;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#8217;s net asset value as a result of the Fund&#8217;s
investment activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#8217;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.</p></ix:continuation></div>

<p id="xdx_982_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--DebtOverlayStrategyRiskMember_gBFRTB-BMWA_zaly9NEDbsoi" style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember" continuedAt="ConU000136-01" escape="true" id="Fact000136" name="cef:RiskTextBlock"><b>Debt Overlay Strategy Risk</b></ix:nonNumeric></p>

<div id="xdx_C0C_gBFRTB-BMWA_zQrSYLs7KWhd"><ix:continuation continuedAt="ConU000136-02" id="ConU000136-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#8217;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#8217;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The call options sold as part of the Debt Overlay
Strategy are generally not &#8220;covered.&#8221; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund</p></ix:continuation></div>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFRTB-BMWA_zqLLot7cSIFi"><ix:continuation id="ConU000136-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#8217;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#8220;naked&#8221; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#8220;Risks Associated with the Fund&#8217;s Covered Call Option Strategy and Put Options,&#8221; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.</p></ix:continuation></div>

<p id="xdx_985_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--SyntheticAutocallableELNStrategyRiskMember_gBFRTB-WQGPR_zhpFuvuy832a" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember" continuedAt="ConU000139-01" escape="true" id="Fact000139" name="cef:RiskTextBlock"><b>Synthetic Autocallable ELN Strategy Risk</b></ix:nonNumeric></p>

<div id="xdx_C0E_gBFRTB-WQGPR_zzbvOrmOByWl"><ix:continuation continuedAt="ConU000139-02" id="ConU000139-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;</td></tr></table>
</ix:continuation></div>
<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

    <div id="xdx_C0B_gBFRTB-WQGPR_zZzeh3lyHij8"><ix:continuation id="ConU000139-02">
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">


<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).</td></tr></table></ix:continuation></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProManagementFund"></span>Management of
the Fund</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Trustees and Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees is broadly responsible
for the management of the Fund, including general supervision of the duties performed by the Investment Adviser and the Sub-Adviser. The
names and business addresses of the Trustees and officers of the Fund and their principal occupations and other affiliations during the
past five years are set forth under &#8220;Management of the Fund&#8221; in the SAI.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Advisers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Adviser</i>. Guggenheim Funds Investment
Advisors, LLC acts as the Fund&#8217;s Investment Adviser pursuant to the Advisory Agreement (as defined below). The Investment Adviser
is a registered investment adviser and acts as investment adviser to a number of closed-end and open-end management investment companies.
The Investment Adviser is a Delaware limited liability company, with its principal offices located at 227 West Monroe Street, Chicago,
Illinois 60606. The Investment Adviser is responsible for the management of the Fund. The Investment Adviser furnishes office facilities
and equipment and clerical, bookkeeping and administrative services on behalf of the Fund and oversees the activities of the Fund&#8217;s
Sub-Adviser. The Investment Adviser provides all services through the medium of any directors, officers or employees of the Investment
Adviser or its affiliates as the Investment Adviser deems appropriate in order to fulfill its obligations. The Investment Adviser pays
the compensation of all officers and Trustees of the Fund who are its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sub-Adviser</i>. Guggenheim Partners Investment
Management, LLC acts as the Fund&#8217;s Sub-Adviser pursuant to the Sub-Advisory Agreement (as defined below). The Sub-Adviser is a Delaware
limited liability company, with its principal offices located at 100 Wilshire Boulevard, Santa Monica, California 90401. The Sub-Adviser,
under the oversight and supervision of the Board of Trustees and the Investment Adviser, manages the investment of the assets of the Fund
in accordance with its investment policies, places orders to purchase and sell securities on behalf of the Fund, and, at the request of
the Investment Adviser, consults with the Investment Adviser as to the overall management of the assets of the Fund and its investment
policies and practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Investment Adviser and Sub-Adviser make investment
decisions for the assets of the Fund and continuously review,&#160;supervise and administer the Fund&#8217;s investment program. In carrying
out these functions, the personnel of the Investment&#160;Adviser and Sub-Adviser operate in teams with various roles. For example, the
macroeconomic research team develops&#160;the outlook for key economic themes and trends; a sector/security research team selects specific
securities for investment consideration and identifies the outlook for different sectors; a portfolio construction team targets investment
portfolio positionings and sector weightings; and the portfolio </p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">management team provides portfolio monitoring and implementation and risk
management services.&#160;The Investment Adviser and Sub-Adviser have created a fixed-income&#160;investment process designed around the
specialization of functions and advances in behavioral finance in an&#160;effort&#160;to make investment decisions that seek to avoid
behavioral anomalies and cognitive biases. To accomplish this, the&#160;Investment Adviser and Sub-Adviser have disaggregated the primary
functions of investment management into four specialized teams that work in a systematic process. The teams are (1)&#160;Macroeconomic
Research and Market Strategy,&#160;(2) Sector Teams,&#160;(3) Portfolio Construction, and (4) Portfolio Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Each of the Investment Adviser and the Sub-Adviser
is a wholly-owned subsidiary of Guggenheim Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial
services firm with wealth management, capital markets, investment management and proprietary investing businesses, the clients of which
are a mix of individuals, family offices, endowments, investment funds, foundations, insurance companies and other institutions that have
entrusted Guggenheim Partners with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners
is headquartered in Chicago and New York with a global network of offices throughout the United States, Europe, and Asia.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#8220;Guggenheim Investments&#8221; refers to
the global asset management and investment advisory division of Guggenheim Partners and includes the Investment Adviser, the Sub-Adviser
and other affiliated investment management businesses of Guggenheim Partners.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Advisory Agreement and Sub-Advisory
Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to an investment advisory agreement
between the Fund and the Investment Adviser (the &#8220;Advisory Agreement&#8221;), the Fund pays the Investment Adviser a fee, payable
monthly in arrears at an annual rate equal to 1.00% of the Fund&#8217;s average daily Managed Assets (from which the Investment Adviser
pays the Sub-Adviser&#8217;s fees), as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to an investment sub-advisory agreement
among the Fund, the Investment Adviser and the Sub-Adviser (the &#8220;Sub-Advisory Agreement&#8221;), the Investment Adviser pays the
Sub-Adviser a fee, payable monthly in arrears at an annual rate equal to 0.50% of the Fund&#8217;s average daily Managed Assets, less
0.50% of the Fund&#8217;s average daily assets attributable to any investments by the Fund in Affiliated Investment Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A discussion regarding the basis for the most
recent approval of the Advisory Agreement and the Sub-Advisory Agreement by the Board of Trustees is available in the Fund&#8217;s annual
report to shareholders for the period ending May 31, 2025.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Portfolio Management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s personnel primarily responsible
for the day-to-day management of the Fund&#8217;s portfolio are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Anne B. Walsh, Managing Partner, Chief Investment
Officer and Portfolio Manager of Guggenheim Investments.</i> Ms. Walsh joined Guggenheim Investments (or its affiliate or predecessor)
in 2007. Ms. Walsh provides the vision guiding the firm&#8217;s investment strategies and leads the investment process to include the
macroeconomic outlook, portfolio design, sector allocation, and risk management. She also chairs the Environmental, Social, and Governance
(ESG) Oversight Committee and the Alternatives Investment Committee. Ms. Walsh, whose career in financial services spans nearly four decades,
is highly regarded for her active fixed-income, alternatives, and insurance portfolio management expertise in addition to deep background
in credit and liability managed investment.&#160;She is&#160;also a member of the Investor Advisory Committee on Financial Markets (IACFM),
an advisory body to the President of the New York Fed.&#160;Ms. Walsh holds a BSBA and MBA from Auburn University, and a JD from the University
of&#160;Miami School of Law. She has earned the right to use the Chartered Financial Analyst&#174;&#160;designation and is a member of
the CFA Institute.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Steven H. Brown, CFA, Chief Investment Officer,
Fixed Income, and Senior Managing Director and Portfolio Manager of Guggenheim Investments</i>. Mr. Brown joined Guggenheim Investments
(or its affiliate or predecessor) in 2010. Mr. Brown works with the Chief Investment Officer&#160;the Sector Teams, Portfolio Management,
Macroeconomic Research,&#160;and the Portfolio Construction Group&#160;to develop and execute investment strategy. Mr. Brown was previously
a&#160;member of&#160;the structured credit sector team at Guggenheim. Prior to joining Guggenheim, Mr. Brown held roles focused on structured
products at Bank of America and ABN AMRO. Mr. Brown received a B.S.&#160;in Finance from&#160;Indiana University's Kelley School of Business.
He has earned the right to use the Chartered Financial Analyst&#174;&#160;designation and is a member of the CFA Institute.</p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Adam J. Bloch, Managing Director and Portfolio
Manager of Guggenheim Investments</i>. Mr. Bloch joined&#160;Guggenheim Investments in 2012 and is a Portfolio Manager for the firm's
Active Fixed Income and Total Return mandates.&#160;He oversees strategy implementation, working with research analysts and traders to
generate trade ideas&#160;and manage day-to-day risk. Mr. Bloch works with the Chief Investment Officers, the Sector Teams, the&#160;Macroeconomic
Research and Market Strategy Group, and the Portfolio Construction Group to develop and execute investment strategy.&#160;Prior to joining
Guggenheim Investments, he worked in Leveraged Finance at Bank of America&#160;Merrill Lynch&#160;where he structured high-yield bonds
and leveraged loans for leveraged buyouts, restructurings, and&#160;corporate refinancings across multiple industries. Mr. Bloch graduated
with a&#160;B.A.&#160;in Philosophy, Politics, and Economics from the University of Pennsylvania.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Evan L. Serdensky, Managing Director and Portfolio
Manager of Guggenheim Investments</i>. Mr. Serdensky joined&#160;Guggenheim in 2018 and is a Portfolio Manager for Guggenheim&#8217;s
Active Fixed Income and Total Return mandates. Previously, Mr. Serdensky was a Trader on the Investment Grade Corporate team at Guggenheim
Investments, where he was responsible for identifying and executing investment opportunities across corporate securities. Prior to joining
Guggenheim, Mr. Serdensky was a Vice President and Portfolio Manager at BlackRock, responsible for actively managing High Yield and Multi-Sector
Credit portfolios. Mr. Serdensky started his career at PIMCO supporting Total Return and Alternative strategies. Mr. Serdensky completed
his B.S. in Finance from the University&#160;of Maryland and earned his M.S. in Finance from the Washington University in St. Louis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The SAI provides additional information about
the portfolio managers&#8217; compensation, other accounts managed by the portfolio managers and the portfolio managers&#8217; ownership
of securities of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProNetAssetValue"></span>Net Asset Value</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value of the Common Shares is calculated
by subtracting the Fund&#8217;s total liabilities (including from Borrowings) and the liquidation preference of any outstanding Preferred
Shares from total assets (the current market value of the securities the Fund holds plus cash and other assets). The per share net asset
value is calculated by dividing its net asset value by the number of Common Shares outstanding and rounding the result to the nearest
full cent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund generally calculates its net asset value
once each day on which there is a regular trading session on the NYSE as of the scheduled close of normal trading on the &#8220;NYSE&#8221;
(normally 4:00 p.m., Eastern time). The NYSE is open Monday through Friday, except on observation of the following holidays: New Year&#8217;s
Day, Martin Luther King, Jr. Day, President&#8217;s Day, Good Friday, Memorial Day, Juneteenth, Independence Day, Labor Day, Thanksgiving
Day and Christmas Day. If the NYSE has an earlier closing time (scheduled or unscheduled), such as on days in advance of holidays generally
observed by the NYSE, the Fund may calculate its net asset value as of the earlier closing time or calculate its net asset value as of
the normally scheduled close of regular trading on the NYSE for that day, so long as the Investment Adviser, with the assistance of the
Sub-Adviser, believes there generally remains an adequate market to obtain reliable and accurate market quotations. The Fund generally
does not calculate its net asset value on any day that the NYSE is not open for business. However, if the NYSE is closed for any other
reason on a day it would normally be open for business, the Fund may calculate its net asset value as of the normally scheduled close
of regular trading on the NYSE for that day, so long as the Investment Adviser, with the assistance of the Sub-Adviser, believes there
generally remains an adequate market to obtain reliable and accurate market quotations. The Fund discloses its net asset value on a daily
basis. Information that becomes known to the Fund or its agent after the Fund&#8217;s net asset value has been calculated on a particular
day will not be used to retroactively adjust the price of a security or the Fund&#8217;s previously determined net asset value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees has adopted policies and
procedures for the valuation of the Fund&#8217;s investments (the &#8220;Fund Valuation Procedures&#8221;). Pursuant to Rule 2a-5 under
the 1940 Act, the Board designated the Investment Adviser as the valuation designee to perform fair valuation determinations for the Fund
with respect to all Fund investments and/or other assets. As the Fund&#8217;s valuation designee pursuant to Rule 2a-5, the Investment
Adviser has adopted separate procedures (the &#8220;Valuation Designee Procedures&#8221; and collectively with the Fund Valuation Procedures,
the &#8220;Valuation Procedures&#8221;) reasonably designed to prevent violations of the requirements of Rule 2a-5 and Rule 31a-4 under
the 1940 Act. The Investment Adviser, in its role as valuation designee, utilizes the assistance of a valuation committee, consisting
of representatives from Guggenheim&#8217;s investment management, fund administration, legal and compliance departments (the &#8220;Valuation
Committee&#8221;), in determining fair value of the Fund&#8217;s securities and/or other assets. The Valuation Procedures permit the Fund
to use a variety of valuation methodologies in connection with valuing the Fund&#8217;s investments. The methodology used for a specific
type of investment may vary based on available market data or other relevant considerations. As a general matter, valuing </p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities and
assets accurately is difficult and can be based on inputs and assumptions, which may not always be accurate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In general, portfolio securities and assets of
the Fund will be valued on the basis of readily available market quotations at their current market value. With respect to portfolio securities
and assets of the Fund for which market quotations are not readily available, or are deemed unreliable by the Investment Adviser, the
Fund will fair value those securities and assets in good faith in accordance with the Valuation Procedures. Valuations in accordance with
these methods are intended to reflect each security&#8217;s (or asset&#8217;s or liability&#8217;s) &#8220;fair value.&#8221; Fair value
represents a good faith approximation of the value of a security. Fair value determinations may be based on limited inputs and involve
the consideration of a number of subjective factors, an analysis of applicable facts and circumstances, and the exercise of judgment.
Each such determination is based on a consideration of all relevant factors, which are likely to vary from one pricing context to another.
Examples of such factors may include, but are not limited to: market prices; sale prices; broker quotes; and models which derive prices
based on inputs such as prices of securities with comparable maturities and characteristics, or based on inputs such as anticipated cash
flows or collateral, spread over U.S. Treasury securities, and other information analysis. As a result, it is possible that the fair value
for a security determined in good faith in accordance with the Valuation Procedures may differ from valuations for the same security determined
by other funds using their own valuation procedures. Although the Valuation Procedures are designed to value a portfolio security or asset
at the price the Fund may reasonably expect to receive upon its sale in an orderly transaction, there can be no assurance that any fair
value determination thereunder would, in fact, approximate the amount that the Fund could reasonably expect to receive upon the sale of
the portfolio security or asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Equity securities listed or traded on a recognized
U.S. securities exchange or the Nasdaq Stock Market (&#8220;NASDAQ&#8221;) are generally valued on the basis of the last sale price on
the primary U.S. exchange or market on which the security is listed or traded; provided, however, that securities listed on NASDAQ will
be valued at the NASDAQ official closing price, which may not necessarily represent the last sale price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Open-end investment companies are valued at their
net asset value as of the close of the NYSE, on the valuation date. Exchange-traded funds and closed-end investment companies are generally
valued at the last quoted sale price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Commercial paper and discount notes with a maturity
of greater than 60 days at acquisition are valued at prices that are obtained from independent
third party pricing services, which may consider the trade activity, treasury spreads, yields or prices of bonds of comparable quality,
coupon, maturity, and type, as well as prices quoted by dealers who make markets in such securities. Commercial paper and discount notes
with a maturity of 60 days or less at acquisition are valued at amortized cost, unless the Investment Adviser concludes that amortized
cost does not represent the fair value of the applicable asset in which case it will be valued using an independent third party pricing
service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">CLOs, CDOs, MBS, ABS, and other structured finance
securities are generally valued using an independent third&#160;party pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">U.S. Government securities are valued by independent
third party pricing services, using the last traded fill price, or at the reported bid price at the close of business on the valuation
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Typically, loans are valued using information
provided by an independent third party pricing service that uses broker quotes, among other inputs. If the independent third party pricing
service cannot or does not provide a valuation for a particular loan, or such valuation is deemed unreliable by the Investment Adviser,
such investment is valued based on a quote from a broker-dealer or is fair valued by the Investment Adviser. The Fund invests in loans
and asset-backed securities as part of its investment strategies and has a significant amount of these instruments that are fair valued
by the Investment Adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Repurchase agreements are generally valued at
amortized cost, provided such amounts approximate market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Exchange-traded options are valued at the mean
of the bid and ask prices on the principal exchange on which they are traded. Over-the-counter (&#8220;OTC&#8221;) options and options
on swaps (&#8220;swaptions&#8221;) are valued using a price provided by a pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Futures contracts are valued on the basis of
the last sale price as of 4:00 p.m. on the valuation date. In the event that the exchange for a specific futures contract closes earlier
than 4:00 p.m., the futures contract is valued at </p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">the official settlement price of the exchange. However, the underlying securities from
which the futures contract value is derived are monitored until 4:00 p.m. to determine if fair valuation would provide a more accurate
valuation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Interest rate swap agreements entered into by
the Fund are valued on the basis of the last sale price on the primary exchange on which the swap is traded. Other swap agreements entered
into by the Fund are generally valued using an evaluated price provided by an independent third party pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Forward foreign currency exchange contracts are
valued daily based on the applicable exchange rate of the underlying currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Generally, trading in foreign securities markets
is substantially completed each day at various times prior to the close of the NYSE. The values of foreign securities are determined as
of the close of such foreign markets or the close of the NYSE, if earlier. All investments quoted in foreign currencies are valued in
U.S. dollars on the basis of the foreign currency exchange rates prevailing at the close of U.S. business at 4:00 p.m. E.T. Investments
in foreign securities may involve risks not present in domestic investments. The Investment Adviser will determine the current value of
such foreign securities by taking into consideration certain factors which may include those discussed above, as well as the following
factors, among others: the value of the securities traded on other foreign markets, American Depository Receipt trading, closed-end fund
trading, foreign currency exchange activity, and the trading prices of financial products that are tied to foreign securities. In addition,
under the Valuation Procedures , the Investment Adviser is authorized to use prices and other information supplied by an independent third-party
pricing vendor in valuing foreign securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may also fair value securities and other
assets when a significant event is deemed to have occurred after the time of a market quotation including for securities and assets traded
on foreign markets and securities and assets for which market quotations are provided by independent third party pricing services as of
a time that is prior to the time when the Fund determines its NAV. There can be no assurance in each case that significant events will
be identified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Valuations of the Fund&#8217;s securities and
other assets are supplied primarily by independent third-party pricing services appointed pursuant to the processes set forth in the Valuation
Designee Procedures. Valuations provided by the independent third-party pricing services are generally based on methods designed to approximate
the amount that the Fund could reasonably expect to receive upon the sale of the portfolio security or asset. When providing valuations
to the Fund, independent third-party pricing services use various inputs, methods, models and assumptions, which may include information
provided by broker-dealers and other market makers. Independent third-party pricing services face the same challenges as the Fund in valuing
securities and assets and may rely on limited available information. If the independent third-party pricing service cannot or does not
provide a valuation for a particular investment, or such valuation is deemed unreliable, such investment is fair valued by the Investment
Adviser. The Fund may also use third party service providers to model certain securities, using models to determine fair market value.
While the Fund&#8217;s use of fair valuation is intended to result in calculation of net asset value that fairly reflects values of the
Fund&#8217;s portfolio securities as of the time of pricing, the Fund cannot guarantee that any fair valuation will, in fact, approximate
the amount the Fund would actually realize upon the sale of the securities in question.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Quotes from broker-dealers (i.e., prices provided
by a broker-dealer or other market participant, which may or may not be committed to trade at that price), adjusted for fluctuations in
criteria such as credit spreads and interest rates, may also be used to value the Fund&#8217;s securities and other assets. Quotes from
broker-dealers and vendor prices based on broker quotes can vary in terms of depth (e.g., provided by a single broker-dealer) and frequency
(e.g., provided on a daily, weekly, or monthly basis, or any other regular or irregular interval). Although quotes from broker-dealers
and vendor prices based on broker quotes are typically received from established market participants, the Fund may not have the transparency
to view the underlying inputs which support such quotes. Significant changes in a quote from a broker-dealer would generally result in
significant changes in the fair value of the security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Proportions of the Fund&#8217;s investments that
are fair valued vary from time to time and the Fund may fair value a significant amount of its portfolio securities and other assets.
The Fund&#8217;s shareholder reports contain more information about the Fund&#8217;s holdings that are fair valued. Investors should consult
these reports for additional information. For underlying funds in which the Fund may invest, additional information about the circumstances
</p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">when those underlying funds may use fair value pricing may be found in each underlying fund&#8217;s respective prospectus.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDistributions"></span>Distributions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund intends to pay substantially all of
its net investment income, if any, to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any
net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on Common Shares will generally
consist of (i) investment company taxable income taxed as ordinary income, which includes, among other things, dividend and interest income
accrued on portfolio assets, short-term capital gain and income from certain hedging and interest rate transactions, (ii) long-term capital
gain and (iii) return of capital. To the extent the Fund receives dividends with respect to its investments in Common Equity Securities
that consist of qualified dividend income (income from domestic and certain foreign corporations), a portion of the Fund&#8217;s distributions
to its Common Shareholders may consist of qualified dividend income. Qualified dividend income and long-term capital gains of certain
non-corporate U.S. Common Shareholders (including individuals) will be taxable at reduced maximum rates. The Fund cannot assure you, however,
as to what percentage of the dividends paid on Common Shares, if any, will consist of qualified dividend income or long-term capital gains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to the requirements of the 1940 Act,
in the event the Fund makes distributions from sources other than income, a notice will accompany each monthly distribution with respect
to the estimated source of the distribution made. Such notices will describe the portion, if any, of the monthly dividend which, in the
Fund&#8217;s good faith judgment, constitutes long-term capital gain, short-term capital gain, investment company taxable income or a
return of capital. The actual character of such dividend distributions for U.S. federal income tax purposes, however, will only be determined
finally by the Fund at the close of its fiscal year, based on the Fund&#8217;s full year performance and its actual net investment company
taxable income and net capital gains for the year, which may result in a recharacterization of amounts distributed during such fiscal
year from the characterization in the monthly estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s distributions may be greater
than the Fund&#8217;s net investment income or profit. As a result, all or a portion of a distribution may be a return of capital, which
is in effect a partial return of the amount a Common Shareholder invested in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Fund&#8217;s total distributions in any
year exceed the amount of its investment company taxable income and net capital gain for the year, any such excess would generally be
characterized as a return of capital for U.S. federal income tax purposes, to the extent such amounts exceed the Fund&#8217;s current
and accumulated earning and profits. For example, because of the nature of the Fund&#8217;s investments, the Fund may distribute net short-term
capital gains early in the calendar year, but incur net short-term capital losses later in the year, thereby offsetting the short-term
net capital gains for which distributions have already been made by the Fund. In such a situation, the amount by which the Fund&#8217;s
total distributions exceed the Fund&#8217;s current and accumulated earning and profits would generally be treated as a tax-free return
of capital up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis, with
any amounts exceeding such basis treated as a gain from the sale of their Common Shares. Although a return of capital may not be taxable,
it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the Common Shareholder&#8217;s potential loss, on
any subsequent sale or other disposition of Common Shares. Common Shareholders who receive the payment of a distribution consisting of
a return of capital may be under the impression that they are receiving net investment income or profits when they are not. Common Shareholders
should not assume that the source of a distribution from the Fund is net investment income or profit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund expects that over time it will distribute
all of its investment company taxable income. The investment company taxable income of the Fund will consist of all dividend and interest
income accrued on portfolio assets, short-term capital gain and income from certain hedging and interest rate transactions, less all expenses
of the Fund. Expenses of the Fund will be accrued each day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To permit the Fund to maintain more stable monthly
distributions, the Fund may distribute more or less than the entire amount of the net investment income earned in a particular period.
As a result, the distributions paid by the Fund for any particular monthly period may be more or less than the amount of net investment
income actually earned by the Fund during the period, and, to pay distributions, the Fund may have to use net proceeds of an offering
or sell a portion of its investment portfolio to make a distribution at a time when independent investment judgment might not dictate
such action. Any undistributed net investment income may be available to supplement future distributions. Undistributed net investment
income is included in the Common Shares&#8217; net asset value, and, </p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">correspondingly, distributions from net investment income will reduce
the Common Shares&#8217; net asset value. In certain circumstances, the Fund may elect to retain income or capital gain and pay income
or excise tax on such undistributed amount. During the Fund&#8217;s fiscal year ended May 31, 2025, the Fund paid excise tax of $0. See
&#8220;U.S. Federal Income Tax Considerations.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Distributions paid on the Common Shares
that consist of investment company taxable income and/or long-term capital gains are taxable even if they are paid from income or
gains earned by the Fund before your investment in the Fund (and thus were included in the price paid for your Common Shares). These
distributions are likely to occur in respect of Common Shares purchased at a time when the Fund&#8217;s net asset value
(&#8220;NAV&#8221;) reflects earnings realized but not distributed. These distributions may be taxable despite constituting an
economic return of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s distribution rate is not constant
and the amount of distributions, when declared by the Board of Trustees, is subject to change. There is no guarantee of any future distribution
or that the current returns and distribution rates will be maintained. The Fund reserves the right to change its distribution policy and
the basis for establishing the rate of distributions at any time and may do so without prior notice to Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If you hold your Common Shares in your own name
or if you hold your Common Shares with a brokerage firm that participates in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;),
unless you elect to receive cash, all dividends and distributions that are declared by the Fund will be automatically reinvested in additional
Common Shares of the Fund pursuant to the Plan. If you hold your Common Shares with a brokerage firm that does not participate in the
Plan, you will not be able to participate in the Plan and any dividend reinvestment may be effected on different terms than those described
below. Consult your financial adviser for more information. See &#8220;Dividend Reinvestment Plan.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDividend"></span>Dividend Reinvestment
Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Dividend Reinvestment
Plan,&#8221; which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment plan.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDescCapStruct"></span>Description of
Capital Structure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is an unincorporated statutory trust
organized under the laws of Delaware pursuant to a Certificate of Trust, dated as of November 13, 2006, and pursuant to an Amended and
Restated Agreement and Declaration of Trust, dated as of February 29, 2024, as amended and/or restated from time to time (the &#8220;Declaration
of Trust&#8221;). The following is a brief description of the terms of the Common Shares, Borrowings and Preferred Shares which may be
issued by the Fund. This description does not purport to be complete and is qualified by reference to the Fund&#8217;s Governing Documents.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is an unincorporated statutory trust
organized under the laws of Delaware pursuant to a Certificate of Trust, dated as of November 13, 2006. Pursuant to the Declaration of
Trust, the Fund is authorized to issue an unlimited number of common shares of beneficial interest, par value $0.01 per share. Each Common
Share has one vote (fractional Common Shares are entitled to a vote of such fraction) and, when issued and paid for in accordance with
the terms of this offering, will be fully paid and non-assessable, except that the Board of Trustees shall have the power to cause shareholders
to pay certain expenses of the Fund by setting off charges due from shareholders from declared but unpaid dividends or distributions owed
the shareholders and/or by reducing the number of Common Shares owned by each respective shareholder. <span>All Common Shares are equal as to
dividends, assets and voting privileges and shall not entitle the holders to preference, preemptive, appraisal, conversion or exchange
rights, except as otherwise required by law or permitted by the Declaration of Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under Delaware law applicable to the Fund as
of August 1, 2022, if a shareholder acquires direct or indirect ownership or power to direct the voting of shares of the Fund in an amount
that equals or exceeds certain percentage thresholds specified under Delaware law (beginning at 10% or more of shares of the Fund), the
shareholder&#8217;s ability to vote certain of these shares may be limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will send annual and semi-annual reports,
including financial statements, to all Common Shareholders, as required by applicable law or regulation.</p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any additional offerings of Common Shares will
require approval by the Board of Trustees. Any additional offering of Common Shares will be subject to the requirements of the 1940 Act,
which provides that shares may not be issued at a price below the then current net asset value, exclusive of distributing commissions
or discounts, except in connection with an offering to existing Common Shareholders, with the consent of a majority of the Fund&#8217;s
outstanding voting securities or as otherwise permitted under the 1940 Act.</p>

<p id="xdx_98F_ecef--SecurityVotingRightsTextBlock_c20251121__20251121_zIE3uNwvpVua" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000140" name="cef:SecurityVotingRightsTextBlock"><i>Voting
Rights</i>. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#8217;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#8217;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#8217;s Trustees, and will have certain other voting rights. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s Governing
Documents.&#8221;</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Issuance of Additional Common Shares. </i>The
provisions of the 1940 Act generally require that the public offering price (less underwriting commissions and discounts) of common shares
sold by a closed-end investment company must equal or exceed the net asset value of such company&#8217;s common shares (calculated within
48 hours of the pricing of such offering, excluding Sundays and holidays), unless such sale is made with the consent of a majority of
its common shareholders and under certain other enumerated circumstances. The Fund may, from time to time, seek the consent of Common
Shareholders to permit the issuance and sale by the Fund of Common Shares at a price below the Fund&#8217;s then-current net asset value,
subject to certain conditions. If such consent is obtained, the Fund may, contemporaneous with and in no event more than one year following
the receipt of such consent, sell Common Shares at a price below net asset value in accordance with any conditions adopted in connection
with the giving of such consent. Additional information regarding any consent of Common Shareholders obtained by the Fund and the applicable
conditions imposed on the issuance and sale by the Fund of Common Shares at a price below net asset value will be disclosed in the Prospectus
Supplement relating to any such offering of Common Shares at a price below net asset value. Until such consent of Common Shareholders,
if any, is obtained (or other applicable 1940 Act requirements are met), the Fund may not sell Common Shares at a price below net asset
value. Because the Fund&#8217;s advisory fee and sub-advisory fee are based upon average Managed Assets, the Investment Adviser&#8217;s
and the Sub-Adviser&#8217;s interests in recommending the issuance and sale of Common Shares at a price below net asset value may conflict
with the interests of the Fund and its Common Shareholders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Borrowings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The Fund is
permitted, without prior approval of the Common Shareholders, to borrow money. The Fund may issue notes or other evidence of indebtedness
(including bank borrowings or commercial paper) and may secure any such Borrowings by mortgaging, pledging or otherwise subjecting the
Fund&#8217;s assets as security. In connection with such Borrowings, the Fund may be required to maintain minimum average balances with
the lender or to pay a commitment or other fee to maintain a line of credit. Any such requirements will increase the cost of borrowing
over the stated interest rate.</span></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-weight: normal"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Limitations</i>.
Borrowings by the Fund are subject to certain limitations under the 1940 Act, including the amount of asset coverage required. In addition,
agreements related to the Borrowings may also impose certain requirements, which may be more stringent than those imposed by the 1940
Act. See &#8220;Use of Leverage.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Distribution
Preference</i>. The rights of lenders to the Fund to receive interest on, and repayment of, principal of any such Borrowings will be senior
to those of the Common Shareholders, and the terms of any such Borrowings may contain provisions which limit certain activities of the
Fund, including the payment of dividends to Common Shareholders in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Voting Rights</i>.
The 1940 Act does (in certain circumstances) grant to the lenders to the Fund certain voting rights in the event of default in the payment
of interest on, or repayment of, principal. Any Borrowings will likely be ranked senior or equal to all other existing and future borrowings
of the Fund.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Preferred Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The Fund&#8217;s
Governing Documents provide that the Board of Trustees may authorize and issue Preferred Shares with rights as determined by the Board
of Trustees, by action of the Board of Trustees without prior approval of the holders of the Common Shares. Common Shareholders have no
preemptive right to purchase any Preferred Shares that might be issued. Under the 1940 Act, the Fund may not issue Preferred Shares if,
immediately after issuance, the Fund would have asset coverage (as defined in the 1940 Act) of less than 200%, calculated as the ratio
of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount
of the Fund&#8217;s outstanding senior securities representing indebtedness plus the aggregate liquidation preference of any outstanding
shares of preferred stock. In addition, the Fund generally is not permitted to declare any cash dividend or other distribution on the
Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the time of such declaration, the Fund would have asset coverage
(as described above) of at least 200% after deducting the amount of such dividend or other distribution. The 1940 Act grants to the holders
of senior securities representing stock issued by the Fund certain voting rights. Failure to maintain certain asset coverage requirements
under the 1940 Act could entitle the holders of Preferred Shares to elect a majority of the Board. If the Fund issues and has Preferred
Shares outstanding, the Common Shareholders will generally not be entitled to receive any distributions from the Fund unless all accrued
dividends on Preferred Shares have been paid. Issuance of Preferred Shares would constitute financial leverage and would entail special
risks to the Common Shareholders. The Fund has no present intention to issue Preferred Shares.</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<div id="xdx_880_ecef--CapitalStockTableTextBlock_zxw5abQ7kEtj"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000142" name="cef:CapitalStockTableTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Capitalization</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Title of Class</b></td>
    <td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount</b><br/>
<b>Authorized</b></td>
    <td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Held by the<br/>
Fund or for its Account</b></td>
    <td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Outstanding</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>Common shares of beneficial interest, par value $0.01 per share</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Unlimited</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#8212;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span><span id="xdx_90E_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zSfDQT4tjKYk"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="AsOf2025-11-21" id="Fact000143" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">199,267,847</ix:nonFraction></span></span></td></tr>
  </table></ix:nonNumeric></div>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProAntiTakeover"></span>Anti-Takeover and
Other Provisions in the Fund&#8217;s Governing Documents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund presently has provisions in its Governing
Documents which could have the effect of limiting, in each case, (i) the ability of other entities or persons to acquire control of the
Fund, (ii) the Fund&#8217;s freedom to engage in certain transactions or (iii) the ability of the Fund&#8217;s Board of Trustees or shareholders
to amend the Governing Documents or effectuate changes in the Fund&#8217;s management. These provisions of the Governing Documents of
the Fund may be regarded as &#8220;anti-takeover&#8221; provisions. The Board of Trustees is divided into two classes, with the terms
of one class expiring at each annual meeting of shareholders. At each annual meeting, one class of Trustees is elected to a two-year term.
This provision could delay for up to one year the replacement of a majority of the Board of Trustees. A Trustee may be removed from office,
for cause only, and not without cause, by the action of a majority of the remaining Trustees followed by a vote of the holders of at least
75% of the shares then entitled to vote for the election of the respective Trustee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Declaration of Trust requires
the affirmative vote or consent of a majority of the Board of Trustees followed by the affirmative vote of the holders of at least 75%
of the outstanding shares of each affected class or series of the Fund, voting separately as a class or series, to approve, adopt or authorize
certain transactions with 5% or greater holders of a class or series of shares and their associates, unless the transaction has been approved
by at least 80% of the Board Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined in the
1940 Act) of the Fund shall be required. For purposes of these provisions, a 5% or greater holder of a class or series of shares (a &#8220;Principal
Shareholder&#8221;) refers to any person who, whether directly or indirectly and whether alone or together with its affiliates and associates,
beneficially owns 5% or more of the outstanding shares of any class or series of shares of beneficial interest of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 5% holder transactions subject to these special
approval requirements are:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal Shareholder;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the issuance of any securities of the Fund to any Principal Shareholder for cash (other than pursuant to any automatic dividend reinvestment
plan);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal Shareholder, except assets having
an aggregate fair market value of less than $1,000,000, aggregating for purpose of such computation all assets sold, leased or exchanged
in any series of similar transactions within a twelve-month period; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange to the Fund or any subsidiary of the Fund, in exchange for securities of the Fund, of any assets of any
Principal Shareholder, except assets having an aggregate fair market value of less than $1,000,000, aggregating for purposes of such computation
all assets sold, leased or exchanged in any series of similar transactions within a twelve-month period.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To liquidate the Fund, the Declaration of Trust
requires the affirmative vote of a majority of the Board of Trustees followed by the affirmative vote of the holders of at least 75% of
the outstanding shares of each affected class or series of the Fund, voting separately as a class or series, unless such liquidation has
been approved by at least 80% of Board of Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined
in the 1940 Act) of the Fund shall be required.</p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">For the purposes of calculating &#8220;a majority
of the outstanding voting securities&#8221; under the Declaration of Trust, each class and series of the Fund shall vote together as a
single class, except to the extent required by the 1940 Act or the Declaration of Trust with respect to any class or series of shares.
If a separate vote is required, the applicable proportion of shares of the class or series, voting as a separate class or series, also
will be required. A &#8220;majority of the outstanding voting securities&#8221; means the lesser of (i) 67% or more of the Fund&#8217;s
voting securities present at a meeting, if the holders of more than 50% of the Fund&#8217;s outstanding voting securities are present
or represented by proxy; or (ii) more than 50% of the Fund&#8217;s outstanding voting securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees has determined that provisions
with respect to the Board of Trustees and the shareholder voting requirements described above, which voting requirements are greater than
the minimum requirements under Delaware law or the 1940 Act, are in the best interest of shareholders generally. Reference should be made
to the Declaration of Trust on file with the SEC for the full text of these provisions. See &#8220;Additional Information.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Declaration of Trust contains
provisions relating to forum selection. For example, the Fund&#8217;s Declaration of Trust provides that, unless the Fund consents in
writing to the selection of an alternative forum, any claims, suits, actions or proceedings arising under the Securities Act shall be
exclusively brought in the federal district courts of the United States of America. The designation of exclusive forum may make it more
expensive for a shareholder to bring a suit and may limit a shareholder&#8217;s ability to litigate a claim in a jurisdiction or forum
that may be more convenient and that a shareholder believes is favorable to the shareholder for the claim.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProClosedEndFundStruct"></span>Closed-End Fund
Structure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Closed-end management investment companies (&#8220;closed-end
funds&#8221;) differ from open-end management investment companies (commonly referred to as &#8220;mutual funds&#8221;) in that closed-end
funds generally list their shares for trading on a securities exchange and do not redeem their shares at the option of the shareholder.
By comparison, mutual funds issue securities redeemable at net asset value at the option of the shareholder and typically engage in a
continuous offering of their shares. Mutual funds are subject to continuous asset in-flows and out-flows that can complicate portfolio
management, whereas closed-end funds generally can stay more fully invested in securities consistent with the closed-end fund&#8217;s
investment objective and policies. In addition, in comparison to open-end funds, closed-end funds have greater flexibility in their ability
to make certain types of investments, including investments in illiquid securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">However, shares of closed-end funds listed for
trading on a securities exchange frequently trade at a discount from net asset value, but in some cases trade at a premium. The market
price may be affected by trading volume of the shares, general market and economic conditions and other factors beyond the control of
the closed-end fund. The foregoing factors may result in the market price of the Common Shares being greater than, less than or equal
to net asset value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund reserves the right to merge or reorganize
with another fund, liquidate or convert into an open-end fund, in each case subject to applicable approvals by shareholders and the Fund&#8217;s
Board of Trustees as required by law and the Fund&#8217;s Governing Documents. The Board of Trustees has reviewed the structure of the
Fund in light of its investment objective and policies and has determined that the closed-end structure is in the best interests of the
shareholders. Investors should assume that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management
investment company.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProRepurchaseConversion"></span>Repurchase of
Common Shares; Conversion to Open-End Fund</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Repurchase of Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees will review periodically
the trading range and activity of the Fund&#8217;s shares with respect to its net asset value and may take certain actions to seek to
reduce or eliminate any such discount. Such actions may include open market repurchases or tender offers for the Common Shares at net
asset value. There can be no assurance that the Board of Trustees will decide to undertake any of these actions or that, if undertaken,
such actions would result in the Common Shares trading at a price equal to or closer to net asset value per Common Share.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Conversion to Open-End Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To convert the Fund to an open-end management
investment company, the Declaration of Trust requires the favorable vote of a majority of the Board of Trustees followed by the favorable
vote of the holders of at least </p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">75% of the outstanding shares of each affected class or series of shares of the Fund, voting separately
as a class or series, unless such action has been approved by at least 80% of the Board of Trustees, in which case &#8220;a majority of
the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund shall be required. A &#8220;majority of the outstanding
voting securities&#8221; means the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting, if the holders
of more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s
outstanding voting securities. The foregoing vote would satisfy a separate requirement in the 1940 Act that any conversion of the Fund
to an open-end management investment company be approved by the shareholders. If approved in the foregoing manner, conversion of the Fund
to an open-end management investment company could not occur until 90 days after the shareholders&#8217; meeting at which such conversion
was approved and would also require at least 30 days&#8217; prior notice to all shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event of conversion, the Common Shares
would cease to be listed on the NYSE or other national securities exchange or market system. If the Fund were converted to an open-end
management investment company, it is likely that new Common Shares would be sold at net asset value plus a sales load. The Board of Trustees
believes, however, that the closed-end structure is desirable, given the Fund&#8217;s investment objective and policies. Investors should
assume, therefore, that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management investment
company. Shareholders of an open-end management investment company may require the company to redeem their shares at any time (except
in certain circumstances as authorized by or under the 1940 Act) at their net asset value, less such redemption charge, if any, as might
be in effect at the time of a redemption. In the event of conversion, the Fund would expect to pay all such redemption requests in cash,
but would intend to reserve the right to pay redemption requests in a combination of cash or securities. If such partial payment in securities
were made, investors could incur brokerage costs in converting such securities to cash.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProUSFedIncTax"></span>U.S. Federal
Income Tax Considerations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="background-color: white">The following
discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the ownership and disposition of
the Fund&#8217;s Common Shares. A more complete discussion of the tax rules applicable to the Fund and its Common Shareholders can be
found in the SAI that is incorporated by reference into this Prospectus. Except as otherwise noted, this discussion assumes you are a
taxable U.S. person (as defined for U.S. federal income tax purposes) and that you hold your Common Shares as capital assets for U.S.
federal income tax purposes (generally, assets held for investments). This discussion is based upon current provisions of the Internal
Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative authorities,
all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal tax concerns affecting the
Fund and its Common Shareholders (including Common Shareholders subject to special treatment under U.S. federal income tax law). No assurance
can be given that the IRS would not assert, or that the court would not sustain, a position contrary to any of the tax aspects set forth
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The discussion set forth herein does not constitute
tax advice and potential investors are urged to consult their own tax advisers to determine the specific U.S. federal, state, local and
foreign tax consequences to them of investing in the Fund.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of the Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has elected to be treated and intends
to continue to qualify annually as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Code. Accordingly, the
Fund must, among other things, meet certain income, asset diversification and distribution requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(i)</td><td>The Fund must derive in each taxable year at least 90% of its gross income from the following sources: (a) dividends, interest (including
tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities
or foreign currencies, or other income (including gain from options, futures and forward contracts) derived with respect to its business
of investing in such stock, securities or foreign currencies; and (b) net income derived from interests in &#8220;qualified publicly traded
partnerships&#8221; (as defined in the Code). Generally, a qualified publicly traded partnership includes a partnership the interests
of which are traded on an established securities market or readily tradable on a secondary market (or the substantial equivalent thereof)
and that derives less than 90% of its gross income from the items described in (a) above.</td></tr></table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(ii)</td><td>The Fund must diversify its holdings so that, at the end of each quarter of each taxable year, (a) at least 50% of the market value
of the Fund&#8217;s total assets is represented by cash and cash items, including receivables, </td></tr></table>
<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"/><td> U.S. government securities, the securities
of other RICs and other securities, with such other securities limited, in respect of any one issuer, to an amount not greater than 5%
of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer and (b) not more
than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. government securities and
the securities of other RICs) of (I) any one issuer, (II) any two or more issuers that the Fund controls and that are determined to be
engaged in the same business or similar or related trades or businesses or (III) any one or more &#8220;qualified publicly traded partnerships&#8221;
(as defined in the Code).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As long as the Fund qualifies as a RIC, the Fund
generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its Common Shareholders, provided
that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company taxable income (which includes,
among other items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable
income, other than any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for
dividends and distributions paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest
over certain disallowed deductions). The Fund intends to distribute substantially all of such income each year. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will either distribute or retain for
reinvestment all or part of its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term
capital loss). If any such gain is retained, the Fund will be subject to a corporate income tax (at regular corporate rates) on such retained
amount. In that event, the Fund may report the retained amount as undistributed capital gain in a notice to its Common Shareholders, each
of whom, if subject to U.S. federal income tax on long-term capital gains, (i) will be required to include in income for U.S. federal
income tax purposes as long-term capital gain its share of such undistributed amounts, (ii) will be entitled to credit its proportionate
share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds
such liability and (iii) will increase its basis in its Common Shares by the amount of undistributed capital gain included in such Common
Shareholder&#8217;s gross income net of the tax deemed paid by the shareholder under clause (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Code imposes a 4% nondeductible excise tax
on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income
(not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss
(adjusted for certain ordinary losses) for a one-year period generally ending on October 31 of the calendar year. In addition, the minimum
amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution
or over-distribution, as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed
any income on which it paid federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute
any income and capital gain in order to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that amounts
of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event,
the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or otherwise
limit the allowance of certain losses or deductions, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend income&#8221;
into higher taxed short-term capital gains or ordinary income, (iii) convert an ordinary loss or a deduction into a capital loss (the
deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash, (v)
adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization
of certain complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the
90% gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing and character
of distributions to Common Shareholders. The Fund intends to structure and monitor its transactions and may make certain tax elections
and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a
RIC (which may adversely affect the net after-tax return to the Fund).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If for any taxable year the Fund does not qualify
as a RIC, all of its taxable income (including its net capital gain) will be subject to tax at regular corporate rates without any deduction
for distributions to Common Shareholders, and such distributions will be taxable to the Common Shareholders as ordinary dividends to the
extent</p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> of the Fund&#8217;s current or accumulated earnings and profits. Provided that certain holding period and other requirements are
met, such dividends, however, would generally be eligible (i) to be treated as qualified dividend income in the case of U.S. Common Shareholders
taxed as individuals and (ii) for the dividends-received deduction in the case of U.S. Common Shareholders taxed as corporations. The
Fund could be required to recognize unrealized gains, pay taxes and make distributions (which could be subject to interest charges) before
requalifying for taxation as a RIC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of Common Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distributions. </i>Distributions paid to you
by the Fund from its net capital gains, which is the excess of net long-term capital gain over net short-term capital loss, if any, that
the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as long-term capital gains, regardless
of how long you have held your Common Shares. All other dividends paid to you by the Fund from its current or accumulated earnings and
profits (including dividends from short-term capital gains) (&#8220;ordinary income dividends&#8221;) are generally subject to tax as
ordinary income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the case of corporate shareholders, properly
reported ordinary income dividends paid by the Fund generally will be eligible for the dividends received deduction to the extent that
the Fund&#8217;s income consists of dividend income from U.S. corporations and certain holding period requirements are satisfied by both
the Fund and the corporate shareholders. In the case of individuals, any properly reported ordinary income dividend that you receive from
the Fund generally will be eligible for taxation at the rates applicable to long-term capital gains to the extent that (i) the ordinary
income dividend is attributable to &#8220;qualified dividend income&#8221; (i.e., generally dividends paid by U.S. corporations and certain
foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements with respect to the
stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements with respect
to your Common Shares. Qualified dividend income eligible for these special rules is not actually treated as capital gains, however, and
thus will not be included in the computation of your net capital gain and generally cannot be used to offset any capital losses. In general,
you may include as qualified dividend income only that portion of the dividends that may be and are so reported by the Fund as qualified
dividend income. Dividend income from &#8220;passive foreign investment companies&#8221; (as defined in the Code) and, in general, dividend
income from REITs is not eligible for the reduced rate for qualified dividend income and is taxed as ordinary income. There can be no
assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified dividend income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any distributions you receive that are in excess
of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-free return of capital to the extent of your
adjusted tax basis in your Common Shares, and thereafter as capital gain from the sale of Common Shares. The amount of any Fund distribution
that is treated as a tax-free return of capital will reduce your adjusted tax basis in your Common Shares, thereby increasing your potential
gain or reducing your potential loss on any subsequent sale or other disposition of your Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Dividends and other taxable distributions are
taxable to you even if they are reinvested in additional Common Shares of the Fund. Dividends and other distributions paid by the Fund
are generally treated as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend in
January that was declared in the previous October, November or December and you were the Common Shareholder of record on a specified date
in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received
by you on December 31 of the year in which the dividend was declared.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will send you information after the
end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sale of Common Shares. </i>The sale or other
disposition of Common Shares of the Fund will generally result in capital gain or loss to you and will be long-term capital gain or loss
if you have held such Common Shares for more than one year. Any loss upon the sale or other disposition of Common Shares held for six
months or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited
as an undistributed capital gain) by you with respect to such Common Shares. Any loss you recognize on a sale or other disposition of
Common Shares will be disallowed if you acquire other Common Shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the Common Shares. In such case, your
tax basis in Common Shares acquired will be adjusted to reflect the disallowed loss.</p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Current U.S. federal income tax law taxes both
long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term
capital gain is currently taxed at rates applicable to ordinary income, while long-term capital gain generally is taxed at reduced maximum
rates. The deductibility of capital losses is subject to limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund or your financial intermediary (if any)
will be required to report to you and the IRS annually on Form 1099-B not only the gross proceeds of Common Shares sold but also, for
Common Shares purchased on or after January 1, 2012, their cost basis. You should consult with your tax advisors to determine the appropriate
cost basis method for your tax situation and to obtain more information about the cost basis reporting rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Medicare Tax</i>. Certain U.S. Common Shareholders
who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all
or part of their &#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale
or other disposition of the Fund&#8217;s stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Backup Withholding. </i>The Fund may be required
to withhold, for U.S. federal backup withholding tax purposes, a portion of the dividends, distributions and redemption proceeds payable
to non-corporate Common Shareholders who fail to provide the Fund (or its agent) with their correct taxpayer identification number (in
the case of individuals, generally, their social security number) or to make required certifications, or who are otherwise subject to
backup withholding. Backup withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S.
federal income tax liability, if any, provided that you timely furnish the required information to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The foregoing is a general and abbreviated
summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its
Common Shareholders. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.
A more complete discussion of the tax rules applicable to the Fund and its Common Shareholders can be found in the SAI that is incorporated
by reference into this Prospectus. Common Shareholders are urged to consult their tax advisers regarding specific questions as to U.S.
federal, state, local and foreign income or other taxes.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProPlanDistributions"></span>Plan of Distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell up to $1,000,000,000 aggregate
initial offering price of Common Shares from time to time under this Prospectus and any related Prospectus Supplement (1) directly to
one or more purchasers; (2) through agents; (3) through underwriters; (4) through dealers; or (5) pursuant to the Plan. Each Prospectus
Supplement relating to an offering of Common Shares will state the terms of the offering, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the names of any agents, underwriters or dealers;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any sales loads or other items constituting underwriters&#8217; compensation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any discounts, commissions, or fees allowed or paid to dealers or agents;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the public offering or purchase price of the offered Common Shares and the net proceeds the Fund will receive from the sale; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any securities exchange on which the offered Common Shares may be listed.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Direct Sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell Common Shares directly to,
and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for any
resales of the securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the
internet, to sell offered securities directly. The Fund will describe the terms of any of those sales in the Prospectus Supplement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Agents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer Common Shares through agents
that the Fund may designate. The Fund will name any agent involved in the offer and sale and describe any commissions payable by the Fund
in the Prospectus Supplement. Unless otherwise indicated in the Prospectus Supplement, the agents will be acting on a best efforts basis
for the period of their appointment.</p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Underwriters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer and sell Common Shares from
time to time to one or more underwriters who would purchase the Common Shares as principal for resale to the public, either on a firm
commitment or best efforts basis. If the Fund sells Common Shares to underwriters, the Fund will execute an underwriting agreement with
them at the time of the sale and will name them in the Prospectus Supplement. In connection with these sales, the underwriters may be
deemed to have received compensation from the Fund in the form of underwriting discounts and commissions. The underwriters also may receive
commissions from purchasers of Common Shares for whom they may act as agent. Unless otherwise stated in the Prospectus Supplement, the
underwriters will not be obligated to purchase the Common Shares unless the conditions set forth in the underwriting agreement are satisfied,
and if the underwriters purchase any of the Common Shares, they will be required to purchase all of the offered Common Shares. The underwriters
may sell the offered Common Shares to or through dealers, and those dealers may receive discounts, concessions or commissions from the
underwriters as well as from the purchasers for whom they may act as agent. Any public offering price and any discounts or concessions
allowed or reallowed or paid to dealers may be changed from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Prospectus Supplement so indicates, the
Fund may grant the underwriters an option to purchase additional Common Shares at the public offering price, less the underwriting discounts
and commissions, within 45 days from the date of the Prospectus Supplement, to cover any overallotments.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Dealers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer and sell Common Shares from
time to time to one or more dealers who would purchase the securities as principal. The dealers then may resell the offered Common Shares
to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set forth the names of
the dealers and the terms of the transaction in the Prospectus Supplement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">General Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Agents, underwriters, or dealers participating
in an offering of Common Shares may be deemed to be underwriters, and any discounts and commission received by them and any profit realized
by them on resale of the offered Common Shares for whom they act as agent, may be deemed to be underwriting discounts and commissions
under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer to sell securities either
at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at prices related to prevailing market prices
or at negotiated prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To facilitate an offering of Common Shares in
an underwritten transaction and in accordance with industry practice, the underwriters may engage in transactions that stabilize, maintain,
or otherwise affect the market price of the Common Shares or any other security. Those transactions may include overallotment, entering
stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions allowed to an underwriter or a dealer.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>An overallotment in connection with an offering creates a short position in the common stock for the underwriter&#8217;s own account.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing, or maintaining the price
of the Common Shares.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the price of the Common Shares
by bidding for, and purchasing, the Common Shares or any other securities in the open market in order to reduce a short position created
in connection with the offering.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering
when the Common Shares originally sold by the syndicate member is purchased in syndicate covering transactions or otherwise.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any of these activities may stabilize or maintain
the market price of the Common Shares above independent market levels. The underwriters are not required to engage in these activities,
and may end any of these activities at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any underwriters to whom the offered Common Shares
are sold for offering and sale may make a market in the offered Common Shares, but the underwriters will not be obligated to do so and
may discontinue any market-</p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">making at any time without notice. There can be no assurance that there will be a liquid trading market for
the offered Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under agreements entered into with the Fund,
underwriters and agents may be entitled to indemnification by the Fund against certain civil liabilities, including liabilities under
the Securities Act, or to contribution for payments the underwriters or agents may be required to make.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The underwriters, agents, and their affiliates
may engage in financial or other business transactions with the Fund in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to a requirement of the Financial Industry
Regulatory Authority, Inc., or FINRA, the maximum compensation to be received by any FINRA member or independent broker-dealer may not
be greater than eight percent (8%) of the gross proceeds received by the Fund for the sale of any securities being registered pursuant
to SEC Rule 415 under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The aggregate offering price specified on the
cover of this Prospectus relates to the offering of the Common Shares not yet issued as of the date of this Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent permitted under the 1940 Act and
the rules and regulations promulgated thereunder, the underwriters may from time to time act as a broker or dealer and receive fees in
connection with the execution of portfolio transactions on behalf of the Fund after the underwriters have ceased to be underwriters and,
subject to certain restrictions, each may act as a broker while it is an underwriter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A Prospectus and accompanying Prospectus Supplement
in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of
Common Shares for sale to their online brokerage account holders. Such allocations of Common Shares for internet distributions will be
made on the same basis as other allocations. In addition, Common Shares may be sold by the underwriters to securities dealers who resell
Common Shares to online brokerage account holders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Dividend Reinvestment Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may issue and sell Common Shares pursuant
to the Plan.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProCustAdminTransAgDiv"></span>Custodian, Administrator,
Transfer Agent and Dividend Disbursing Agent</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Bank of New York Mellon (&#8220;BNY&#8221;)
acts as the custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the custodian holds the
Fund&#8217;s assets in compliance with the 1940 Act. For its services, the custodian receives a monthly fee based upon, among other things, the average value of the total assets of the Fund, plus certain securities transactions. The
Bank of New York Mellon is located at 101 Barclay Street, New York, New York 10286.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><span style="font-weight: normal; text-transform: none">Computershare
Inc. acts as the Fund&#8217;s dividend disbursing agent, transfer agent and registrar for the Common Shares of the Fund. Computershare
Inc. is located at 250 Royall Street, Canton, MA 02021. Computershare Trust Company, N.A. acts as Plan Agent under the Fund&#8217;s Dividend
Reinvestment Plan. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">MUFG Investor Services (US) LLC (&#8220;MUFG&#8221;),
acts as the Fund&#8217;s administrator. Pursuant to an accounting and administration agreement, MUFG is responsible for providing administrative
services to the Fund, including assisting the Fund with regulatory filings. For these services, the Fund pays MUFG a fee, accrued daily
and paid monthly, at the annual rate equal to 0.0275% of the first $200 million in average daily Managed Assets, 0.0200% of the next $300
million in average daily Managed Assets, 0.0150% of the next $500 million in average daily Managed Assets, and 0.0100% of average daily
Managed Assets above $1 billion, along with an annual fixed fee ranging from $500 to $11,000 for assisting the Fund with certain regulatory
filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">MUFG also acts as fund accounting agent to the
Fund. Pursuant to an accounting and administration agreement, MUFG performs certain accounting services to the Fund. For the services,
the Fund pays MUFG a fee, accrued daily and paid monthly, at the annual rate equal to 0.0300% of the first $200 million in average daily
Managed Assets, 0.0150% of the next $300 million in average daily Managed Assets, 0.0100% of the next $500 million in average daily Managed
Assets, and 0.0075% of average daily Managed Assets above $1 billion, subject to a minimum fee of $50,000 per year, and reimburses MUFG
for certain out-of-pocket expenses.</p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProLegalMatters"></span>Legal Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left"><span style="font-weight: normal; text-transform: none">Certain
legal matters will be passed on by Dechert LLP as counsel to the Fund in connection with the offering of the Common Shares. If certain
legal matters in connection with an offering of Common Shares are passed upon by counsel for the underwriters of such offering, that counsel
will be named in the Prospectus Supplement related to that offering.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProIndRegPubAcctFirm"></span>Independent Registered
Public Accounting Firm</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Ernst &amp; Young LLP, 1775 Tysons Blvd, Tysons,
Virginia 22102, is the independent registered public accounting firm of the Fund. The Fund&#8217;s independent registered public accounting
firm is expected to render an opinion annually on the financial statements of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProAdditionalInfo"></span>Additional Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">This Prospectus constitutes part of a Registration
Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act. This Prospectus omits certain of the information contained
in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information
with respect to the Fund and the Common Shares offered hereby. Any statements contained herein concerning the provisions of any document
are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration
Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration
Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, may be obtained
from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC website (http://www.sec.gov),
by calling (800) 345-7999, by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago,
Illinois 60606, or by visiting our website at www.guggenheiminvestments.com.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProPrivacy"></span>Privacy Principles
of the Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is committed to maintaining the privacy
of its shareholders and to safeguarding their non-public personal information. The following information is provided to help you understand
what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information
with select other parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Generally, the Fund does not receive any non-public
personal information relating to its shareholders, although certain non-public personal information of its shareholders may become available
to the Fund. The Fund does not disclose any non-public personal information about its shareholders or former shareholders to anyone, except
as permitted by law or as is necessary in order to service shareholder accounts (for example, to a transfer agent or third party administrator).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund restricts access to non-public personal
information about its shareholders to employees of the Fund&#8217;s Investment Adviser and its delegates and affiliates with a legitimate
business need for the information. The Fund maintains physical, electronic and procedural safeguards designed to protect the non-public
personal information of its shareholders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProIncorp"></span>Incorporation
By Reference</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As noted above, this Prospectus is part of a registration
statement that has been filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221; the information that it files
with the SEC, which means that the Fund can disclose important information to you by referring you to those documents. The information
incorporated by reference is considered to be part of this Prospectus, and later information that the Fund files with the SEC will automatically
update and supersede this information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund incorporates by reference any future filings
it will make with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, or pursuant to
Section 30(b)(2) under the 1940 Act, until the Fund has sold all of the offered securities to which this Prospectus, the SAI and any accompanying
Prospectus Supplement relate, or the offering is otherwise terminated. The documents incorporated by reference herein include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Fund&#8217;s SAI, dated November 21, 2025, filed with this Prospectus;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/gug88924gof.htm">Fund&#8217;s annual report on Form
N-CSR for the fiscal year ended May 31, 2025</a>, filed with the SEC on August 4, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000077/cef-def14a.htm">Fund&#8217;s definitive proxy statement
on Schedule 14A, filed with the SEC on February 28, 2025</a>; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000134100407001955/chi551212.htm">description of the Fund&#8217;s common
shares contained in its Registration Statement on Form 8-A</a> (File No. 001-33565), filed with the SEC on June 27, 2007, including any
amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">To obtain copies of these filings, see &#8220;Additional Information.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center">&#160;</p>




<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyVkEFuwjAQRU/AHaysETiu2kV2NFBUNVAUEOrWOAMd4Xgie0LJkXrLmqCqK6RiWbLsP++NNUkyTOb0gha8+HguC7GBurGaQZSwBw/OQKzIX98yEc8SDhjYa8f99RfMKTIQmafRg47vfeUJA1SZSNOxkmP1KFKVKSlWi2RwyXNye6zAMWortKvEylPjEVj77mrY6DM5qru+0xZ8QHJRN5LX+FsomSqxpJP+In8MoijyZDDs1yCZe2qbWDU7M7gLKWYW6tguXOm/3f/GtIGpzlYencFG2xLDMSyg3oGPaSqVSuVE3uQW2h+BpxgMtY4nrooiA1uKc0SL3F10/7dNYcfvJ/BWd+s4a4bDnYJ15/gTGM2kZTLaWr2zMCuWd9h+AAjYnO0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>cantor.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cantor.jpg
M_]C_X  02D9)1@ ! 0'_____  #_[@ .061O8F4 9      !_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M"%'4YV_\(><GG'OC'(%#?\'$G_!+3^#XW>-6'3_DB'Q@!_,>#1@]L]O;&3_
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'YI6?Q:G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>guggenheimlogonew2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 guggenheimlogonew2.jpg
M_]C_X0QX17AI9@  34T *@    @ # $   ,    ! K@   $!  ,    ! )0
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   A    M $R  (    4    U8=I  0    !    [    4  "  (  @ %?D
M   G$  5^0   "<0061O8F4@4&AO=&]S:&]P(#(R+C(@*$UA8VEN=&]S:"D
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
M A$#$0 _ /3,WJ/3^GUMMS\JG$K>=K7WV-K:7<[6NM<WW(&/]8.@Y7J#&ZEB
M7^C6ZZWT[ZW[*V_SEUFQYV5,GWV.6-];<;('6^A]3'3[>I8>$<MN350QEKP;
MZV5T_H;7LW-W,^G^8LC Q?K!FGK%#<2]N)D=-R*J1E8F-AV?:+3MQ\:I^,[=
M;3Z7Y]C_ /C4:T7"(J[>Y?GX+,9F6_(J;BV;#7>7M%;A9'H[+9V.]7>WTO\
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M       0Z/%<\R_!&*&B>V>MQ635NCA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 )     !  $
MD     $  3A"24T$)@      #@             _@   .$))300-       $
M    'CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #5P    8              #L   $6    $0!G '4 9P!G
M &4 ;@!H &4 :0!M &P ;P!G &\ ;@!E '<    !
M      $              18    [                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!0
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M'_5L=C?2?[W.>_\ [=57J.)T:WJ]@=FW8_4[;L7T36V?2N;5E?9_3WTV4O\
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M65H@!^D  0 !  ,    686-S<$%04$P     05!03
M     /;6  $     TRUA<'!L
M                           19&5S8P   5    !B9'-C;0   ;0   'J
M8W!R=    Z     C=W1P=    \0    4<EA96@   ]@    49UA96@   ^P
M   48EA96@  !      4<E120P  !!0   @,86%R9P  #"     @=F-G=
M#$     P;F1I;@  #'     ^;6UO9   #+     H=F-G<   #-@    X8E12
M0P  !!0   @,9U120P  !!0   @,86%B9P  #"     @86%G9P  #"     @
M9&5S8P         (1&ES<&QA>0
M
M             &UL=6,         )@    QH<DA2    "    =AK;TM2
M"    =AN8DY/    "    =AI9       "    =AH=4A5    "    =AC<T-:
M    "    =AD841+    "    =AN;$Y,    "    =AF:49)    "    =AI
M=$E4    "    =AE<T53    "    =AR;U)/    "    =AF<D-!    "
M =AA<@      "@   >!U:U5!    "    =AH94E,    "    =AZ:%17
M"    =AV:59.    "    =AS:U-+    "    =AZ:$-.    "    =AR=5)5
M    "    =AE;D="    "    =AF<D92    "    =AM<P      "    =AH
M:4E.    "    =AT:%1(    "    =AC8453    "    =AE;D%5    "
M =AE<UA,    "    =AD941%    "    =AE;E53    "    =AP=$)2
M"    =AP;%!,    "    =AE;$=2    "    =AS=E-%    "    =AT<E12
M    "    =AP=%!4    "    =AJ84I0    "    =@ :0!- &$ 8R / &D
M30!A &,  '1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C4  %A9
M6B        #S%@ !     1;*6%E:(        (.'   ]J?___[M865H@
M    2^4  +/O   *W5A96B         G:@  #F@  ,B58W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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MQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P87)A       #     F9F  #RIP
M#5D  !/0   *6W9C9W0          0 !          $    !          $
M   !          $  &YD:6X         -@  K@   %(   !#P   L,   "9
M   -@   4    %1   (S,P ",S,  C,S          !M;6]D        !A
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M?2+?/W_12'_G#G_R[2_]PK5/^R7+/RF3N;OR.;N>J_D__P Y;_D%^?'F:_\
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MH+;SW166[E6&%?2MTD<\G8"H7;O@A S-!&/'+(:CS8IK/_.1'Y2>7_RBT?\
M/35?,SVWY8Z]#8SZ7Y@%E=NTB:BZQVQ^K)"9UYLP&Z"G>F2&*1EP]60P3,^
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M6&GQ8HS!C.RSW\W_ /Y%7^5=30?HKR;4^'^EPY"']^?BPQ?XT?BQK\H?.O\
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M>4O^<K_^<;//7F#3O*GE+\[/*6N>8]7D]+2M&@U&(3W,O:.%7*\W/95J3V&
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MOK#\B_R*\@_\X]^0=/\ (/D'3S#:PGZQK6M7%'OM5OG ]6\O)J O(Y^A115
M RG)D,S9<?+EEEE9>R96U.Q5_]3[^8J[%78J[%78J[%78J_*_1]ORT_Y^DTV
M/^*_-N__ (+=OF8?JQ_#[W8'ZL7N'WOM7\@_*WEBX_(S\F)Y_+FES3R^1O+S
MRS/9P,S,VFP%B24J22:G*,LCQGWN+FD>.6_4O@ORW^4?_*R/R+_YSM_++RK:
MQZ=>>5OSG\RZK^5=A:IZ<6FZMI2V>HV2VD:"D8:>/C113XSMOE\I<,H'R#E2
MGPSQD]8BWT#Y^_YR9DO_ /G!J'\[?+@_YW'\Q/+%GHWE?30*2?XIUIETL6ZJ
MI%&ANW<TJ/L97''62CR#3##6;A/('['A/YI>2-#_ "$U'_GWQ^7MWY+U;\R]
M%_+N/S%)>^2-$LX]4OM1U>WTB(M>Q6<CQ1S/'<SRSU9OA!9AOED#Q\9NN3?C
MEX@R&ZNMRCO^<G//#_G!^1_GSR%Y+_YP^_-G3/.NKV\$OE'6+WR;:6J6>H6M
MS%/%<+<PW<DL3H$/%D6M33OCBAPR!,A7O1AAP3!,XU[WJ_YQ>3/S"T#\[/RD
M_P"<A(?RDNOSU\O^7OR_NO*FO^3+.2T.MZ1J-U/%='5;.VU"2*&9I%!@D"N)
M .FV5PD#$QNMVK'*)@871N[_ $/7/RE_/G\J/.OG:3R)!Y"U[\HOS/739-1M
M?*'G+R[^@=1N[%'"3RV,HYPW*(U.?I2M3K2@-(3QD"[L->3%*(NP1Y&WG'_.
M&6@Z%JN@_P#.04^J:+8:E,/SU\\QB:ZMHIFX"YAHO)U)H*G;+-02#'W!LU4B
M#'^J$5>Z9INH?\_ [>TO]/MKVUA_($M%;7$221J1YEX@JK @4!(^6"_W/^=^
MA02,'^=^A)_^<I]"T.P_-S_G":.QT:PLTN/S:=9U@MHHPX_1%V:-Q45%0#0^
M&#&34O<QPR/#+?HF?_.??E?RW#_SBS^86L0:!I]OJ_EVYT34M U2&WCCN+*\
MBUBS"3P2(H9' 8BH/0D8=,;R ,M&2<H!>9?G_P":+30/^<S/R&U?7?R]U_\
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8BKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gof-20251128.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aMpw7xRiXgOn8uPaXpMSa6JWbOdwJd1aekxtGh7bWnKXywrelL7hCrqmE8mkYMJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:GOF="http://guggenheiminvestments.com/20251128" elementFormDefault="qualified" targetNamespace="http://guggenheiminvestments.com/20251128">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251128_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251128_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251128_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="GOF_PrincipalRisksMember" name="PrincipalRisksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_MarketDiscountAndPriceVolatilityRiskMember" name="MarketDiscountAndPriceVolatilityRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_DebtOverlayStrategyRiskMember" name="DebtOverlayStrategyRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_SyntheticAutocallableELNStrategyRiskMember" name="SyntheticAutocallableELNStrategyRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>gof-20251128_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#AddressTypeOnly" roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_PrincipalRisksMember" xlink:label="loc_GOFPrincipalRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFPrincipalRisksMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="loc_GOFDebtOverlayStrategyRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFDebtOverlayStrategyRiskMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="loc_GOFSyntheticAutocallableELNStrategyRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFSyntheticAutocallableELNStrategyRiskMember" xlink:type="arc" order="30" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>gof-20251128_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_PrincipalRisksMember" xlink:label="GOF_PrincipalRisksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_PrincipalRisksMember" xlink:to="GOF_PrincipalRisksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_PrincipalRisksMember_lbl" xml:lang="en-US">Principal Risks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="GOF_MarketDiscountAndPriceVolatilityRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:to="GOF_MarketDiscountAndPriceVolatilityRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_MarketDiscountAndPriceVolatilityRiskMember_lbl" xml:lang="en-US">Market Discount And Price Volatility Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="GOF_DebtOverlayStrategyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_DebtOverlayStrategyRiskMember" xlink:to="GOF_DebtOverlayStrategyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_DebtOverlayStrategyRiskMember_lbl" xml:lang="en-US">Debt Overlay Strategy Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="GOF_SyntheticAutocallableELNStrategyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:to="GOF_SyntheticAutocallableELNStrategyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_SyntheticAutocallableELNStrategyRiskMember_lbl" xml:lang="en-US">Synthetic Autocallable E L N Strategy Risk [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>gof-20251128_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2Cover" roleURI="http://xbrl.sec.gov/cef/role/N2Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_PrincipalRisksMember" xlink:label="loc_GOFPrincipalRisksMember" />
      <link:presentationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFPrincipalRisksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" />
      <link:presentationArc order="1010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="loc_GOFDebtOverlayStrategyRiskMember" />
      <link:presentationArc order="1020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFDebtOverlayStrategyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251128.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="loc_GOFSyntheticAutocallableELNStrategyRiskMember" />
      <link:presentationArc order="1030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFSyntheticAutocallableELNStrategyRiskMember" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 21, 2025</div></th>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>May 31, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001380936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">424B5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">GUGGENHEIM STRATEGIC OPPORTUNITIES FUND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_z2y2e9RZ92pd" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%" summary="xdx: Disclosure - ShareholderTransactionExpenses">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 74%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    load (<span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zBWckfJSG7ed">as a percentage of offering price</span>)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecef--SalesLoadPercent_c20251121__20251121_fKDEp_z6UnYZnJq9zd">2.00%</span><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    expenses borne by the Fund (as a percentage of offering price)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zpKblAGbcg4j">0.60%</span><sup>(1),(2)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan fees<sup>(3)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zOjvtsbiRmF3">None</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_ecef--AnnualExpensesTableTextBlock_zeXzA1pV4WUl" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%" summary="xdx: Disclosure - AnnualExpenses">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual
    Expenses </b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to Common Shares<sup>(4)</sup></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    fees<sup>(5)</sup></span></td>
    <td style="padding: 0.75pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zemq8N7t62We">1.19%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquired
    fund fees and expenses<sup>(6)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____z586YeyWySFh">0.03%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expenses<sup>(7)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zcXQCTRKuz81">0.89%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expenses<sup>(8)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____z0hMJo7ICW95">0.10%</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    annual expenses<sup>(9)</sup></span></td>
    <td style="padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDQpICg5KQ_____ziPkcHmbW9ji">2.21%</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">1.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[6]</sup></td>
<td class="nump">0.89%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AcquiredFundFeesAndExpensesPercent', window );">Acquired Fund Fees and Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[7]</sup></td>
<td class="nump">0.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[8]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[9]</sup></td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">As required by relevant SEC regulations, the following Example
illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual expenses&#8221;
of 2.21% of net assets attributable to Common Shares and (2) the sales load of $20 and estimated offering expenses of $6, and (3) a 5%
annual return*:</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years </b></span></td>
    <td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Annual Expense Paid by Common Shareholders </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zKFxI2H6dFx3">$48</span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zEtVxhsAwuB4">$93</span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_z6C2CQU7Bgth">$141</span>
    </span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3XobfVXfa05">$274</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">$ 274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The following table contains information about the costs and expenses
that the Common Shareholders will bear directly or indirectly. The table reflects the use of leverage in an amount equal to approximately
16% of the Fund&#8217;s total managed assets, which reflects approximately the percentage of the Fund&#8217;s total managed assets attributable
to leverage as of May 31, 2025 (audited), and shows Fund expenses as a percentage of net assets attributable to Common Shares. The table
and example below are based on the Fund&#8217;s capital structure as of May 31, 2025 (audited) after giving effect to the anticipated
net proceeds of the Common Shares offered pursuant to this Prospectus Supplement and assuming the Fund incurs the estimated offering expenses
described below. The extent of the Fund&#8217;s assets attributable to leverage following an offering, and the Fund&#8217;s associated
expenses, are likely to vary (perhaps significantly) from these assumptions. The purpose of the table and the example below is to help
you understand the fees and expenses that you, as a Common Shareholder, would bear directly or indirectly. The following table should
not be considered a representation of the Fund&#8217;s future expenses. Actual expenses may be greater or less than shown. The following
table shows estimated Fund expenses as a percentage of average net assets attributable to Common Shares, and not as a percentage of managed
assets. See &#8220;Management of the Fund&#8221; in the accompanying Prospectus.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">as a percentage of offering price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionFeesNoteTextBlock', window );">Other Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s
registration statement and any offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under
such registration statement, to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s
behalf in an amount up to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common
Shares sold in such offerings. Amounts in excess of 0.60% of the total offering price of shares sold pursuant to the registration statement
will not be subject to recoupment from the Fund. This agreement will be in effect for the life of the registration statement with respect
to all Common Shares sold pursuant to the registration statement and may only be terminated by the Board of Trustees of the Fund.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Other expenses are based on estimated amounts for the current fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesNoteTextBlock', window );">Senior Securities, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">For information about the Fund&#8217;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Other Information (unaudited)&#8212;Senior Securities&#8221;
which is incorporated by reference herein. Information regarding the Fund&#8217;s senior securities is also contained in the Financial
Highlights in the Fund&#8217;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp; Young LLP for the last five
fiscal years. The Fund&#8217;s audited financial statements, including the report of Ernst &amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#8217;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment Objective<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Investment Objective,&#8221; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Policies</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Principal Investment Strategies and Portfolio
Composition</span><span style="font-weight: normal">&#8212;Investment Policies<span style="color: windowtext">&#8221; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#8217;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#8217;s and S&amp;P&#8217;s ratings.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><span style="color: windowtext">Rating agencies, such as Moody&#8217;s or S&amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#8217;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#8217;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#8217;s credit analysis than would be the case when
the Fund invests in rated securities.</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Principal Investment Strategies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is predicated</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s analysis of a fixed-income
security&#8217;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#8217;s
industry to determine the Sub-Adviser&#8217;s internal judgment as to the security&#8217;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#8217;s judgment, may provide risk-adjusted outperformance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#8217;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In the Sub-Adviser&#8217;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#8217;s
desired sector exposures.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Additional Information About
the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Income Securities Strategy. </i>The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#8220;high-yield&#8221; or &#8220;junk&#8221;
bonds), which are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Corporate bonds;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Loans and loan participations (including senior secured floating rate loans, &#8220;second lien&#8221; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#8220;debtor-in-possession&#8221; financings) (collectively, &#8220;Loans&#8221;);</td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">U.S. government and agency securities and sovereign or supranational debt obligations;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Mezzanine and preferred securities; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Convertible securities.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Debt Overlay Strategy. </i>As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#8220;Debt
Overlay Basket&#8221;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#8220;Underlying Bond ETF&#8221;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#8220;Debt Overlay Strategy&#8221;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#8220;covered,&#8221;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#8217;s shares) in the amount necessary to meet the Fund&#8217;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#8217;s options counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Equity Securities and Covered Call
Options Strategy. </i>The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#8220;Common Equity Securities&#8221;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#8220;naked&#8221; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#8220;OTC options&#8221;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#8220;ETFs&#8221;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Autocallable ELN Strategy.</i> The
Fund may employ a synthetic autocallable equity linked-note (&#8220;ELN&#8221;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#8220;Synthetic
Autocallable ELN Strategy&#8221;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#8220;Synthetic Autocallable Contracts&#8221;),
and will typically not invest directly in autocallable ELNs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;P 500 Index, Russell
2000 Index, or &#8220;worst of&#8221; two or more indices) (the &#8220;Autocallable ELN Reference Index&#8221;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#8220;Maturity Barrier&#8221; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#8220;buyer&#8221; and its counterparty as &#8220;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#8217;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#8217;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#8220;Coupon Payment&#8221; and a &#8220;Principal Payment&#8221;) net of the financing amount owed
to the counterparty, subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Autocall Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#8220;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Coupon Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#8220;Coupon Barrier&#8221;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>No-Coupon Zone</i>. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#8220;Missed
Coupon&#8221;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Full Principal Zone</i>. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#8220;Maturity Barrier&#8221;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Reduced Principal Zone</i>. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Real Property Asset Companies. </i>The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#8220;real property assets,&#8221; such as real estate and the natural resources upon or within real estate (&#8220;Real Property Asset
Companies&#8221;). These Real Property Asset Companies include:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#8220;REITs&#8221;); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Personal Property Asset Companies. </i>The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#8220;Personal Property Asset Companies&#8221;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Securities. </i>The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#8220;Private Securities&#8221;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Funds. </i>As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#8220;Investment Funds&#8221;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#8217;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#8220;hedge funds,&#8221; or &#8220;private equity funds&#8221;
(including &#8220;single asset continuation funds&#8221;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Investments. </i>As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#8220;SOFR&#8221;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#8217;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#8217;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#8217;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#8217;s return could be adversely affected by an adverse tax ruling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>Portfolio Contents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>The Fund&#8217;s investment portfolio consists
of investments in the following types of securities:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Corporate Bonds. </i>Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#8217;s
performance and perceptions of the corporation in the marketplace. <i>Investment Grade Bonds. </i>The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#8220;Investment Grade Bonds&#8221;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#8217;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Below-Investment Grade Bonds. </i>The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#8220;Below-Investment Grade Bonds&#8221;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#8217;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#8220;debtor-in-possession&#8221; or &#8220;DIP&#8221; financings
newly issued in connection with &#8220;special situation&#8221; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#8217;s otherwise unencumbered assets or secured by a junior lien on the debtor&#8217;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distressed and Defaulted Securities. </i>The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Structured Finance Investments. </i>The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#8217;s investment policies, structured finance investments
are not deemed to be &#8220;private investment funds&#8221; (as discussed below). Structured finance investments primarily include (among
others):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Mortgage-Related Securities</span>. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Asset-Backed Securities</span>. Asset-backed securities (&#8220;ABS&#8221;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Collateralized Debt Obligations</span>. A collateralized debt
obligation (&#8220;CDO&#8221;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#8220;CBO&#8221;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#8220;CLO&#8221;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#8217;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions
are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#8217;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Risk-Linked Securities</span>. Risk-linked securities (&#8220;RLS&#8221;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#8220;trigger event.&#8221; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#8217;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Senior Loans. </i>Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#8220;Prime Rate&#8221;) and the certificate of deposit (&#8220;CD&#8221;) rate or
other base lending rates used by commercial lenders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Second Lien Loans. </i>Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Subordinated Secured Loans. </i>Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#8217;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Unsecured Loans. </i>Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mezzanine Investments. </i>The Fund may invest
in certain lower grade securities known as &#8220;Mezzanine Investments,&#8221; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Convertible Securities. </i>Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#8217;s capital structure and, therefore, generally entail
less risk than the corporation&#8217;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#8217;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Stocks. </i>Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#8217;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#8217; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#8217;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#8217;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>U.S. Government Securities. </i>The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#8220;STRIPS&#8221;), all of which are backed by the full faith and</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Securities. </i>While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#8217;s assets denominated in that currency and the Fund&#8217;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#8220;&#8212;Derivative Transactions&#8212;Foreign Currency Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sovereign and Supranational Obligations. </i>The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#8217;s and S&amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#8217;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#8217;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#8217;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Stocks and Other Common Equity Securities.
</i>The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options. </i>As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#8220;American style&#8221; options may be exercised at any time during the term of the option. Other options, known
as &#8220;European style&#8221; options, may be exercised only on the expiration date of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will follow a strategy known as &#8220;covered
call option writing,&#8221; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as disclosed further below and in connection
with the Fund&#8217;s Debt Overlay Strategy, the Fund may not sell &#8220;naked&#8221; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#8220;covered&#8221;
if the Fund owns the security <span style="background-color: white">or instrument</span> underlying the call or has an absolute and immediate
right to acquire that security <span style="background-color: white">or instrument</span> without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#8217;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#8217;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#8217;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Restricted and Illiquid Securities. </i>The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Government Sponsored Investment Programs</i>.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Derivatives Transactions</i>. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#8217;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#8220;VaR&#8221;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#8220;limited derivatives users&#8221; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#8220;limited derivatives user&#8221; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#8217;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#8220;interested persons&#8221; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#8217;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#8217;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#8220;derivatives transaction&#8221; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Credit Derivatives. </i>Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#8220;buyer&#8221; in a credit default swap contract
is obligated to pay the &#8220;seller&#8221; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#8220;par value,&#8221; of the reference obligation. Credit default swap transactions are either &#8220;physical delivery&#8221; settled
or </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#8220;cash&#8221; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Currency Transactions. </i>The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Sub-Adviser seeks to use derivatives
to further the Fund&#8217;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#8217;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#8220;Investment Objective and Policies&#8212;Derivative Instruments&#8221; in the Fund&#8217;s SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Municipal Securities</i>. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Temporary Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;P
or Prime-1 by Moody&#8217;s; and certificates of deposit and bankers&#8217; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#8217;s limitations on investments in other investment companies. See &#8220;Investment Restrictions&#8221; in
the Fund&#8217;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#8220;Management of
the Fund.&#8221; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Certain Other Investment Practices</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>When Issued, Delayed Delivery Securities
and Forward Commitments</i>. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#8220;when
issued&#8221; or &#8220;delayed delivery&#8221; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#8217;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#8217;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Loans of Portfolio Securities</i>. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#8217;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#8217;s ability to sell the collateral and the Fund would suffer a
loss. See &#8220;Investment Objective and Policies Loans of Portfolio Securities&#8221; in the Fund&#8217;s SAI.<br/>
<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offsetting. </i>In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#8220;ISDA Master Agreement&#8221;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Repurchase Agreements</i>. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#8220;Qualifying
Collateral&#8221;) and meet certain liquidity standards generally may be deemed to be &#8220;collateralized fully&#8221; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#8220;Alternative Collateral&#8221;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#8220;collateralized fully&#8221; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#8220;collateralized fully&#8221; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#8217;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#8217;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#8217;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Reverse Repurchase Agreements</i>. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#8217;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#8217;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#8217;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#8217;s cash available for distribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Sleeve Structure.
</i>The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#8217;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#8217;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Interest Rate <span style="color: windowtext">Transactions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Interest Rate Transactions,&#8221;
which is incorporated by reference herein, for a discussion of the Fund&#8217;s use of interest rate transactions in connection with the
Fund&#8217;s use of Financial Leverage.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Portfolio Turnover</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#8217;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#8217;s portfolio turnover rate was 25% and 30%, respectively.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Restrictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#8220;Investment Restrictions&#8221;
in the SAI for a complete list of the fundamental investment policies of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="ProUseLeverage"></span>Use of Leverage</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Use of Leverage,&#8221; which is incorporated
by reference herein, for a discussion of the Fund&#8217;s use of leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">See the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Borrowing</i>. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#8217;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#8217;s portfolio in accordance with the Fund&#8217;s investment objective and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#8217;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#8217;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#8217;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#8217;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#8217;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#8217;s audited and unaudited financial statements contained in the Fund&#8217;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Reverse Repurchase Agreements and Dollar Roll
Transactions. </i>The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Shares.</i> The Fund&#8217;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#8220;NYSE&#8221;) under the symbol &#8220;GOF&#8221;. The Fund&#8217;s Common Shares commenced trading on the NYSE on July 27,
2007.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#8217;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#8217;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#8220;Risks&#8212;Market Discount
and Price Volatility Risk.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#8220;Net Asset Value&#8221; for information as to the determination of the Fund&#8217;s net asset value.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">&#160;</td>
    <td id="xdx_48F_ecef--HighestPriceOrBid_zO3IGU7U3t91" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--LowestPriceOrBid_zPkCalkajAZc" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_480_ecef--HighestPriceOrBidNav_zOgODog8Fyha" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_480_ecef--LowestPriceOrBidNav_zphdGz8OJ2R1" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_48C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zLmJtETNL4x4" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_486_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zq3jvEzA6Rxh" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Fiscal Quarter Ended</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Market Price</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>NAV per Common<br/>
Share on Date of Market<br/>
Price High and Low<span style="font-size: 8.5pt"><sup>(1)</sup></span></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Premium/(Discount) on<br/>
Date of Market Price</b><br/>
<b>High and Low<span style="font-size: 8.5pt"><sup>(2)</sup></span></b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td></tr>
  <tr id="xdx_41C_20250601__20250831_zGSPc6ziVBE1" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.10</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.55</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.50</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.38</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">31.30%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.86%</span></td></tr>
  <tr id="xdx_41A_20250301__20250531_z32gpkuCXGX" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.91</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$13.74</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.67</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.06</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">36.33%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">24.23%</span></td></tr>
  <tr id="xdx_413_20241201__20250228_zExVTB8B9ySf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 28, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.99</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.74</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">33.14%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.77%</span></td></tr>
  <tr id="xdx_414_20240901__20241130_zXDzAhdrZVmf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$16.03</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.26</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.99</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">33.69%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.06%</span></td></tr>
  <tr id="xdx_414_20240601__20240831_zSarr1dFl2V5" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.75</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.65</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.06</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.93</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">30.60%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">22.80%</span></td></tr>
  <tr id="xdx_41B_20240301__20240531_zcXEJChhSsgf" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.90</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$13.80</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.26</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.82</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">21.53%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">16.75%</span></td></tr>
  <tr id="xdx_411_20231201__20240229_zBaztg4uzQw7" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 29, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.67</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.12</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.34</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">17.90%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">2.67%</span></td></tr>
  <tr id="xdx_413_20230901__20231130_zVGetGPX04Nj" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.96</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.16</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.30</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.71</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">29.76%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">-4.70%</span></td></tr>
  <tr id="xdx_41C_20230601__20230831_zWTrLzH0iW75" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$16.28</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.51</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.48</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.30</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">30.45%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">26.10%</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.55<span></span>
</td>
<td class="nump">$ 13.74<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.26<span></span>
</td>
<td class="nump">$ 14.65<span></span>
</td>
<td class="nump">$ 13.80<span></span>
</td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="nump">$ 11.16<span></span>
</td>
<td class="nump">$ 15.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.10<span></span>
</td>
<td class="nump">15.91<span></span>
</td>
<td class="nump">15.99<span></span>
</td>
<td class="nump">16.03<span></span>
</td>
<td class="nump">15.75<span></span>
</td>
<td class="nump">14.90<span></span>
</td>
<td class="nump">14.29<span></span>
</td>
<td class="nump">15.96<span></span>
</td>
<td class="nump">16.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.38<span></span>
</td>
<td class="nump">11.06<span></span>
</td>
<td class="nump">11.74<span></span>
</td>
<td class="nump">12.01<span></span>
</td>
<td class="nump">11.93<span></span>
</td>
<td class="nump">11.82<span></span>
</td>
<td class="nump">12.34<span></span>
</td>
<td class="nump">11.71<span></span>
</td>
<td class="nump">12.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.67<span></span>
</td>
<td class="nump">$ 12.01<span></span>
</td>
<td class="nump">$ 11.99<span></span>
</td>
<td class="nump">$ 12.06<span></span>
</td>
<td class="nump">$ 12.26<span></span>
</td>
<td class="nump">$ 12.12<span></span>
</td>
<td class="nump">$ 12.30<span></span>
</td>
<td class="nump">$ 12.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
<td class="nump">36.33%<span></span>
</td>
<td class="nump">33.14%<span></span>
</td>
<td class="nump">33.69%<span></span>
</td>
<td class="nump">30.60%<span></span>
</td>
<td class="nump">21.53%<span></span>
</td>
<td class="nump">17.90%<span></span>
</td>
<td class="nump">29.76%<span></span>
</td>
<td class="nump">30.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.86%<span></span>
</td>
<td class="nump">24.23%<span></span>
</td>
<td class="nump">27.77%<span></span>
</td>
<td class="nump">27.06%<span></span>
</td>
<td class="nump">22.80%<span></span>
</td>
<td class="nump">16.75%<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="num">(4.70%)<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Capitalization</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Title of Class</b></td>
    <td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount</b><br/>
<b>Authorized</b></td>
    <td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Held by the<br/>
Fund or for its Account</b></td>
    <td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Outstanding</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span>Common shares of beneficial interest, par value $0.01 per share</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Unlimited</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#8212;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span><span id="xdx_90E_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zSfDQT4tjKYk">199,267,847</span></span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><i>Voting
Rights</i>. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#8217;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#8217;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#8217;s Trustees, and will have certain other voting rights. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s Governing
Documents.&#8221;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199,267,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_PrincipalRisksMember', window );">Principal Risks [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; text-transform: none">Principal Risks of the Fund,&#8221;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember', window );">Market Discount And Price Volatility Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Market Discount and Price Volatility Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#8217;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#8217;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#8217;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#8217;s net asset value as a result of the Fund&#8217;s
investment activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#8217;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember', window );">Debt Overlay Strategy Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Debt Overlay Strategy Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#8217;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#8217;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The call options sold as part of the Debt Overlay
Strategy are generally not &#8220;covered.&#8221; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#8217;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#8220;naked&#8221; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#8220;Risks Associated with the Fund&#8217;s Covered Call Option Strategy and Put Options,&#8221; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember', window );">Synthetic Autocallable E L N Strategy Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Synthetic Autocallable ELN Strategy Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;</td></tr></table>

    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">


<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the estimated commission with respect to Common Shares being sold in this offering.
Cantor Fitzgerald will be entitled to compensation of up to 2.00% of the gross proceeds of the sale of any Common Shares under the Sales
Agreement, with the exact amount of such compensation to be mutually agreed upon by the Fund and Cantor Fitzgerald from time to time.
The Fund has assumed that Cantor Fitzgerald will receive a commission of 2.00% of the gross sale price of the Common Shares sold in this
offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">You will pay brokerage charges if you direct the Plan Agent to sell your Common Shares held
in a dividend reinvestment account. See &#8220;Dividend Reinvestment Plan&#8221; in the accompanying Prospectus.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s
registration statement and any offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under
such registration statement, to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s
behalf in an amount up to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common
Shares sold in such offerings. Amounts in excess of 0.60% of the total offering price of shares sold pursuant to the registration statement
will not be subject to recoupment from the Fund. This agreement will be in effect for the life of the registration statement with respect
to all Common Shares sold pursuant to the registration statement and may only be terminated by the Board of Trustees of the Fund.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Based upon average net assets attributable to Common Shares during the fiscal year ended
May 31, 2025, after giving effect to the anticipated net proceeds of all of the Common Shares offered by this Prospectus Supplement based
on an assumed price per share of $12.91 (the last reported sale price of the Fund&#8217;s Common Shares on the NYSE as of November 14,
2025). The price per share of any sale of the Common Shares may be greater or less than the price assumed herein, depending on the market
price of the Common Shares at the time of any sale. There is no guarantee that there will be any sales of the Common Shares pursuant
to this Prospectus Supplement. The number of the Common Shares actually sold pursuant to this Prospectus Supplement may be less than
as assumed herein.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to
1.00% of the Fund&#8217;s average daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable
to the assets purchased with the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other
forms of debt (&#8220;Borrowings&#8221;) or reverse repurchase agreements, dollar rolls or similar transactions or through a combination
of the foregoing (collectively &#8220;Financial Leverage&#8221;), which means that Common Shareholders effectively bear the entire advisory
fee. Because the management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#8217;s Managed Assets, the
management fee as a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial
Leverage. If Financial Leverage of more than 16% of the Fund&#8217;s Managed Assets is used, the management fee shown would be higher.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements.
Interest payments on borrowed funds is estimated based upon the Fund&#8217;s outstanding Borrowings as of May 31, 2025, which included
Borrowings under the Fund&#8217;s committed facility agreement in an amount equal to 2.08% of the Fund&#8217;s Managed Assets, at an
average interest rate of 5.08%. Interest expense on reverse repurchase agreements is estimated based on the Fund&#8217;s outstanding
reverse repurchase agreements as of May 31, 2025, which included leverage in the form of reverse repurchase agreements in an amount equal
to 13.77% of the Fund&#8217;s Managed Assets, at a weighted average interest rate cost to the Fund of 4.52%. The  actual amount of interest payments and expenses borne by the Fund will vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the
Fund as an investor in other investment companies during the fiscal year ended May 31, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Other expenses are based on estimated amounts for the current fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">The total annual expenses in this fee table may not correlate to the expense
ratios in the Fund&#8217;s financial highlights and financial statements because the financial highlights and financial statements reflect
only the operating expenses of the Fund and do not include Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly
by the Fund through its investments in certain underlying investment companies.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#8220;Distributions&#8221;
and &#8220;Dividend Reinvestment Plan.&#8221;</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AcquiredFundFeesAndExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 10<br> -Subparagraph a, g, h<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AcquiredFundFeesAndExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph Instruction 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 1<br> -Paragraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_PrincipalRisksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_PrincipalRisksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>14</ContextCount>
  <ElementCount>36</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="gug89339-424b5.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gof-20251128.xsd</File>
    <File>gof-20251128_def.xml</File>
    <File>gof-20251128_lab.xml</File>
    <File>gof-20251128_pre.xml</File>
    <File doctype="424B5" isUsgaap="true" original="gug89339-424b5.htm">gug89339-424b5.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cantor.jpg</File>
    <File>guggenheimlogonew2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="83">http://xbrl.sec.gov/cef/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gug89339-424b5.htm": {
   "nsprefix": "GOF",
   "nsuri": "http://guggenheiminvestments.com/20251128",
   "dts": {
    "schema": {
     "local": [
      "gof-20251128.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gof-20251128_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gof-20251128_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gof-20251128_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gug89339-424b5.htm"
     ]
    }
   },
   "keyStandard": 36,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 4,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 14,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 198,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2025": 83,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-11-21",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug89339-424b5.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-11-21",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug89339-424b5.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "GOF_DebtOverlayStrategyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251128",
     "localname": "DebtOverlayStrategyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Overlay Strategy Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "GOF_MarketDiscountAndPriceVolatilityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251128",
     "localname": "MarketDiscountAndPriceVolatilityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Discount And Price Volatility Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "GOF_PrincipalRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251128",
     "localname": "PrincipalRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Risks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "GOF_SyntheticAutocallableELNStrategyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251128",
     "localname": "SyntheticAutocallableELNStrategyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Synthetic Autocallable E L N Strategy Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001821268-25-000251-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001821268-25-000251-xbrl.zip
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M@T.8X9%/HV/3,[-S\PO?%I>P./SFUO;W'SN[Q..?OWZ?_"']/?T/%Q6 ^O]
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M!^^1U@%_6WMW5]0?_3:F'6!AI>T#!O/P/M3&$K,8@:E52G)PK%ZVD'G;+M_
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MR\&;&G-LMRRU6$N1)3F/+2VNX4ZEIP[88U3XQ6:G#[&9)C8V4>?;(14A_!>
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MY.PF9=*"5YX]E^" K<UFEGY'IX1-2]GFDF0G;E&(DFT(A3,UY&0AN^H;'!"
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M8T'<9I3#S^[UKCFO@O]H!:@^]_5J-%:JT<0;MC)WP,>E$[X=^0M02P,$%
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MZYI+B8>H0&61!YE-T]!QZLYQY4HH\ZW&5:)EOH&K/M%)"7(Y,<5#K9O\"-W
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M@A0*7P&+R-<.[WG)")AH8+$&L\-Y6UWCTLJP%$!06&(9R07+MEC#<BH*.UJ
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M:J#=7>^.?NV\<]]WKJZ.+IY,9.4A2\).@%.%<:4I.8^E>6""C*COLKKY5O1
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M%Q_&0IFX*B(%UQZCDV.1SI LI<5%#IT9I)IJ%3$X>>-PY659<\NO%+VK(\S
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M*[#;*G#=' /7S5TUKMN#^YF[167/YK!]\OMF)DO'4U4OR;VEE7LM(4MHJZQ
M*\4.8UA<S#Z=&MT#72_\E#G(*!1.]%7343PSX]^L=@>B3V:;F:->4@H.?^&^
ME<,[T>%UAY(!9@81^>B%P !#X;Z),*Q(AD3SB,QD:4J4KAMA2CVZ6*FJ!2R5
MF#GY%'2UW0\;H/R_\U'JBG_?_87O/_"XO'E?&9/G6I-WGDLF?,\E$U:#U9/G
M?)+O61(RVJQ"^JM0\29+&6(+R5U 6U52;A5XHEG@)U2)1W#+QJ8A2Z4A)3DK
M%3)#;XHP)Z0\9JP+J\W(K"595A8O;A*5^CZ%_-A2.W VLL5@1JU\(]&O.-DK
M<OX4FI9KHD;/R^7D^X)6$P1,NP81?J<2K$*9YTL .5CV-)]0(H,"_X;?D[Y/
M6IES0YHV;A*_+*M9ZWM4U3BR$LA0'1]+.36_O]YD(KQ8\VU[ S$T'6MA<XEK
M#A9F8<3)ZDN4",S6A:KBD&I&Z$IFOE1AZ?0^6XW)[,[^8SAW/I*7]I(:RTFU
MX#EUP8!ZD78U="C&U!.UHPM<2\.4M"QS%&QF< Z\FP57UE;S+O4POC2Q9A6]
M62$7] "9Z9$"7KAP $7<\Q+!LA 9>RA)-\1E2G@M%N 3?N5!FLE_JQP9E97)
M#2_VAR.)JP=L.J.,NX+76S<$W $&WOS]W,J(]_?2S6/5\Y7]TD4@D6&,N1:;
MO2B(8IC(L+O>:FS76NW]6FMG9V--WD0%[/H#!,TO]B3G*/W7?IA]HE'T)\9C
M^)*Z:I3I[;\("GD,RSVS4K[D9V@"HUNS8F#-_,!H;Y8<&44@J1OY6ZS_'R-0
M=HJ+_M +C7SRZ':R]EK^3G;C*>5)LA&X<M7OO])[WW:E%U/Z@RVZ-J_^!@L6
MX*(E:T; :/;I ZSZP0]&WX199JXS?V*$L#_ (C>_,1?YAK0-4A<RCLPY_@27
M]VL3\8=$G$NGX=IKZ<Q2'SS!Y?V&U,M9!*<BI0!"]&ZLO5XNL^ )[L/7)O.S
M[M\JL7-M#E:O?.0A%KSUPQ(^<!7EW=4L1GWP "O=^L'$$'*TK[VF?QY@.=L_
M,L=6N 4L=KPOQ9]XB#7?_K%(6%V*=/.MO<Y=A0^QP+L_+%&;R'; -JQ?'V*E
M?S!N_%8&)^+*\D_NA3 \"0@P^ #+O-WX<0E:)+U#;W))\-NP[%E=1X)ZE+@T
MEPJ=^PDN_M>F\4Z8^E?>)X'N^;77^-NF^I7$Z#-R@9UGI;?*0"9_U;EU;U6(
MV$-L3?N'/1>'5!7D*.SCLJO3P1]NPJ=L@WW08_&#23$7.BOKD,#VD?9!+L]R
MM?+(LR_=[$'T#9Y-1*BWY@ENR+?402^/1?\D[%UYMZ"#(O:)BC^2L"/P!>Z&
MD='P$!NP\V.="!1V<O)F&<#R0ZST_@]+ZH?3).WTQWY(@?2=(<BAP/?APZCO
MXR3I.Z[XB,D.]!1&<72&"J!/2ZZP2=TIL">XI.G;!]BHG1],=GHGAE[PWL.*
MWW :Z#=7_OH0J_OC&F].POZ%&)Y/NYU>+SWVXS':?;/"4Q<9 A<\$_@]%Y[#
MM"8D=GS\">[&5]<3= (%>SO*DXF>X$)_0[(_QUSR'D6WT ^NS,@*[!#^)[CH
M7YNZ3R@.%;E*+XMM=]_,@+7(@-2'7F05UOL(8\,?NN3%_4/[CJ,8RQ!NOHLB
M#)%U='K:<H&(7S3<OT%*\P>S*D0 *\C5R"=VEBC2K3,C=8Z8'4J=V$\/Y"H$
MO I6QAB&)$N+SEAX9,*1\;@R+\2,'PZ\&\(8\%*52VZDDD]#B8%A%0W+JKO+
MTBXE%1\FH$9PS3U9MK(FH2F]@*O0%=[@NI0R'AQCD649-J-@O,Q.U/@&65)5
M+E280I^G*2Z.SLSG9$"%M6# 0F8Y4':\=R'2&58VBON)KH0F,QBQOBF5&81)
MJDQ8^94J@Y?_G/'1"A_K<HWZ&T=^0^N6?YR7(_\IIATBCG;N8RH5F?\0HZ/S
MGV&9O-Q'E,J3'Q*'C>M'*9E/@IW ]&*1L&D14Y(((H("U1'8 !.;S3JO\TC9
M4_ -"=H <D\Z!B5*(!'9,V9)J9#\8%:,KM=9U#+@._$&< "]N!O%G 9;.20+
MF>R2D\>=UEY'ITEF)TOC[[7;E?A[]N,:%O!;L*_57"ASP*LJDI"NE\A!VGW.
M0?J.<Y"Z4=#_ N(LN^GG20E^_Y<U,TQ<7OEET>(/#?1*5[Z?R+07N!AT '5Y
M&JP($L').<4\&N125%*+V^A'0J)J\MMFS2:S<5TK2]6!4M6?9*6FTI1+G2!\
MKYJ1[I(U(ROJ4TFL!0G6TD<P@H!2A,ORR>:MV'+U'->3#<2GB6*NF:[2JLJ+
MFM4<(>%S@EEAJ3-TH0R9"LL[^(@>62RR4AZZ9MZ79DDS#>4L<_$=2M&^\9,1
MCCM+S#=S\BWYJ0*FP8(%N0<@@[,(D"&'>>%E/5>C ]01#?GACZ=B<;JOC+N:
MW#3/;>\\'H.O8N& &(ACD\KD3A)@]>JG?%)/7G.&6Z RXZ:U\W.F<))&^L+=
MJ>_MF'JP==7:RC$_:J6RL[)4G4JSMYH>#9R%2ZD+]-PS"W:,X2(,"E1DK8K]
M6(5O:HQ=WM\4!-6E [X*,/TS!;DQ'J,0 4+_1&-A 4'^8XH8K+MX !I[I9!\
MZO3Z"7..6Y!N/]LXW1KX,0\@K3&ZC8KJ9<6N#=&4!$M$7))%4:\%\]Q-5EF,
M^4U&/BQ!-!G-U.F3:$@)%LM T=;3;(>K9ZC?O6"6\'10';"D<+M&63)!+IWH
M$J;&M[2J?7'M9Y5A87MC!HGRKPDGUU?WA815!KZ=1C$5"<%"$0C94&Z)6NI,
M?#E5&K+/ZALOD-(77K(UKD "5U(&^U1VWVK-5X*%%4OGSF]'OJ9:LTPR16O>
M#5OSK+I$]TWLABM:"G'?FC D@U25O"N9Y.JHI+0\>':[WKL\>!Z(\ NJ=W-5
MGF5J>+M?7,/[1V ,2Y7O=A^P?'?M;O6[Z8ZZ;_WN^Y;K=K^+<MU5@_W:Y;K=
M59?K]NY7K%M7#5Y!L6[SH*_$43)7&[B' O" 8OV==8O5*0"%',***^[.0UR1
MQO A#*@>$=KU;Q"V@Q1RJGE)>&J3C&X3 QS1@$(E^[>!BHA?A812FX&OSB5B
M6@KL#"27N$_P6(0,0W57#/1D2\&?2 6?0 Q3HYZ? O"ZR3!(R!F#G5C#\A"#
M,8!7X!2=I*AW9!55,B=#/\?K%?ZI J#5U=42G063G[Q"E>&YTT!L;G/ON6O7
M$P+308/I*)'E5G <B''J3U(-!:[&5*<AG LNR<&%6717A.^+6F#9"NA993CY
M^![3"H41&AAEMHJ#A0!5<<$:#2 9P76RB7R.$<LV);IQ4E4&DDPT4UGP7 \%
M'0A8OA/GHG0^!<I> !GV9M)D0R.P*CK5[%J!4GV%%Q4X+X)SYE"*>UZ"V->!
M!>IO=CKO'"#\, UCFDS) #:5*,I8I- N-E5"( 6#E/D&4\C,K!7@*1T:M65>
MIII&D%4G4.)@2]$BT[M5)1A9>Z8$*]FB!&UW*@-5QD*^3)K7(K<IKE?8EES=
MP9)9J EF1D)_K/QAFG)GLNPJ]JKVQ3))DMD X?SC:."G- PJ_:#?!4&AQ&QA
M;Y,<B4)G)P#VPCXMZ)H[431" RDHELB("6BR"/5):6)<OHQ03C/+96;BSE"J
M"H)/KCB#K'^ @U#\3F&NFD8&:\,D)CT>2P)V0A\<G"4_DB< [K+ZUY9&T"+Y
M-2R@W\C..L>5M_?2/6//_@OL6+I07W(F(0SK"VK73.;YOBSW9$D3%+UC#EP-
M^:5[-9O R#JQU_5[+]U3;RQX6J<1#K9I><G46_A-YE%=>5F=B;TR<OCE'3YD
MW9V2O5]A/9^'D=;GR^K%&#<IX)>8Y'-Q2U2JCFN=OU@T9:.L7;,A)?,RWY$5
MT\12>JFM?I5#*5PJ97(?#.0K&<9[7L@Q&\DT-D'\\"K%4<CJ#UYOA+$VE8)J
MR659*L_ZB5GM&8OZ>K*4KF==0AI\4*K<,)24*]/$T369Y$HK.)B;*:,$[TF/
M*]QQ=8CS=/:@77PWLT?D/ET6P3B$ESIXK?P4KG (YP'5N:'X/AV4E)6FP%^_
M5GD**S[ _4;%*4IW 4;#GO0X!3W9IW(C!&,-C2[7PDHJ5;BE[G==Q-WD*EGX
M8T4LA([6(!N=%==A5X7(@C\8>=^MP-\M1DGD54Z+K&S#8'[_%JRF"@AT@1O"
M_<V!IB'),6ZSI>I5Z)@+#=)+*J4RTA86TC8G?I<,XX=GEP8YZ-/XS",?"X\L
M^VX5G%'M0@KZ4L)LTC"YF14P@"_J>/A\Z6$2YJ@"R S^@27P8B 7R57ORD91
M*)O+2+\&&\VV&(9C;G+'"HK2''#!%KO_[8WAI%=N,>YB"4-NZP)"[G?#DFUW
M:^Z3[XGAW:DH5A4G7(5F;-F?51"/"$=<1\W0P,B=<(/V-(_-<FR#BP8.*DA*
M"[/-A5U5@IZ2+?24\V5N[3J5:/ ?)B_<=7^#C9VJI#J<C DQ#=2C9/#+NI8L
MY!>.'3):@V:@'5V&7;E4S48IHBNFD4V\"1L.9<G,2+HHL21J5OM<E_BV>H%N
MBO6QG<IRO6B=+"O0BYYT_WJCJ.CBL/&X#2.<AQI,H"G&;,6,X$%+!:NBP:RF
MDBV*])<%V5HD(2/!YE?,I'*K7)XLR6K#&,SF4$;0Z12&[4;-J4AA4+59U8!>
MNJ/H!OMDTVU9(=FR.I8RV%D[O#A%AOT/XA;]%6Z[[3:WVC\7:M:5%"-?]S Y
M:4"\7%9GDWXH]BXI<I+Q:9K>5I=Y81U5715L035YO*'>G)Z[YW#G=;W$@9M@
M+-PW<?2)5^F$2HIY?)G4W'=IOUZS,E)R=RG9_VEN.I HJT[/E*,*/2M7BDZ&
MPJ@?>M7)'!DEHZ=JJ60)*<:96$,CR<",(<CF/=100^6=8"UYIU!+WBADZ69G
MW'"[%(+PJA<> \SM*O,_90NEW%)&27K'?KBU3$5Z61=#5ZFH966YW1L\7';_
M[=:!&@"*(T5>9906=ZRBGH71YIIN;M]GN+@);F$3"AD%E660YXQG=YGQ/%R9
MK^<2[X^VQ/N]"[F[A4+NSC<HY.Y6%')WYA5R7WD=][)*Q+0W9:GL3HGOJ2IY
M\-X/S/$?[C]B5V'KL;L*C?U:V5XO?.#[]P(6U-A2_]S#7%S=,@N"O+R*O <3
MR^QKX6(*B]O<'VQN&Y*3Q6JD5VL!>U\--R\PU$IQ CG\-29*8I2S/X#!D=I
M&)<H>SHJT]_65D'X2ZG *PU[VMV4-6&M@)4D4?$_XPS_/[L9--9 S36Q S)?
MHIG>Y+!.5U5U/E>O#H.#:+$H]$K%[<@(EG+-B8)Z0$8TY;*<4NASQ3X)GZ J
MLL_7$2=P_8T%A1=GD=;RXG8[*BT?GY3$5F$B*5=X'4,@816"IDJ1B7KU"!I
M#[=O.YCQJWR.0\H1>?#+-&#;HI&-F*%:8 ':L8=4,Z-UD4%FLBA<$"446U<Q
M'V/&Y5,K@=&0*:7ZMI<" D[!*'&<U!S;Q!CXGT3@CZ*HC[TI8H#&O905&/@4
M@[<XQHIRAVJ*8E4>",MN?0D8E[A*2LH%;5^9A>\<(Y:6USXAK_I<!;YZKUU+
M.5'N^J[,_P4]/THT$D,BEXT(V*D^-G.Z*X18VA&2QCGUN-KS##,$X.2Q(4SI
MOL3U2/%PE*!OU XW0RCO.KH$[Z50(/,M"Q"P]T*?$N<.>V$M>#$DCST4*HJ4
MH"DX>R],Z6V#JI+\NCAVX!]G=\B1T:91BAD5> XCPG'A\L(4]^BI16%,#3)H
MSS0Y2-,5UA"M89R@^KVFGX#[#&M&#Z9!W3'2#'(E*_+I<-^#C^C;>(@HL;P@
M\;=>5JB/Y=9L:N7N[J%2[Q#00X0!/O *'W-6,[Y,9C"$Q>_.;W EQKA&P&,R
MZ^K#1Y-T4KK)R 1'Q@0/IJL& NR6Q0 )N72=*?&N*1')M+\;2I'"'5O7*7Q&
M8Q1'F]G5S3N]II.12-ST6$5'-L=AZI&*T6:&QNS&#\F?&HJ9NLE,;R%2::GA
MA2UDY(!C>H\HUT*_69)DM2A>#,;1G\;L)LM/&,=NI%PDTX3L"]C4_"AD*SVJ
M(.P:-")/JJ8?\ASJ;[,DJN\P/N"'CXZH*D/SP*?>@%K _DQR<CLLZL#;[]X=
M6NZ;["$8D*$,$?B"UV,[<$&&R$M1(K9L_5Z8"5<Y]X;F$.8@.NKACGI8N[=@
M5.<Y+T+QZ5K>@:5X&# Y9 LH=^-955APX](=XL1(B;XL8IZV-T X@\2.^BHI
M%,VY)E*MZ49P-=,+,; &84-[6C-_HYZ\DD^JBU:.U'S,7),.>310@F-I@#2E
M%'6U^!HSN U6//%F2=7Z>)P="X\0+Z.,+0JVP,Q8X<6DD>)N2ID%=32!25,H
M"KINL]YHE-ON/2E7]#T,WLA9\M6L[(_5S/.VS[Q)<X#KJ49,-@L9>JOI O=1
MWV06H91[!A$ED9>(54QY%UE[IIS=N!CEDK%+EVYV,A+3ZHY+VAD,0*(EZ<?8
M"CJK&WFMI;R/7*(9^MNP3^V^)#(M>,-+S+LN$/DT@8O9ZZ(J2?B,Q@R-SS6X
M$AWK6:D)0YUB/3_KMN(9JMWEM2Z@M?AV;ER<H3^7/SHA2[ZES@V(Z4F/KHJ2
MG$118#=R+4"$#2B5G Y!GX.-F!++_"3&NZ9XA.)MR%A?N%%J[@7JIL.:IV\*
M0Z+UUI2^F B_A$8P2#/SD7X#&N'H/1C&<_Q>B78&@Z =7E$47E[/*F71E7:[
ML@BO5;I_YGAW#AZQ=Z?][-WY0N?-$T1<FP,H\V! :^=>G(8HOQIW<*:3%%6
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MS%/1,*BY\T$HJ;'JU89I5LV]D*7D3+<CY ^H/*09I>(-.7.*J%3U0===:VU
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MQ=A?5PJ EM^J789NK4$U%<5MZKH&J?</AUM&]1LZ3TZA+=\"I&OZ;7J5^$G
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M*7=Y.*=/)GO*.BN4OI?EMZ-XNH2/)_^>L+?Y%:APNVKV >QXT0VKGH3V37B
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M[IUN\_CX;W4S'#N'S<[&0[#J)J-L7;-F^&T?-'M'=;OMQ]CYM68P85+JMV9
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MMX$YY6D<#4NE,IL#_%/_^6M.D/G'/,C05G^%OEC.V;.Q#0SM6P G"@J=:6V
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M8%N79F:U6RH15,&YM##](6"_J+Q^$?*/OQ[YO28V/_C.D%]E W[) >RWOOX
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M1AA[9B XCDJS!B$WK:F)7SL>NTCO7S@,^WW_SP\@AP<1JF-";6_,$;VG6<M
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M2<*A=5X[1DKWL66:R6Z>!#,JPP;UB.MW?&GFHBOL\1^+(?8(8I"7@$2\=*.
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M.A:<K?DUZ>UX.2V-VLTV59TDSM$\5E.<V7E DR'2OL0@581Y$&1#VU> Z79
M%=KA,)G.V94&ZJ;5E\M3OY 5Z7OR4D85CU*(JO F-@FF>8%]RQ/>.;';_OI"
ME9!OE='?55Z^A]@@.M:3&"D7R6),<\[R_H15JI1M?%X1"A>'6Q3F*GY13=]2
M^D-M.'+<\X#0@/E*TO$IYB&9RO>:SS%V&H7<2":?D[WO"*99P5SZAM+FU#7
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MFQ8=]8V+P'II7PFP@;5KW18I9*R)2*+TQ;5KB+\)1$7H2XA>57C5!5 IZNF
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M(:2A99:SJMSP:TI*J"9(%-89@ :-CEKQH 2[C*HKZY@9&4&*&=!'2LK\C6M
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M$_&D4."\B+'9;B'K^')EXBPGG6)CPRI$N^',;F#/7G6^,:X5^27]@MJJP<"
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M)T$5? ( @KVMS P88U%>BQ:A";U1S[A$X35A4A2G&R^A;$&,[7731LQ;V*Z
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M@NA\Z 3F*P5H&B)(K2%N\#MBX-%3%!<:H5:@[]DR8;"-47?A>\.$AQ(%=<,
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M$IBW-<Z>7RH,W+3U^3F%&)/,%9RE\\:1$ 1T"C)88[-!!%X _P] DHA/327
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M7?V>OJ8<RW#5T=:3SAV+\)W-V8QB4Q'#[$73$OPFE0'QV/+Y,>BV6M3C<OP
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M#;1_S-:<F[$/Y$)*=0N\T[9>XE2"/]&TB3OAQT<N8_0DEH9X^V?KJ?B.HQ2
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M^4\^%K.%1D/!12H4A$#.P6#@AKML7+W/.ZZ?_,ERK[;_7W4MT;&REPT^G%3
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MV&.*1#GM2]* $@>2IA[ENEO1N0!@0AV%;,8@!*1-,Y:.30!K<A): @<L9?[
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M+1!Q>:4N H:FN%I=O=&R[;[IR_< 7/Q@R%JKNR0O%YJ*XOIBVA#GU'+7S*,
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M&$,JJ%.AXR@Y[@">'SU]G+R>V]_M;.XF?R7(Z$H-FD$US[!"!!*&G9E1JZ:
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M]I&1]$.@HU=  LT8RKIIC>&FD3Y"KL3N"$KA^-E2]-=^JN1EQJG5#4[:$<M
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MJAR2T9A+SPV=M(XCSHL/)!4:49Y*R'B7:,:[5+7!",@496=/P47#J?B #+<
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MOL 1,-9 9+=A#C".W/ $:'[7_PPF6B!?6S].(H@0W;>3:KNB7! "ISQ0&%2
M!\I/0%962E;@F)DSW!.YA1$#9*5E%51E9%1EI05D9%7E%%3EY8"M0'L7 .C!
ME$9:5DXF_OHVO!_L1^K^[_%2* !PGVJ'!PC7?>I=?M2V"&A;Z1H;@ZD5'(U
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MWUN6=,='1S;4F$2/C*ILZ@YZB]>MS*^?<_H13"Q#E:YA;E=^*M%<^E;%YWQ
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M'X3YS[4#MEPVJ"4B !6(AB/T@Q!(C-!.<U?X;EL_T)O='K4K'(KP0?B"U0+
M]C)_9>P_=R0HL#LB55.$NS,\Q/C4:5T]3W=$ ,BBGKR,GK*NGHJR@;2TCJRT
MO+Z*LK2TBHJROJZ!LKRLDOY?6V][FF8H5X2&H-Q?\<:ZNJ?0*#=/'[! SS/
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M_E857%>NSACG_ZGRUO+<'I>19P &A0[YK?Y6"/_?D(^GP+8FJCK#MQ:#AF"
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MG".JS//WLH&Y#3#'.%=Q/ 36/S[;V#.QF&Y>$3GW=OSHO:SW'R%1KF)VW3>
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MM%>;S4U,DFHNGEOPM[N?:OIP/N9:+-OK*5DY-_:[0GDI1</,"?NI$^1!QD3
M&$1 D6:@<U+Y1"Q.$FM$X"H.F^>-=A1?YG1W"+SN8.(0:+#^/ _-0LU>>\S
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M+FIP9U!+ 0(4 Q0    ( -JK=5M<8TM_JP,  ,T/   0              "
M >TR  !G;V8M,C R-3$Q,C@N>'-D4$L! A0#%     @ VJMU6U $JR,# P
M%1$  !0              ( !QC8  &=O9BTR,#(U,3$R.%]D968N>&UL4$L!
M A0#%     @ VJMU6_^OTK#^ @  !Q$  !0              ( !^SD  &=O
M9BTR,#(U,3$R.%]L86(N>&UL4$L! A0#%     @ VJMU6P4A_LFT @  _0P
M !0              ( !*ST  &=O9BTR,#(U,3$R.%]P<F4N>&UL4$L! A0#
M%     @ VJMU6V;1E%Q:G0$ /]H( !(              ( !$4   &=U9S@Y
M,S,Y+30R-&(U+FAT;5!+ 0(4 Q0    ( -JK=5LY% 01V$0  /YD   6
M          "  9O= 0!G=6=G96YH96EM;&]G;VYE=S(N:G!G4$L%!@     '
-  < P $  *<B @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>gug89339-424b5_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:GOF="http://guggenheiminvestments.com/20251128"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gof-20251128.xsd" xlink:type="simple"/>
    <context id="AsOf2025-11-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-06-012025-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_PrincipalRisksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:PrincipalRisksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:MarketDiscountAndPriceVolatilityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:DebtOverlayStrategyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:SyntheticAutocallableELNStrategyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-11-21" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-11-21" id="Fact000004">0001380936</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-11-21" id="xdx2ixbrl0010">424B5</dei:DocumentType>
    <dei:AmendmentFlag contextRef="AsOf2025-11-21" id="Fact000011">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="AsOf2025-11-21" id="Fact000012">GUGGENHEIM STRATEGIC OPPORTUNITIES FUND</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000013">The following table contains information about the costs and expenses
that the Common Shareholders will bear directly or indirectly. The table reflects the use of leverage in an amount equal to approximately
16% of the Fund&#x2019;s total managed assets, which reflects approximately the percentage of the Fund&#x2019;s total managed assets attributable
to leverage as of May 31, 2025 (audited), and shows Fund expenses as a percentage of net assets attributable to Common Shares. The table
and example below are based on the Fund&#x2019;s capital structure as of May 31, 2025 (audited) after giving effect to the anticipated
net proceeds of the Common Shares offered pursuant to this Prospectus Supplement and assuming the Fund incurs the estimated offering expenses
described below. The extent of the Fund&#x2019;s assets attributable to leverage following an offering, and the Fund&#x2019;s associated
expenses, are likely to vary (perhaps significantly) from these assumptions. The purpose of the table and the example below is to help
you understand the fees and expenses that you, as a Common Shareholder, would bear directly or indirectly. The following table should
not be considered a representation of the Fund&#x2019;s future expenses. Actual expenses may be greater or less than shown. The following
table shows estimated Fund expenses as a percentage of average net assets attributable to Common Shares, and not as a percentage of managed
assets. See &#x201c;Management of the Fund&#x201d; in the accompanying Prospectus.</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2025-11-21" id="Fact000015">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_z2y2e9RZ92pd" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%" summary="xdx: Disclosure - ShareholderTransactionExpenses"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 74%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder
    Transaction Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 26%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
    load (&lt;span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zBWckfJSG7ed"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecef--SalesLoadPercent_c20251121__20251121_fKDEp_z6UnYZnJq9zd"&gt;2.00%&lt;/span&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
    expenses borne by the Fund (as a percentage of offering price)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zpKblAGbcg4j"&gt;0.60%&lt;/span&gt;&lt;sup&gt;(1),(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-indent: 9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend
    Reinvestment Plan fees&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zOjvtsbiRmF3"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000016">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000017"
      unitRef="Ratio">0.0200</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000018"
      unitRef="Ratio">0.0060</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000019"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2025-11-21" id="Fact000021">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecef--AnnualExpensesTableTextBlock_zeXzA1pV4WUl" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%" summary="xdx: Disclosure - AnnualExpenses"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
    a Percentage of Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Annual
    Expenses &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Attributable
    to Common Shares&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; width: 66%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
    fees&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding: 0.75pt; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 33%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zemq8N7t62We"&gt;1.19%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Acquired
    fund fees and expenses&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____z586YeyWySFh"&gt;0.03%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zcXQCTRKuz81"&gt;0.89%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    expenses&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____z0hMJo7ICW95"&gt;0.10%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    annual expenses&lt;sup&gt;(9)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDQpICg5KQ_____ziPkcHmbW9ji"&gt;2.21%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000022"
      unitRef="Ratio">0.0119</cef:ManagementFeesPercent>
    <cef:AcquiredFundFeesAndExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000023"
      unitRef="Ratio">0.0003</cef:AcquiredFundFeesAndExpensesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000024"
      unitRef="Ratio">0.0089</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000025"
      unitRef="Ratio">0.0010</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000026"
      unitRef="Ratio">0.0221</cef:TotalAnnualExpensesPercent>
    <cef:OtherTransactionFeesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000029">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#x2019;s
registration statement and any offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under
such registration statement, to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#x2019;s
behalf in an amount up to the lesser of the Fund&#x2019;s actual offering costs or 0.60% of the total offering price of the Common
Shares sold in such offerings. Amounts in excess of 0.60% of the total offering price of shares sold pursuant to the registration statement
will not be subject to recoupment from the Fund. This agreement will be in effect for the life of the registration statement with respect
to all Common Shares sold pursuant to the registration statement and may only be terminated by the Board of Trustees of the Fund.</cef:OtherTransactionFeesNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000036">Other expenses are based on estimated amounts for the current fiscal year.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2025-11-21" id="Fact000039">
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"&gt;As required by relevant SEC regulations, the following Example
illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#x201c;Total annual expenses&#x201d;
of 2.21% of net assets attributable to Common Shares and (2) the sales load of $20 and estimated offering expenses of $6, and (3) a 5%
annual return*:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1
    Year &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3
    Years &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5
    Years &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; width: 10%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10
    Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Annual Expense Paid by Common Shareholders &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zKFxI2H6dFx3"&gt;$48&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zEtVxhsAwuB4"&gt;$93&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_z6C2CQU7Bgth"&gt;$141&lt;/span&gt;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3XobfVXfa05"&gt;$274&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000040"
      unitRef="USD">48</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000041"
      unitRef="USD">93</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000042"
      unitRef="USD">141</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000043"
      unitRef="USD">274</cef:ExpenseExampleYears1to10>
    <cef:SeniorSecuritiesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000045">For information about the Fund&#x2019;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;
Fund&#x2019;s most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Other Information (unaudited)&#x2014;Senior Securities&#x201d;
which is incorporated by reference herein. Information regarding the Fund&#x2019;s senior securities is also contained in the Financial
Highlights in the Fund&#x2019;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp;amp; Young LLP for the last five
fiscal years. The Fund&#x2019;s audited financial statements, including the report of Ernst &amp;amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#x2019;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.</cef:SeniorSecuritiesNoteTextBlock>
    <cef:SharePriceTableTextBlock contextRef="AsOf2025-11-21" id="Fact000047">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#x201c;NYSE&#x201d;) under the symbol &#x201c;GOF&#x201d;. The Fund&#x2019;s Common Shares commenced trading on the NYSE on July 27,
2007.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#x2019;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#x2019;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#x201c;Risks&#x2014;Market Discount
and Price Volatility Risk.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#x201c;Net Asset Value&#x201d; for information as to the determination of the Fund&#x2019;s net asset value.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_48F_ecef--HighestPriceOrBid_zO3IGU7U3t91" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_483_ecef--LowestPriceOrBid_zPkCalkajAZc" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_480_ecef--HighestPriceOrBidNav_zOgODog8Fyha" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_480_ecef--LowestPriceOrBidNav_zphdGz8OJ2R1" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_48C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zLmJtETNL4x4" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_486_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zq3jvEzA6Rxh" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Fiscal Quarter Ended&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Market Price&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;NAV per Common&lt;br/&gt;
Share on Date of Market&lt;br/&gt;
Price High and Low&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Premium/(Discount) on&lt;br/&gt;
Date of Market Price&lt;/b&gt;&lt;br/&gt;
&lt;b&gt;High and Low&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20250601__20250831_zGSPc6ziVBE1" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.38&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;31.30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20250301__20250531_z32gpkuCXGX" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;May 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$13.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.06&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;36.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;24.23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_413_20241201__20250228_zExVTB8B9ySf" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;February 28, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;33.14%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20240901__20241130_zXDzAhdrZVmf" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;November 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$16.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;33.69%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.06%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20240601__20240831_zSarr1dFl2V5" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.65&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.06&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;30.60%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;22.80%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20240301__20240531_zcXEJChhSsgf" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;May 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$13.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;21.53%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;16.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20231201__20240229_zBaztg4uzQw7" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;February 29, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;17.90%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;2.67%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_413_20230901__20231130_zVGetGPX04Nj" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.71&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;29.76%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;-4.70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20230601__20230831_zWTrLzH0iW75" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$16.28&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.51&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.48&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;30.45%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;26.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000048"
      unitRef="USDPShares">15.10</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000049"
      unitRef="USDPShares">14.55</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000050"
      unitRef="USDPShares">11.50</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000051"
      unitRef="USDPShares">11.38</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000052"
      unitRef="Ratio">0.3130</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000053"
      unitRef="Ratio">0.2786</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">15.91</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000055"
      unitRef="USDPShares">13.74</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000056"
      unitRef="USDPShares">11.67</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000057"
      unitRef="USDPShares">11.06</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000058"
      unitRef="Ratio">0.3633</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000059"
      unitRef="Ratio">0.2423</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">15.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000061"
      unitRef="USDPShares">15.00</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000062"
      unitRef="USDPShares">12.01</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000063"
      unitRef="USDPShares">11.74</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000064"
      unitRef="Ratio">0.3314</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000065"
      unitRef="Ratio">0.2777</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000066"
      unitRef="USDPShares">16.03</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000067"
      unitRef="USDPShares">15.26</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000068"
      unitRef="USDPShares">11.99</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000069"
      unitRef="USDPShares">12.01</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000070"
      unitRef="Ratio">0.3369</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000071"
      unitRef="Ratio">0.2706</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000072"
      unitRef="USDPShares">15.75</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000073"
      unitRef="USDPShares">14.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000074"
      unitRef="USDPShares">12.06</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000075"
      unitRef="USDPShares">11.93</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000076"
      unitRef="Ratio">0.3060</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000077"
      unitRef="Ratio">0.2280</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000078"
      unitRef="USDPShares">14.90</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000079"
      unitRef="USDPShares">13.80</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000080"
      unitRef="USDPShares">12.26</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000081"
      unitRef="USDPShares">11.82</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000082"
      unitRef="Ratio">0.2153</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000083"
      unitRef="Ratio">0.1675</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">14.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">12.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">12.12</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000087"
      unitRef="USDPShares">12.34</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000088"
      unitRef="Ratio">0.1790</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000089"
      unitRef="Ratio">0.0267</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">15.96</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">11.16</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">12.30</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000093"
      unitRef="USDPShares">11.71</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000094"
      unitRef="Ratio">0.2976</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000095"
      unitRef="Ratio">-0.0470</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">16.28</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">15.51</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">12.48</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000099"
      unitRef="USDPShares">12.30</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000100"
      unitRef="Ratio">0.3045</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000101"
      unitRef="Ratio">0.2610</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2025-11-21" id="Fact000129">Investment Objective&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Investment Objective,&#x201d; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Investment Policies&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Principal Investment Strategies and Portfolio
Composition&lt;/span&gt;&lt;span style="font-weight: normal"&gt;&#x2014;Investment Policies&lt;span style="color: windowtext"&gt;&#x201d; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#x2019;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#x2019;s and S&amp;amp;P&#x2019;s ratings.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal"&gt;&lt;span style="color: windowtext"&gt;Rating agencies, such as Moody&#x2019;s or S&amp;amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#x2019;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#x2019;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#x2019;s credit analysis than would be the case when
the Fund invests in rated securities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Principal Investment Strategies&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#x2019;s investment philosophy is predicated&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser&#x2019;s analysis of a fixed-income
security&#x2019;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#x2019;s
industry to determine the Sub-Adviser&#x2019;s internal judgment as to the security&#x2019;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#x2019;s judgment, may provide risk-adjusted outperformance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser&#x2019;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#x2019;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;In the Sub-Adviser&#x2019;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;The Sub-Adviser&#x2019;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;The Sub-Adviser&#x2019;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#x2019;s
desired sector exposures.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Additional Information About
the Fund&#x2019;s Principal Investment Strategies &amp;amp; Portfolio Composition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Income Securities Strategy. &lt;/i&gt;The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#x201c;Income
Securities&#x201d;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#x201c;high-yield&#x201d; or &#x201c;junk&#x201d;
bonds), which are considered speculative with respect to the issuer&#x2019;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Corporate bonds;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Loans and loan participations (including senior secured floating rate loans, &#x201c;second lien&#x201d; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#x201c;debtor-in-possession&#x201d; financings) (collectively, &#x201c;Loans&#x201d;);&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;U.S. government and agency securities and sovereign or supranational debt obligations;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Mezzanine and preferred securities; and&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Convertible securities.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Debt Overlay Strategy. &lt;/i&gt;As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#x201c;Debt
Overlay Basket&#x201d;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#x201c;Underlying Bond ETF&#x201d;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#x201c;Debt Overlay Strategy&#x201d;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#x201c;covered,&#x201d;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#x2019;s shares) in the amount necessary to meet the Fund&#x2019;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#x2019;s options counterparties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Common Equity Securities and Covered Call
Options Strategy. &lt;/i&gt;The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#x201c;Common Equity Securities&#x201d;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#x201c;naked&#x201d; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#x201c;OTC options&#x201d;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#x201c;ETFs&#x201d;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Synthetic Autocallable ELN Strategy.&lt;/i&gt; The
Fund may employ a synthetic autocallable equity linked-note (&#x201c;ELN&#x201d;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#x201c;Synthetic
Autocallable ELN Strategy&#x201d;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#x201c;Synthetic Autocallable Contracts&#x201d;),
and will typically not invest directly in autocallable ELNs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;amp;P 500 Index, Russell
2000 Index, or &#x201c;worst of&#x201d; two or more indices) (the &#x201c;Autocallable ELN Reference Index&#x201d;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#x201c;Maturity Barrier&#x201d; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#x201c;buyer&#x201d; and its counterparty as &#x201c;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#x2019;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#x2019;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#x201c;Coupon Payment&#x201d; and a &#x201c;Principal Payment&#x201d;) net of the financing amount owed
to the counterparty, subject to the following structure:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Autocall Zone&lt;/i&gt;. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#x201c;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Coupon Zone&lt;/i&gt;. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#x201c;Coupon Barrier&#x201d;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;No-Coupon Zone&lt;/i&gt;. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#x201c;Missed
Coupon&#x201d;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Full Principal Zone&lt;/i&gt;. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#x201c;Maturity Barrier&#x201d;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Reduced Principal Zone&lt;/i&gt;. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Real Property Asset Companies. &lt;/i&gt;The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#x201c;real property assets,&#x201d; such as real estate and the natural resources upon or within real estate (&#x201c;Real Property Asset
Companies&#x201d;). These Real Property Asset Companies include:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#x201c;REITs&#x201d;); and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Personal Property Asset Companies. &lt;/i&gt;The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#x201c;Personal Property Asset Companies&#x201d;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Private Securities. &lt;/i&gt;The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#x201c;Private Securities&#x201d;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;i&gt;Investment Funds. &lt;/i&gt;As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#x201c;Investment Funds&#x201d;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#x2019;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#x201c;hedge funds,&#x201d; or &#x201c;private equity funds&#x201d;
(including &#x201c;single asset continuation funds&#x201d;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Synthetic Investments. &lt;/i&gt;As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#x2019;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#x2019;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#x2019;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#x2019;s return could be adversely affected by an adverse tax ruling.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"&gt;&lt;b&gt;Portfolio Contents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;The Fund&#x2019;s investment portfolio consists
of investments in the following types of securities:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Corporate Bonds. &lt;/i&gt;Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#x2019;s
performance and perceptions of the corporation in the marketplace. &lt;i&gt;Investment Grade Bonds. &lt;/i&gt;The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#x201c;Investment Grade Bonds&#x201d;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#x2019;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Below-Investment Grade Bonds. &lt;/i&gt;The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#x201c;Below-Investment Grade Bonds&#x201d;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#x2019;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#x201c;debtor-in-possession&#x201d; or &#x201c;DIP&#x201d; financings
newly issued in connection with &#x201c;special situation&#x201d; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#x2019;s otherwise unencumbered assets or secured by a junior lien on the debtor&#x2019;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Distressed and Defaulted Securities. &lt;/i&gt;The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Structured Finance Investments. &lt;/i&gt;The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#x2019;s investment policies, structured finance investments
are not deemed to be &#x201c;private investment funds&#x201d; (as discussed below). Structured finance investments primarily include (among
others):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Mortgage-Related Securities&lt;/span&gt;. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt; return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Asset-Backed Securities&lt;/span&gt;. Asset-backed securities (&#x201c;ABS&#x201d;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Collateralized Debt Obligations&lt;/span&gt;. A collateralized debt
obligation (&#x201c;CDO&#x201d;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#x201c;CBO&#x201d;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#x201c;CLO&#x201d;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#x2019;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#x201c;equity&#x201d; tranche).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#x2019;s indenture. These provisions
are referred to as the &#x201c;priority of payments&#x201d; or the &#x201c;waterfall&#x201d; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#x2019;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Risk-Linked Securities&lt;/span&gt;. Risk-linked securities (&#x201c;RLS&#x201d;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#x201c;trigger event.&#x201d; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#x2019;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt; catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Senior Loans. &lt;/i&gt;Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#x201c;Prime Rate&#x201d;) and the certificate of deposit (&#x201c;CD&#x201d;) rate or
other base lending rates used by commercial lenders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Second Lien Loans. &lt;/i&gt;Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#x2019;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Subordinated Secured Loans. &lt;/i&gt;Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#x2019;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Unsecured Loans. &lt;/i&gt;Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#x2019;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Mezzanine Investments. &lt;/i&gt;The Fund may invest
in certain lower grade securities known as &#x201c;Mezzanine Investments,&#x201d; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Convertible Securities. &lt;/i&gt;Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#x2019;s capital structure and, therefore, generally entail
less risk than the corporation&#x2019;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#x2019;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Preferred Stocks. &lt;/i&gt;Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#x2019;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#x2019; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#x2019;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#x2019;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;U.S. Government Securities. &lt;/i&gt;The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#x201c;STRIPS&#x201d;), all of which are backed by the full faith and&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Foreign Securities. &lt;/i&gt;While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#x2019;s assets denominated in that currency and the Fund&#x2019;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#x201c;&#x2014;Derivative Transactions&#x2014;Foreign Currency Transactions.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Sovereign and Supranational Obligations. &lt;/i&gt;The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#x2019;s and S&amp;amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#x2019;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#x2019;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#x2019;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Common Stocks and Other Common Equity Securities.
&lt;/i&gt;The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Options. &lt;/i&gt;As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#x2019;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#x201c;strike&#x201d; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#x201c;American style&#x201d; options may be exercised at any time during the term of the option. Other options, known
as &#x201c;European style&#x201d; options, may be exercised only on the expiration date of the option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#x2019;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will follow a strategy known as &#x201c;covered
call option writing,&#x201d; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#x2019;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Except as disclosed further below and in connection
with the Fund&#x2019;s Debt Overlay Strategy, the Fund may not sell &#x201c;naked&#x201d; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#x201c;covered&#x201d;
if the Fund owns the security &lt;span style="background-color: white"&gt;or instrument&lt;/span&gt; underlying the call or has an absolute and immediate
right to acquire that security &lt;span style="background-color: white"&gt;or instrument&lt;/span&gt; without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#x2019;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#x2019;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#x201c;covered.&#x201d; A put option written by the Fund on a security is &#x201c;covered&#x201d;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#x2019;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#x2019;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Restricted and Illiquid Securities. &lt;/i&gt;The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#x201c;Securities Act&#x201d;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Government Sponsored Investment Programs&lt;/i&gt;.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Derivatives Transactions&lt;/i&gt;. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#x2019;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#x201c;VaR&#x201d;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#x201c;limited derivatives users&#x201d; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#x201c;limited derivatives user&#x201d; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#x2019;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#x201c;interested persons&#x201d; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#x2019;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#x2019;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#x2019;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#x201c;Delayed-Settlement Securities Provision&#x201d;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#x201c;derivatives transaction&#x201d; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Credit Derivatives. &lt;/i&gt;Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#x201c;buyer&#x201d; in a credit default swap contract
is obligated to pay the &#x201c;seller&#x201d; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#x201c;par value,&#x201d; of the reference obligation. Credit default swap transactions are either &#x201c;physical delivery&#x201d; settled
or &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#x201c;cash&#x201d; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Foreign Currency Transactions. &lt;/i&gt;The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although the Sub-Adviser seeks to use derivatives
to further the Fund&#x2019;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#x2019;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#x201c;Investment Objective and Policies&#x2014;Derivative Instruments&#x201d; in the Fund&#x2019;s SAI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Municipal Securities&lt;/i&gt;. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Temporary Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#x201c;temporary period&#x201d;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;amp;P
or Prime-1 by Moody&#x2019;s; and certificates of deposit and bankers&#x2019; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#x2019;s limitations on investments in other investment companies. See &#x201c;Investment Restrictions&#x201d; in
the Fund&#x2019;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#x201c;Management of
the Fund.&#x201d; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"&gt;&lt;b&gt;Certain Other Investment Practices&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;When Issued, Delayed Delivery Securities
and Forward Commitments&lt;/i&gt;. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#x201c;when
issued&#x201d; or &#x201c;delayed delivery&#x201d; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#x2019;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#x2019;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Loans of Portfolio Securities&lt;/i&gt;. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#x2019;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#x2019;s ability to sell the collateral and the Fund would suffer a
loss. See &#x201c;Investment Objective and Policies Loans of Portfolio Securities&#x201d; in the Fund&#x2019;s SAI.&lt;br/&gt;
&lt;br/&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Offsetting. &lt;/i&gt;In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#x201c;ISDA Master Agreement&#x201d;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Repurchase Agreements&lt;/i&gt;. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#x201c;Qualifying
Collateral&#x201d;) and meet certain liquidity standards generally may be deemed to be &#x201c;collateralized fully&#x201d; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#x201c;Alternative Collateral&#x201d;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#x201c;collateralized fully&#x201d; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#x201c;collateralized fully&#x201d; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#x2019;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#x2019;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#x2019;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Reverse Repurchase Agreements&lt;/i&gt;. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#x2019;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#x2019;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#x2019;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#x2019;s cash available for distribution.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Sleeve Structure.
&lt;/i&gt;The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#x2019;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#x2019;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Interest Rate &lt;span style="color: windowtext"&gt;Transactions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Please refer to the section of the &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Additional Information Regarding the Fund&#x2014;Interest Rate Transactions,&#x201d;
which is incorporated by reference herein, for a discussion of the Fund&#x2019;s use of interest rate transactions in connection with the
Fund&#x2019;s use of Financial Leverage.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Portfolio Turnover&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#x2019;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#x2019;s portfolio turnover rate was 25% and 30%, respectively.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Investment Restrictions&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#x201c;Investment Restrictions&#x201d;
in the SAI for a complete list of the fundamental investment policies of the Fund.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;&lt;span id="ProUseLeverage"&gt;&lt;/span&gt;Use of Leverage&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Use of Leverage,&#x201d; which is incorporated
by reference herein, for a discussion of the Fund&#x2019;s use of leverage.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"&gt;See the section of &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;the
Fund&#x2019;s most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Additional Information Regarding the Fund&#x2014;Principal Risks
of the Fund&#x2014;Financial Leverage and Leveraged Transactions Risk,&#x201d; which is incorporated by reference herein, for a discussion
of associated risks.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Borrowing&lt;/i&gt;. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#x2019;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#x2019;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#x2019;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#x2019;s portfolio in accordance with the Fund&#x2019;s investment objective and policies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#x2019;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#x2019;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#x2019;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#x2019;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#x2019;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#x2019;s audited and unaudited financial statements contained in the Fund&#x2019;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#x2019;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#x201c;closed-end
management investment company&#x201d; as defined in the 1940 Act.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#x2019;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#x2019;s
Financial Leverage, but the Fund&#x2019;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Reverse Repurchase Agreements and Dollar Roll
Transactions. &lt;/i&gt;The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#x2019;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#x2019;s asset coverage ratio or treat all such transactions as derivatives transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Preferred Shares.&lt;/i&gt; The Fund&#x2019;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#x2019;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#x2019;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#x2019;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.&lt;/p&gt;</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_PrincipalRisksMember"
      id="Fact000130">&lt;span style="font-weight: normal; text-transform: none"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; text-transform: none"&gt;entitled &#x201c;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; text-transform: none"&gt;Principal Risks of the Fund,&#x201d;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.&lt;/span&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember"
      id="Fact000133">&lt;b&gt;Market Discount and Price Volatility Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#x2019;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#x2019;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#x2019;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#x2019;s net asset value as a result of the Fund&#x2019;s
investment activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#x2019;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#x2019;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember"
      id="Fact000136">&lt;b&gt;Debt Overlay Strategy Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#x2019;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#x2019;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The call options sold as part of the Debt Overlay
Strategy are generally not &#x201c;covered.&#x201d; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#x2019;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#x201c;naked&#x201d; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#x201c;Risks Associated with the Fund&#x2019;s Covered Call Option Strategy and Put Options,&#x201d; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember"
      id="Fact000139">&lt;b&gt;Synthetic Autocallable ELN Strategy Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

    &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;


&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cef:RiskTextBlock>
    <cef:SecurityVotingRightsTextBlock contextRef="AsOf2025-11-21" id="Fact000140">&lt;i&gt;Voting
Rights&lt;/i&gt;. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#x2019;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#x2019;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#x2019;s Trustees, and will have certain other voting rights. See &#x201c;Anti-Takeover Provisions in the Fund&#x2019;s Governing
Documents.&#x201d;</cef:SecurityVotingRightsTextBlock>
    <cef:CapitalStockTableTextBlock contextRef="AsOf2025-11-21" id="Fact000142">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Capitalization&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Title of Class&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;br/&gt;
&lt;b&gt;Authorized&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount Held by the&lt;br/&gt;
Fund or for its Account&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount Outstanding&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span&gt;Common shares of beneficial interest, par value $0.01 per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;Unlimited&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span&gt;&lt;span id="xdx_90E_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zSfDQT4tjKYk"&gt;199,267,847&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:CapitalStockTableTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">199267847</cef:OutstandingSecurityAuthorizedShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000027" xlink:label="Footnote000027" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the estimated commission with respect to Common Shares being sold in this offering.
Cantor Fitzgerald will be entitled to compensation of up to 2.00% of the gross proceeds of the sale of any Common Shares under the Sales
Agreement, with the exact amount of such compensation to be mutually agreed upon by the Fund and Cantor Fitzgerald from time to time.
The Fund has assumed that Cantor Fitzgerald will receive a commission of 2.00% of the gross sale price of the Common Shares sold in this
offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000027"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000028" xlink:label="Footnote000028" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#x2019;s
registration statement and any offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under
such registration statement, to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#x2019;s
behalf in an amount up to the lesser of the Fund&#x2019;s actual offering costs or 0.60% of the total offering price of the Common
Shares sold in such offerings. Amounts in excess of 0.60% of the total offering price of shares sold pursuant to the registration statement
will not be subject to recoupment from the Fund. This agreement will be in effect for the life of the registration statement with respect
to all Common Shares sold pursuant to the registration statement and may only be terminated by the Board of Trustees of the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000028"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000027"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000030" xlink:label="Footnote000030" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">You will pay brokerage charges if you direct the Plan Agent to sell your Common Shares held
in a dividend reinvestment account. See &#x201c;Dividend Reinvestment Plan&#x201d; in the accompanying Prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000030"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000031" xlink:label="Footnote000031" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon average net assets attributable to Common Shares during the fiscal year ended
May 31, 2025, after giving effect to the anticipated net proceeds of all of the Common Shares offered by this Prospectus Supplement based
on an assumed price per share of $12.91 (the last reported sale price of the Fund&#x2019;s Common Shares on the NYSE as of November 14,
2025). The price per share of any sale of the Common Shares may be greater or less than the price assumed herein, depending on the market
price of the Common Shares at the time of any sale. There is no guarantee that there will be any sales of the Common Shares pursuant
to this Prospectus Supplement. The number of the Common Shares actually sold pursuant to this Prospectus Supplement may be less than
as assumed herein.</link:footnote>
        <link:footnote id="Footnote000032" xlink:label="Footnote000032" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to
1.00% of the Fund&#x2019;s average daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable
to the assets purchased with the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other
forms of debt (&#x201c;Borrowings&#x201d;) or reverse repurchase agreements, dollar rolls or similar transactions or through a combination
of the foregoing (collectively &#x201c;Financial Leverage&#x201d;), which means that Common Shareholders effectively bear the entire advisory
fee. Because the management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#x2019;s Managed Assets, the
management fee as a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial
Leverage. If Financial Leverage of more than 16% of the Fund&#x2019;s Managed Assets is used, the management fee shown would be higher.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000033" xlink:label="Footnote000033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the
Fund as an investor in other investment companies during the fiscal year ended May 31, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements.
Interest payments on borrowed funds is estimated based upon the Fund&#x2019;s outstanding Borrowings as of May 31, 2025, which included
Borrowings under the Fund&#x2019;s committed facility agreement in an amount equal to 2.08% of the Fund&#x2019;s Managed Assets, at an
average interest rate of 5.08%. Interest expense on reverse repurchase agreements is estimated based on the Fund&#x2019;s outstanding
reverse repurchase agreements as of May 31, 2025, which included leverage in the form of reverse repurchase agreements in an amount equal
to 13.77% of the Fund&#x2019;s Managed Assets, at a weighted average interest rate cost to the Fund of 4.52%. The  actual amount of interest payments and expenses borne by the Fund will vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other expenses are based on estimated amounts for the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnote id="Footnote000037" xlink:label="Footnote000037" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The total annual expenses in this fee table may not correlate to the expense
ratios in the Fund&#x2019;s financial highlights and financial statements because the financial highlights and financial statements reflect
only the operating expenses of the Fund and do not include Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly
by the Fund through its investments in certain underlying investment companies.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000040"
          xlink:label="Fact000040"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#x2019;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#x201c;Distributions&#x201d;
and &#x201c;Dividend Reinvestment Plan.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000040"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000042"
          xlink:label="Fact000042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000042"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
